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INTRODUCTION 
The science of medicine is of fundamental importance to human’s 
well being. The Siddha system of medicine flourished in the South India 
with the basic science of maintaining not only man’s physical well being 
but also mental well-being. It is pointless to determine the exact point of 
time to which the beginning of this system could be traced. They are 
eternal, 
“BEGIN WITH MAN AND END WITH HIM” 
The exponents of Siddha system of medicines are called Siddhars. 
They are the super human beings with high culture and intellectual 
abilities. They are the spiritual scientists who explored and explained the 
reality of nature and its relationship with man by their Siddhic powers.  
“NATURE CURE IS THE WAY OF LIFE” 
In Siddha system, thousands of raw drugs are used. These drugs 
are categorized into three groups, namely Herbal products, Metal-
Mineral products and Animal products. Siddhars predict more easily 
available simple herbal preparations. Siddhars described that in the 
treatment of any disease should be treated with the herbs. 
“VER PAARU THALAI PAARU MINJINAKKAL” 
“MELLA MELLA PARPACH CHENDHURAM PAARAE” 
According to this, the leaves of Vennochi (Vitex negundo) a simple 
and valuable herbal is taken as Aegomooligai prayogam (Single herbal 
treatment) for Eraippu Erumal as indicated exclusively in the literature 
Pathaartha Guna Vilakkam (Pg. no 478). 
“LIFE IS IN THE BREATH AND ONE HE WHO HALF BREATHES HALF LIVES” 
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Breathing, it is the vehicle for delivery of the vital life giving energy 
to our body cells being is the flywheel of our biological mechanism. It 
regulates controls and affects many of our body functions. 
Therefore when we breathe properly and fully. We have an 
opportunity to manipulate these functions. Breathing is an oxygen 
supplier and it is the sustainer of our life. 
All chronic pains, sufferings and diseases are caused due to lack of 
oxygen in the cell level, and one such suffering in the cell level Eraippu 
Erumal (Bronchial Asthma).  
WHO estimates that 235 million people currently suffer from 
Bronchial Asthma (BA). Asthma (BA) is a public health problem in all 
countries regardless of the level of development. Asthma is under – 
diagnosed and under – treated. It creates substantial burden to 
individuals and families and often restricts individuals activities for a 
lifetime. Many of the characters of the Bronchial asthma coincide with 
that of the Eraippu Erumal in respect of the cause of the disease 
wheezing, tightness of chest, dyspnoea, cough etc., Therefore, I have 
taken up a simple, cost effective drug Vennochi ilai for my dissertation 
work on allergic Bronchial asthma and aimed to explore the clinical 
efficacy and safety of the trial drug in patients with Bronchial Asthma.      
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AIM AND OBJECTIVES 
AIM: 
 Eraippu Erumal is one of the common respiratory disorders 
affecting millions of people all over the world due to environmental 
hazards. Today many synthetic drugs are available for Asthma, yet they 
produce many adverse reactions (leading to many complications to 
follow). Therefore the aim of this trial under the Siddha system is validate 
the safety and efficacy of the simple and cost effective Vennochi ilai 
Chooranam on Bronchial Asthma by pre- clinical & clinical trials. 
OBJECTIVES: 
The main objectives of the study are  
 To collect the literature evidence regarding the trial medicine. 
 To get proper authentication. 
 To prepare the trial medicine as per the text. 
 To standardize the trial drug. 
 To evaluate the anti-histaminic & anti-spasmodic activity of the 
trial drug pre-clinically. 
 To evaluate the therapeutical efficacy of the drug through open 
clinical trial.  
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REVIEW OF LITERATURE 
BOTANICAL ASPECT 
Vitexnegundo, Linn 
1
TAXONOMICAL CLASSIFICATION:- 
Kingdom - Plantae 
Sub Kingdom - Tracheobionta 
Super division - Spermatophyta 
Division - Magnoliophyta 
Class - Magnoliophyta 
Sub Class - Asteridae 
Order - Lamailes 
Family - Verbenaceae 
Sub Family - Vitcoideae 
Genus - Vitex 
Species - negundo 
2
VERNACULAR NAMES 
English - Five leaved Chaste tree 
Monk’s 
pepper -  
Substitute for black pepper in 
monasteries to maintain chastity 
Sanskrit - Nirgundi - Literally means which protects body from 
diseases. 
Hindi - SambhaluShivari, Nisinda 
Malayalam - Indranee, Karunacci, Vellanacchi 
Telugu - Vaavili, Tellavaariti 
Kannada - Lakkigida, Nekki, Nakkigida, Nakkilu 
                                                 
1 Pharmacology online - 1356, 1357 
2 Wealth of India – 522, Pharmacology online - 1356 - 1357 
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Bengali - Nisinda, Samalu 
Assam - Aslok, Pasutia, Aggla-Chita 
Gujarati - Nagod 
Punjab - Banna, Marwan, Shivari 
Marathi - Nirgundi 
Nepali - Simali 
Chinese - Huang jing 
Oriya - Beyguna, Begundia 
Irula name - Loki, neviladi 
GEOGRAPHICAL SOURCE: 
Native to tropical Eastern and Southern Africa and Asia.It grows 
throughout the greater part of India (In southern India, Bengal, Burma) 
ascending to an altitude of 1500m in the outer Himalayas. 
It is abundant along the banks of rivers in moist situations, open 
waste lands and near the deciduous forests. 
It is widely planted as a hedge plant along the roads and between 
the fields and is usually not browsed by cattle. 
HABIT:- 
A small slender tree. 
Large aromatic shrub. 
MORPHOLOGICAL CHARACTERS:- 
Bark - Thin, grey 
Leaves - 3-5 foliolate 
Leaflets - Lanceolate, entire or rarely crenate 
Terminal Leaflets - 5 to 10 cm X 1.6 to 3.2 cm. 
Lateral Leaflets - Smaller, all nearly glabrous above, white 
tomentose beneath. 
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Inflorescence - Bluish purple, small in Peduncled cymes, 
forming large terminal often compound 
pyramidal panicles. 
Drupe - Globose black when ripe 5-6 mm in 
diameter invested at the base with 
enlarged calyx. 
 The rate of growth of shrub is moderate with 7 rings per 2.5 cm of 
radius giving a mean annual girth increment of 2.3 cm. 
MEDICINAL USES:- 
Almost all its parts are employed but the leaves and roots are 
more important. The dried leaves comprise the drug and have the 
general characters of fresh leaves and are dark green above and greyish 
tomentosa below. 
LEAVES:- 
 The Leaves are aromatic and are considered as tonic and 
vermifuge. 
 A decoction of leaves with the addition of long pepper (Piper 
longum) is given in catarrhal fever with heaviness of the head. 
 The leaves are also smoked for the relief of head ache and catarrh. 
 The leaves possess discutient properties and are reported to be 
applied to rheumatic swellings of joints, in sprains. 
 A decoction of leaves and the vapours are employed in baths for 
the treatment of rheumatic affections. 
 The juice of leaves is said to be used for the treatment of foetid 
discharges. 
 An ointment made from the juice is applied as hair tonic. 
 The drug is also reported to poses tranquilizing effects. 
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 A decoction of leaves was found to prevent the development of 
swelling of joints. 
 The leaves are reported to possess insecticidal properties and are 
laid over stored grain to ward off insects. 
 The extract of the leaves and twigs showed anti - bacterial activity 
against Micrococcus pyogens, aureus and Escherichia coli. 
 An extract of the leaves showed anti - cancer activity against 
Ehrlich ascites tumor cells. 
ROOT:- 
 The roots are hard and tough and break with an irregular fracture. 
 The root possess tonic, febrifugal, expectorant and diuretic 
properties. 
 They are used in dyspepsia and rheumatism and also for boils. 
 The powdered root is prescribed as an anthelminthic and as a 
demulcent in dysentery. It is also given for piles. 
FLOWERS:- 
The flowers are astringent and are used in fever, diarrhea, liver 
complaints. 
FRUITS:- 
 The fruits are prescribed in headache, catarrh and watery eyes. 
 When dried, they are considered vermifuge. They are much valued 
medicinally in China. 
 An aqueous extract of the fruit was found to have good analgesic 
action when tested on rats by analgesiometricmethod. 
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3
PHYTOCHEMICAL PROFILE 
GLUCOSIDES:- 
 Leutolin - 7 - glucoside (C21 H20 O11). 
 α - D - glucoside of tetrahydroxymonomethoxy flavones (C22 
H24 O12).  
IRIDOID GLYCOSIDES:- 
 2 - p - hydroxybenzoylmussaenosidic acid 
 6’ - p - hydroxyl mussaenosidic acid 
 Negundoside - C23 H28 O12 
 Nishindaside - C15 H24 O9 
 Agnuside - C22 H26 O11 
 Lagundinin. 
 Acubin. 
FLAVONES GLYCOSIDE :- 
 4, 5, 7 trihydroxy - 3’ - O - β - D glucuronic - acid - 6” methyl ester - 
Vitexoside 
FLAVONES:- 
 5 - O - desmethylnobiletin 
 Gardenin - A 
 Gardenin - B 
 Corymbosin 
ISOMERIC FLAVONES:- 
 5, 3 - dihydroxy - 7, 8, 4 trimethoxyflavanone. 
 5, 3 - dihydroxy - 6, 7, 4 trimethoxyflavanone. 
  
                                                 
3
 Wealth of India, Pharmacology online - 1359 to 1373. 
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STILBENE DERIVATIVE:- 
 4, 4 dimethoxytranstilbene. 
Other phytochemicals are α-elemene, δ-elemene, β-elemene, β-
eudesmol, camphor, camphene, careen, 1,8 - cineol, α-phellandrene, β-
phellandrene, nerolidolBorynl acetate. 
The constituent of the oil werealdehyde and ketone, phenolic 
derivatives and cineol. 
The leaves contain 2 alkaloids Nishindine - C15 H21 O N and 
Hydrocotylene - C22 H33 O8 N. Also contains Glucononitol - C9 H20 O9, 
Tannic acid, Casticin, Orientin, Isoorientin, Vitamin C (150 mg/ 100 g 
fresh weight basis) and carotene (3500 mg / 100 g fresh weight basis) 
4
Plant Constituents Water extract Result 
Test/Reagents Colour 
Alkaloids - Dragendorff’s reagent Yellow Present 
Tannins- Ferric Chloride Solution Greenish black Present 
Sterols- Concentrated Sulphuric acid Red ring Present 
Glycosides -Libermann’s – Burchard reagent Pink Colour Present 
Flavonoids- Ethanolic extract + Magnesium 
ribbonConcentrated HCl 
OrangeColour Present 
Resins- concentrated Nitric acid No colour 
change 
Absent 
Carbohydrates- Molisch’s reagent Pinkish ring Present 
Test for polysaccharides- Anthrone test Green ring Present 
Protein- Pottasium Iodide + Iodine solution Yellow colour Present 
 
                                                 
4 International Journal of Advanced biological research Vol -2 
10 
 
    GUNAPADAM ASPECT 
nehr;rp;;;  - Vitex negundo, Linn 
5NtW ngah;;;; 
 ,e;jpu #hpak;  
 epj;jpy;  
 epHFz;b 
 neh;f;Fz;b 
 rpe;Jk rpe;Jthuk;  
 nehr;rpAl Ngh; jidNa EUff; NfS 
  neha;jhd rpe;J thrpkpw; jhFk; 
 Gf;fpah; ehrpe;J fr;rpe;J gTufkhk; 
  G+Hj;jpahk; ePyG\;gK NkahFk;  
 ePf;fpa #fpr;rNfh epw;Fz;bgk; 
  ePy fe;jfKNk Nrghq;fhdp 
 thr;rpakhk; G+j NfrpfkhFk; 
  kEtdjh nehr;rpAl ehkkhNk.  
,J ,e;jpah KOtJk; tsUfpd;w xU rpwpa kuk;.  
 
6rpe;Jtfk;> jphpGunkhpj;jhd;> ePHf;Fd;W.  
7,e;jpuhzp> thjklf;fp> G+jNjrp.  
8rpe;J> fly;> nehr;rpy;> rpe;Jthhp> nehr;rp. 
tiffs; :;;; -  
 fU nehr;rp 
 ePH nehr;rp 
 ntz; nehr;rp 
ntz; nehr;rp vq;Fk; fpilf;ff; $baJ. 
fUnehr;rp fpilg;gJ mhpJ.  
 
                                                 
5 Nghfh; epfz;L 1200 
6 jl;rehadhh; itj;jpa ml;ltiz - gf;fk; 28> 29> 34 
7 gR%y mfuhjp 
8 rhk;grptk; gps;is mfuhjp ghfk; - III - gf;fk; 2162 & 2163 
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gad;gLk; cWg;Gfs; :; ; ; ;; ; ; ;; ; ; ; - 
,iy> G+> Nth;> gl;il 
Organoleptic Characters    
Rit (Taste)   - ifg;G> Jth;g;G> fhh;g;G  
 jd;ik (Potency)   - ntg;gk;  
 gphpT (Bio-transformation) - fhh;g;G  
 
nra;if :;;; - 
 nghJ :- 
   Alterative (clw;Nww;wp) 
   Vermifuge (GOtfw;wp ) 
Nth; :;;; - 
   Febrifuge (ntg;gfw;wp) 
   Expectorant  (Nfhioafw;wp) 
   Diuretic (rpWePH ngUf;fp)  
G+ :- 
   Astringent  (Jth;g;gp) 
   Refrigerant (Fsph;r;rpAz;lhf;fp) 
 
9ntz; nehr;rp ,iyapd; nghJ Fzk; :; ; ; ;; ; ; ;; ; ; ; - 
ehre; jUthj ehrpg;gpzp aoy;R 
thre; jrdTU td;Nwhlq; - fhrkw  
Yr;rp ailia AiwNehA nkd;gLNkh  
nehr;rp ailia Ety;.  
ntz; nehr;rp ,iyapdhy; kfhthjk> gPeprk;> 
Ruk;>,iug;G>;;; je;jtyp> jphpNjhlk;> ,Uky;> ePNuw;wk; fg Fw;wj;jpdhy; 
jiyapy; Vw;gLk; Neha;fs; ahtw;iwAk; Fzg;gLj;Jk;.  
nra;if :;;; - 
Ntjdhrhe;jpdp> %j;jputh;j;jfhhp> fpUkpehrpdp> 
UJtHj;jdfhhp>tpahjNgjfhhp 
                                                 
9 gjhh;j;j Fz tpsf;fk; - 478  
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tof;F Kiwfs;; ;; ;; ; :- 
1. nehr;rp> kpsF> G+z;L> ,ytq;fk; NrHj;J rpwpjstha; nkd;W 
jpd;d ,iug;G Nehapd; vOr;rp mlq;Fk;.  
2. ,iyiar; Rf;Fld; NrHj;jiuj;J fd;dg;nghwpfspy; gw;wplj; 
jiytyp jPUk;. 
3. nehr;rp ,iyrhWk;> gRePUk; 24 fpuhk; msthf NrHj;J jpdKk; 
fhiyapy; nfhLf;f ,lg;ghl;Buy; tPf;fk; FiwAk;.  
4. nte;ePhpy; ,iyiag;; Nghl;L Ntf itj;J ePuhtp gpbf;f tpah;it 
cz;lhfp Ruk; jzpAk;.  tspf;Fw;wj;jhy; cz;lhd cly;typ 
KjypadTk; Nghk;.  
5. ,jd; ,iyia frf;fp jiyapy; itj;J fl;l jiyg;ghuk; Nghk;.  
6. ,e;j ,iyr; rhw;Wld; rpwpJ kpsF $l;b nkOF Nghy; miuj;J 
rpW Rz;ilf;fha;g; gpukhzk; jpdk; 3 Ntis nfhLg;gJz;L. 
,jdhy; Ruk; Njftyp> m[Puzk;> iffhy; gpbg;G Nghk;.  
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,iug;gpUky; jPh;f;Fk;; ; P ; ; ;; ; P ; ; ;; ; P ; ; ; 
10nehr;rp NrUk; kUe;Jfs;:; ; ; ;; ; ; ;; ; ; ;  
 Rthrfhrf; Fspif;;;  
,Ujhq; nfe;jfk;……. 
xUik nehr;rp ;…….  
……. Rthr ktj;ijnay;yhk;……. 
msT  -  gapwsT 
mDghdk;  -  Njd;> nea;> rh;f;fiu  
jPUk; Neha; -  <is> ,Uky;> Rthrk; 
 
11Rthrfhr `uk;;;; 
fz;L guq;fp apUrq;F ……. 
……. Nkhjf ndhr;rpy; …….  
jPUk; Neha; - Rthrfhrk;> ,iug;G> ,Uky;> ,isg;G  
 
12Vkrz;lkhUjf; FNlhhp; ;; ;; ;  
nehr;rpNahL rpj;jhKl;b NguhKl;b ……. 
Nehf;fhpa FbNahl;b 
msT  -  cSe;jsT 1 khj;jpiu  jf;f mDghdj;Jld; 
jPUk; Neha; -  <is> raNeha;> fhrk;> ke;jhufhrk; 
 
13<is Rthrj;jpw;F; ;; ;; ;  
……. Nrj;Jkq;f spisg;G %r;Nr 
ahklh Njhil nehr;rpy; …….  
jPUk; Neha;  -  rak;> ,Uky; jPUk;   
msT   -  xUtuhfndil  
mDghdk;   -  Njd; 
  
                                                 
10 Njiuah; itj;jpak; - 1000 gf;fk; 176 
11 Neha;fSf;F rpj;j ghpfhuk; gf;fk; 167  
12 gpuk;kKdp itj;jpa #j;jpuk; ghfk; 1 - gf;fk; 136 
13 gpuk;kKdp itj;jpa #j;jpuk; ghfk; II - gf;fk; 51 
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 
14<is ,Uky; jPu nea; ; P ;; P ;; P ;  
ghl;LlNd gr;ir nehr;rp rhW thq;fp 
ghpthd rPiyapNy Jitj;J thl;b 
jPUk; Neha;  -  Rthrk;> ,Uky;  
 
15nehr;rpj; ijyk;; ; ;; ; ;; ; ; 
rPjRur khh;ftQ; rq;F rhwil ............ 
msT   -  fhrsT  
jPUk; Neha;  -  fhrNeha;> rak;  
 
16<is ,UkYf;F  Gif ;;;  
msT   -  Kf;foQ;R  
jPUk; Neha;  -  <is 
 
17fhr Rthr fpUjk;;;; 
jPUk; Neha;  -  RthrfhrKk;> ,Uky;> ,uj;j gpj;jk;  
 
nehr;rp NrUk; gpw kUe;Jfs; ; ; ; ;; ; ; ;; ; ; ;  
 
18raNuhfj;Jf;Fk;> fhr; ; ;; ; ;; ; ; \hzhgrhjp Nyfpak; ;;;  
msT  -  nfhl;ilg; ghf;fsT  
jPUk; Neha; -  11 tif raNuhfk;  
 
19kfhf;Nfhlh #hpf; Fspif; ;; ;; ;  
Xq;F ntz; nzhr;rpiyr; rhh;…… 
XNfNfh Jk;ig…… 
jPUk; Neha;  -  ,Uky; fhJ vOr;rp 
msT   -  rpWgapwsT  
mDghdk;   -  Jk;ig urk; 
  
                                                 
14 gpuk;kKdp itj;jpa #j;jpuk; ghfk; II - gf;fk; 63 
15 rpj;j itj;jpaj; jpul;L gf;fk; 279 
16 mDgt itj;jpa Kiwfs; - gf;fk; 63 
17 mDgt itj;jpa Kiwfs;  - gf;fk; 33 
18 mDgt itj;jpaj;jpul;L - gf;fk; 74  
19 gpuk;kKdp itj;jpa #j;jpuk; ghfk; II - gf;fk; 132 
15 
 
 
20Kf;$l;L ijyk; ; ; ;; ; ;; ; ; - KOFtjw;F ;;;  
ehd;F ehl;fSf;F xU Kiw 
jPUk; Neha;  -  4448 tpahjpfSk; jPUk; 
msT   -  Fd;wp msT (1 - 4 khj;jpiu) 
mDghdk;   -  Jsrp rhW> fhb 
 
21fUthio khj;jpiu;;;  
jPUk; Neha;  -  ,Uky;> gpj;jthj Ruk; 
 
22tPugj;jpud; khj;jpiuP ; ; ;P ; ; ;P ; ; ;  
jPUk; Neha; -  fgk;> ,Uky; 
msT  -  kpsfsT 
mDghdk;  -  go ,Q;rp rhW> Rf;F FbePH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
20 gpuk;kKdp itj;jpa #j;jpuk; ghfk; I - gf;fk; 23 
21 rpj;j kUj;Jtr; Rlh; - gf;fk; 329  
22 rpj;j kUj;Jtr; Rlh;  - gf;fk; 358 
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23mDghdk; ;;; - fha;e;jhwpa ePH; ; P; ; P; ; P  
 
‘fha;e;jeP Uz;Zq;fhy; fz;nrtpNeha; #iyFd;ke;  
Njha;e;jRu Ntfe; njhliuAk; - gha;e;jlUk;  
thjj;jpd; Nfhgkpit khWnkd; yhjpaUs; 
Ntjj;jpd; thf;fpakhk; tps;”.  
 
“fha;e;jhw itj;j ePH fl;Loiy tpf;fnyhL  
 tha;jtop rhugpj;j khw;Wq;fhz; - Nrh;e;J tU  
%Hr;ir tp~k;the;jp Kd;kaf;f Nkfkjp 
 A+h;r;rpjKj; Njh~k; Nghf;Fk;”.  
tpsf;fk; ; ;; ;; ; : 
fha;e;jhwpa nte;ePH> coiy Neha;> tpf;fy;> Ngjpahw;fpisj;j gpj;j 
Nfhgk;> %Hr;ir> rpy;tp~k;> the;jp> kaf;fk;> Rf;fpyNkfk;> jphpNjhlk;> 
fz;Nzha;> nrtpf;Fj;jy;> #iy> Fd;kk;> RuNtfk;> Nfhio> 
thjhjpf;fk; ,itfisj; jPHf;Fk;.  
  
                                                 
23
 gjhh;j;j Fz rpe;jhkzp> Nehapy;yh newp> gf;fk; - 162  
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SIDDHA ASPECT OF THE DISEASE 
,iug;G Neha;; ;; ;; ; 
 
24NtW ngah;fs; : ,Og;G Neha;> Rthrfhrk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
,ay; :;;;  
• ,d;d tifnad;W Fwpg;gplf; $lhjgb xU fhuzKkpd;wp 
khh;ig ,Wf;fpaJ Nghd;w Ntjidj; jUk;. (Tightness of chest) 
• %r;ir ntspaplTk;> cs; ,Of;fTk; Kbahky; jpzwr; nra;jy; 
• ntspahFk; %r;R kpFe;j rpukj;Jld; ntspahjy; (Shortness of 
breath) 
• Foy;> aho;> tPiz Nghd;w thj;jpaq;fisg; Nghy; xyp (Wheezing) 
• ,Uky;> fhzy;> Nfhio ntspahjy; ,y;iy. (Cough) 
25Neha; tUk; top :; ;; ;; ;  
• Iaj;ij kpFjpg;gLj;Jk; czT tiffshYk; 
• Gy;> G+z;L> mhprp> Nfo;tuF Kjypaitfspd; RizahYk; 
• jdf;F xt;thj ehw;wg; nghUl;fis Kfh;tjhYk; ,e;Neha; 
gpwf;Fk;. 
‘ fhy;ngUf; FzT nghUs; jz;zPh; khwy; 
fUjpUky; kpfy;the;jp Fsph;e;j fhw;W 
khy;nra;J ehs;NjhWk; tWj;Jq; fha;r;ry; 
ke;jd Kaph;epiyap ybfs; jhf;fy; 
Vy;rPj Ngjptpl ghz;L Giffs; 
,yfpa ney; yhjpkzpr; RizAl; nry;yy; 
Nky;topapw; rpythpD kpiug;ghk; NehA 
NkTnkd Kdptuh;fs; tpsk;gpdhNu” 
,jdhy;  
 ifg;G> fhh;g;G RitAs;s fpoq;F nghUl;fis cz;gjhYk;> 
 mjprPjs ePiu mUe;jyhYk; 
 mUtUg;ghfpa Gifia Rthrpg;gjhYk; 
,e;Neha; tUnkd;W $wg;gl;Ls;sJ. 
                                                 
24 rpj;j kUj;Jtk; -241  
25 ifnaOj;J gpujp 
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26Nehapd; Kw;Fwp Fzq;fs; :; ; ; ;; ; ; ;; ; ; ;  
gd;dhl;fs; Jd;gg;gl;lth;fs; Neha; tUKd; ,jd; Fwpia 
mwpthh;fs;.  tuf;$ba Nehapd; td;ikiaAk;> mstpLthh;fs;.  
Mfhj czTk;> Mfhj fhw;wpd; kzKk; gl;lTld; %f;fpy; ePh;gha;jy;> 
Jk;kYz;lhjy;> khh;G Nehjy;> khh;ig ,Wf;ff; fl;baJ NghypUj;jy;> 
Ntjid> ,aw;if %r;R jl;Lg;gly;> tpyhg;gf;fk; typj;J %r;Rj; 
jpzwy;> tapWg;gy;> cly; tpah;j;jy; Nghd;w FwpFzq;fs; cz;lhFk;. 
27‘ khh;gpy; tpyhtpuz;by; kz;ZkpU nehpapy; 
Nrh;e;J typj;jy; jpzwy; - jhh;%r;R 
cg;gy; tapw;wp YWtJNt Kw;Fwpahr; 
nrg;gpiug;G Nehaf;fpjidj; Njh;” 
28nghJ Fwp Fzq;fs; :; ;; ;; ;  
‘fl;bNa Nfhio ,UkNt tPo;e;J 
fr;nrtp rPWjy; Nghy; 
Kl;bNa %r;R td;ikaha;r; nrUkp 
%f;foy; va;jpNa Alyk; 
tw;wpNa nkype;Jz; zhtiu ePUk; 
tul;rP uzkpF tpah;it 
fl;bNghy; tapW %jpb ypiug;gh 
kpUknyd; NwhJth; fhNz”. 
 
29‘ td;ikaha;f; Nfhiofl;b ,Ukp tPOk; 
khehfk; NghyNt thq;FQ; Rthrk; 
jpz;ikaha;r; nrUkYz;lh kbf;f bf;FQ; 
rPuz kpyhkNy tapW %Jk; 
ed;ikaha; ehrpaJ jzy;Ngh yhFk; 
eype;Jlk;G tw;wp tUq; FuYq; fk;Kk; 
cz;ikah Az;zhf; fpY}Wq; Nfzp 
Aoe;JNk Rthrfh rj;jp ndhg;Ng”. 
 
 
 
 
 
 
                                                 
26 rpj;j kUj;jthq;f RUf;fk;  
27 A+fp itj;jpa rpe;jhkzp  
28 A+fp itj;jpa rpe;jhkzp 
29 A+fp itj;jpa rpe;jhkzp 
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 ,e;Nehapy; %f;fpypUe;J ntspahFk; fhw;W mdy; tPRk;> 
njhz;il fl;b %r;R vyp $r;rpLjy; Nghy; xypf;Fk;.  khh;gpy; Nfhio 
fl;b ,UknyOk;.  Neha; Kjphpd; ntspahFk; %r;R ey;y ghk;G rPWtJ 
Nghy; xypf;Fk;.  czT nrhpahJ. tapWg;Gk;. 
30Neha; vz; :; ;; ;; ;  
 tsp ,iug;G 
 Ia ,iug;G 
 Iatsp ,iug;G 
 Kf;Fw;w ,iug;G 
 Nky;Nehf;F ,iug;G 
31Kf;Fw;w Kjypa NtWghLfs; :; ; ;; ; ;; ; ; - 
 
‘ tspAk; IaKk; Nrh;e;j kpFjpNa fhuzk; 
cw;wpLk; Iaehb 
Xq;fpNa Jbj;J epd;why; 
gw;wpLk;; kpUk; yPis 
gjwpNa ,iug;Gz;lhf;fp 
nkj;jNt Nfhio thA kpFe;jpLk; 
32ehbeil :- 
“fgj;jpidad;wp fhrRthrk; fhzhJ” 
Ia ehb kpFjpahYk;> tsp Ia njhe;jj;jhYk;> thAthy; 
J}z;lg;gl;l gpj;jkpFjpahYk;> Ia gpj;j njhe;jj;jhYk; ,iug;G Neha; 
cz;lhFk;. 
33vr;rpy; :; ;; ;; ;  
 Nfhio my;yJ rspahdJ Eiuj;Jk; mstpy; kpFe;Jk;> 
gStw;Wk; ,Ug;gpd; tspf;Fw;wj;jpdhy; te;jJ vdyhk;. 
 fWj;Jf; nfl;bg;gl;L> Gyhy; kzj;Jld; fbdkhfTk;> ntSj;jr; 
rPo; fye;jJ NghYk; kQ;rs; epwj;JlDk; fhzpd; 
Iaf;Fw;wj;jpdhy; te;jJ vdyhk;. 
  
                                                 
30 rpj;j kUthq;fr; RUf;fk; gf;fk; 117 
31 A+fp itj;jpa rpe;jhkzp 
32 Neha;ehly; Neha; Kjy; ehly; ghfk; 1 gf;fk; 216 
33 Neha;ehly; Neha; Kjy; ehly; jpul;L ghfk; 1 gf;fk; 115 
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ePh;f;Fwp :P ; ;P ; ;P ; ;  
“mwntsph;g;gpYk; rspiag; Nghy; tpopdJ 
kwtd; mjp nfhjpg;ghy; tUtdNk”  
ePh; kpfTk; ntSj;jhYk;> mjpy; rspiag; Nghy tpOe;jhYk;> me;j 
ePh; Iaj;jpd; kpFe;j nfhjpg;ghy; tUfpd;w ePuhFk;. 
“tpe;Jitg; Nghd;w ePh; tpoy; fg NehiaAk; 
ge;jpj;j re;jp ghjj;ijAe; jUk;”  
vd;gjdhy; ,e;jphpaj;ijg; Nghd;w ePuhdJ> td;ikAs;s fg NehiaAk; 
(Nfhio Neha;fshfpa rak;> Rthrk;> fhrk; Kjypait) cWjpAs;s rd;dp 
NehiaAk; jUk;. 
nea;f;Fwp :; ;; ;; ;  
“Kj;njhj;J epw;fpd; nkhoptnjd; fgNk” 
vz;nza;j;Jsp tpl;lJ tpl;lthNw rpwpJk; guthky; Kj;Jg;Nghy; 
epw;Fkhdhy; me;ePh; Ia Nehiaf; fhl;LtjhFk;. 
34epwf;Fwp :;;;  
“epykpF fgNk Mfpd; 
epiwJiu Nghd;wpUf;Fk; 
,yFkk; %j;jpuj;jpy; 
vz;nza;ia tpl;Lg; ghh;f;fpy; 
rhw;wpd fgj;jp Df;Fr; 
ry;yilf; fz;Nghw; fhZk; 
Ntw;nwhU Jspaha; epd;why; 
tpUjhFQ; rhj;jpae;jhd; 
Mw;wpNa nky;yg; gutpd; 
mJ Rf rhj;jpae; jhd;”  
35Nrj;Jk NfhgeP; P; P; Ph; epwk; :; ;; ;; ;  
“tsKiw nts;isahfp tw;wp ePh; FWfp epd;why; 
njspTwr; Nrj;Jkj;jpd; nra;if nad;Wiwf;Fk; 
Fsph; ikapdhNy nts;isahfpa Fzkhnkd;Wk; 
,sF gr;rpuj;je;jd;dh ypWfpd njd;WQ; nrhy;Ny”. 
 
                                                 
34 Neha;ehly; Neha; Kjy; ehly; ghfk; 1  
35 Neha;ehly; Neha; Kjy; ehly; ghfk; 1  
21 
 
“ePh; ntz;ik epwk; nghUe;jp mstpYk; Fiwe;jpUe;jhy; mJ  
Nrj;Jkj;jhYz;lhd FzkhFk;”. 
rPjkpFjp nea;f;Fwp :P ; ;P ; ;P ; ; - 
ty;yey; nyz;nza; Jdpah thu Neha; Kjy; ehlyj;jpy; ... 
nrhy;yUq; Fsph;ik kPwpj; Njh\Kw; nwa;J nkd;Wk; 
ePhpy; tpl;l vz;nza;j; JspahdJ nefpohky; 
mg;gbNaapUe;jhy;> rPjkpFjpaha; cz;lhdnjd;W mwpayhk;. 
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MODERN ASPECT OF THE DISEASE 
BRONCHIAL ASTHMA:  
ETYMOLOGY: 
The word bronchus came from Greek (bronkhos) – “wind pipe” and 
in Greek,asthma means “short breath, a panting”.   
HISTORY: 
Asthma was recognized in Ancient Egypt and was treated by 
drinking an incensemixture known as kyphi. Officially recognized as a 
specific respiratory problem separate from others was first recognized 
and named by Hippocrates 450 BC. During the 1930s–50s, asthma was 
considered as being one of the 'holy seven' psychosomaticillnesses. Its 
aetiology was considered to be psychological, with treatment often 
basedon psychoanalysis and other 'talking cures'. As these 
psychoanalysts interpreted the asthmatic wheeze as the suppressed cry 
of the child for its mother, they considered that  the treatment of 
depression was especially important for individuals with asthma.  
Among the first papers in modern medicine published on the 
subject is one published in1873, which tried to explain the 
pathophysiology of the disease. 
DEFINITION:  
- Asthma is a syndrome characterized by air flow obstruction that 
varies markedly,Both spontaneously and with treatment.  
- Asthmatics harbor as special type of inflammation in airway that 
makes them more responsive than non asthmatics to a wide range of 
triggers, leading to excessive narrowing with consequent reduced air 
flow and symptomatic wheezing and dyspnoea. Narrowing of airway 
                                                 
36 Harrisons Text book of Medicine Pg 1602 
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is usually reversible but in some patients with chronic asthma there 
may be an element of irreversible airflow obstruction.  
37
EPIDEMIOLOGY: 
Asthma statistics in India (WHO)  
1. 57.5 estimated total deaths   
2. 5.1 estimated deaths per 100000 population  
3. 277 DALYs (disability adjusted life-year) per 100,000  
4. 6.5 age-standardized deaths per 100,000  
5. 268 age-standardised DALYs per 100,000  
6. constitutes 0.2% of all deaths and 0.5% of National Burden of 
Diseases 
TYPES:  
Extrinsic asthma (Atopic asthma, early onset asthma)  
 Onset is in childhood.  
 Identified by skin sensitivity test  
 Asthmatic inflammatory reaction is characterized by a cellular 
infiltrate rich in Eosinophils.  
Intrinsic asthma (Non-atopic asthma, late onset Asthma)  
 It can begin at any age 
 Especially in late adulthood  
 There was no role of allergens in the production of the disease.  
COMMON ASTHMA TRIGGERS INCLUDE:  
 Animals (pet hair or dander)  
 Dust  
 Changes in weather (most often cold weather) 
 
                                                 
37 sancd.org (SOUTH ASIAN NETWORK FOR CHRONIC DISEASE) 
  Chemicals in the air or in food 
 Exercise  
 Mold  
 Pollen 
 Respiratory infections, such as the common cold 
 Strong emotions (stress) 
 Tobacco smoke 
 Drugs - Aspirin and other nonsteroidal anti
(NSAIDs) provoke asthma in some patients. 
Many people with asthma have a personal or family history of 
allergies, such as hay fever (allergic rhinitis) or eczema. Others have no 
history of allergies.  
PATHOPHYSIOLOGY:  
 Chronic airway inflammation as evidenced by cellular infiltration of 
airway by activated eosinophils,mastcells,macrophages and T
lymphocytes  
 Released mediators from the above cells cause bronchial smooth 
muscle contraction
24 
 
 
 
 
-inflammatory drugs 
 
 
 
-
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 Denudation and desquamation of the epithelium forming mucous 
plugs that obstruct the airway  
 Airway remodeling as evidenced 
 Smooth muscle hypertrophy and hyperplasia  
 Goblet cell and sub-mucosal gland hypertrophy leading to mucous 
hypersecretion  
 Collagen deposition causing thickening of lamina reticularis  
 Cellular infiltration, oedema and possible airway wall thickening.  
CLINICAL FEATURES: 
SYMPTOMS: 
Most people with asthma have attacks separated by symptom-
free periods.  
Some people have longterm shortness of breath with episodes of 
increased shortnessof breath. Either wheezing or a cough may be the 
main symptom. Asthma attacks can last for minutes to days, and can 
become dangerous if the airflow is severelyrestricted. 
Symptoms include: 
 Cough with or without sputum (phlegm) production 
 Pulling in of the skin between the ribs when breathing (intercostal 
retractions) 
 Shortness of breath that gets worse with exercise or activity 
 Abnormal breathing pattern --breathing out takes more than twice as 
long as breathing in 
 Breathing temporarily stops 
 Chest pain 
 Tightness in the chest 
 Wheezing, which: 
26 
 
o Comes in episodes with symptom-free periods in between 
o May be worse at night or in early morning 
o Gets better when using drugs that open the airways 
(bronchodilators) 
o Gets worse when breathing in cold air 
o Gets worse with exercise 
o Usually begins suddenly 
Emergency symptoms: 
 Bluish colour to the lips and face 
 Decreased level of alertness, such as severe drowsiness or confusion, 
during an asthma attack 
 Extreme difficulty breathing 
 Rapid pulse 
 Severe anxiety due to shortness of breath 
 Sweating 
Other symptoms that may occur with this disease: 
 Abnormal breathing pattern --breathing out takes more than twice as 
long as breathing 
 Breathing temporarily stops 
 Chest pain 
 Tightness in the chest 
DISEASE PATTERN:  
 Episodic - acute exacerbations interspersed with symptom-free 
periods  
 Chronic - daily airway obstruction which may be mild, moderate or 
severe may or may not superimposed acute exacerbations  
 Life-threatening- slow-onset or fast-onset 
27 
 
STATUS ASTHMATICUS:  
It is a medical emergency, patient is hypoxic and cyanosed due to 
severe bronchospasm.It is characterized by Tachycardia (pulse rate > 
120), Tachypnoea (respiratory rate > 30/minute), sweating, pulsus 
paradoxus (> 10 abnormal,> 20 profound obstruction), altered level of 
consciousness, and an inspiration-expiration ratio of 1:3 or 1:4.  
LIFE THREATENING FEATURES: 
 Patient cannot speak  
 Central cyanosis  
 Exhaustion,confusion,altered consciousness  
 Bradycardia  
 Silent chest 
 Unrecordable peak flow  
 Severe hypoxaemia(< 8 kPa)  
DIAGNOSIS: 
CLINICAL DIAGNOSIS: 
 Episodic asthma: Paroxysms of wheeze, dyspnoea and cough, 
asymptomatic between attacks.  
 Acute severe asthma: Upright position, use accessory respiratory 
muscles, can‘t complete sentences in one breath, tachypnea > 
25/min, tachycardia > 110/min,PEF< 50%, pulsus paradoxus, chest 
hyperresonant, prolonged expiration, breathsounds decreased, 
inspiratory and expiratory rhonchi, cough.  
 Life-threatening features: PEF < 33%, silent chest, cyanosis, 
bradycardia,hypotension, feeble respiratory effort, exhaustion, 
confusion, coma, PaO2 < 60, PCO2normal or increased, acidosis (low 
pH or high [H+]).  
28 
 
 Chronic asthma: Dyspnea on exertion, wheeze, chest tightness and 
cough on daily basis, usually at night and early morning; intercurrent 
acute severe asthma and productive cough, recurrent 
respiratoryinfection, expiratory rhonchi throughout andaccentuated 
on forced expiration.  
PHYSIOLOGICAL DIAGNOSIS: 
 Demonstration of variable airflow obstruction with reversibility by 
spirometer andpeak flow meter.  
IMMUNOLOGICAL DIAGNOSIS: 
 Skin pricks wheal and flare response.  
 IgE 
 Eosinophil cationic protein (ECP).  
 Peripheral blood and sputum eosinophilia  
 Chest X Ray - Rule out other causes of wheezing.  
DIFFERENTIAL DIAGNOSIS: 
 Chronic bronchitis  
 Emphysema  
 Cystic fibrosis  
 Mechanical airway obstruction  
 Foreign body aspiration  
 Endobronchial tumour  
 Cardiac failure  
 Pulmonary embolism  
 Pulmonary eosinophililia  
 Carcinoid syndrome  
 Allergic bronchopulmonary aspergillosis  
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ASANAS 
Asanas focus on Increasing capacity of the lungs and relaxing the 
chest muscles which contract and remain tense during and after 
Bronchial Asthma attacks. 
ARDHACHAKRASANA: 
PROCEDURE: 
 Stand erect in straight line keeping the heels together and toes an 
little apart, expand the chest and drop the shoulders to a relaxed 
position. Keep the neck straight. Fingers together, facing downwards and 
palms stretched along the thighs by the sides and Relaxed face. 
Slowly slide up the palms and support the back at the waist exhale. 
Bend backwards from the lumbar region, and neck bends back wards 
stretching the muscles of the neck. Inhale while bending. This is the final 
position of the asana, breathe normally. 
Exhale come back to straight position keeping the support at the 
back at the waist by palms. 
Release the hands from the support of the waist while exhaling. 
THERAPEUTICAL USES: 
Good in treating Asthma and low back pain. Relaxes cramps in 
thighs and calves. 
USTRASANA: 
PROCEDURE: 
Sit erect with legs stretched, heels together, palms pressing on the 
floor by the side of the buttocks. It is called Dandasana. 
Fold right leg at the knee and place the heel under the right 
buttock. Fold left leg at the knee and place the heel under the left 
buttock. Stand on  the knees making the trunk vertical. Inhale bend the 
body backwards and keep the palms on the soles. Exhale slowly release 
the palms and return to 3
rd
 position.  
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Slowly sit on the heels, unfold the left leg and keep it straight. 
Unfold the right leg and keep it to side of the leg. 
 THERAPEUTICAL USES: 
Good for back aches, breathing problems. Arthritis, Lumbago, 
Sciatica, Flatulence and Gastric troubles. 
BHUJANGASANA: 
PROCEDURE: 
Lie down on the prone with the hands above the head keeping 
straight alongside the head resting the palms on the ground, touching 
the chin on the floor and legs together soles facing up. Keep the body 
from toes to heads in a straight line. 
Bend both the elbows and place the palms on the floor by the side 
of the last rib bone. 
Inhale slowly lift the head and then raise the chest. Feel the weight 
of the body at the lumbar region maintain the position. 
Exhale bring the chest and head down touching the floor with the 
chin. Release the hands and place them above the head region on the 
floor and come back to normal position. 
THERAPEUTICAL USES: 
 Goos for back aches due to over strain work, neck pain cervical 
spondilitis, hunch back, bronchitis, asthma, digestive disorders, 
reduction of the abdominal fat. Improves digestion and bowel action. 
MATSYASANA: 
PROCEDURE: 
 Lie down on the supine keeping the legs together and stretch the 
hands straight above the head region i.e., from toes to head, the entire 
body in a straight line. 
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 Bend the right leg and keep the right foot and the left thigh. Bend 
the left leg then keep the left foot on the right thigh, thus assuming 
Padmasana.  
 Place the palms on the floor above the shoulders, on either side of 
the head, fingers pointing to the shoulders. Then press the palms on the 
floor, inhale, lift the head and chest on the floor. Keep the centre of the 
crown of the head on the floor by bending the dorsal and cervical spine 
backwards. Remove the hands, hook the big toes with the index fingers. 
Maintaining position is normal breathing. 
THERAPEUTICAL USES: 
 Very good for diabetes, asthma and people threatened with other 
lung diseases. 
CHAKRASANA: 
PROCEDURE: 
Lie down on the supine position, keeping the legs together and 
stretch the hands straight above the head region i.e., from toes to head, 
the entire body in straight line. 
Bend the knees and place the heels closest to the buttocks ears by 
bending the elbows. 
 Inhale lift the body up above the ground and balance on the palms 
and feet. Exhales slowly return to the first position. 
THERAPEUTICAL USES: 
 Clears the respiratory track. 
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LATERAL RESEARCH WORK FOR VITEX NEGUNDO 
A perfect example of medicinal plant credited with innumerable 
medicinal qualities validated by modern science and used since ancient 
times is VITEX. 
Vitex negundo has the medicinal activities like analgesic, anti-
inflammatory, anticonvulsant, antioxidant, bronchial relaxant, 
hepatoprotective, etc. 
The brief of research works done in this species are as follows 
38
ANALGESIC ACTIVITY: 
The ethanolic leaf extract of this plant possesses analgesic activity, 
which appears to be due to PG inhibition and reduction of oxidative 
stress. 
ANTIINFLAMMATORY ACTIVITY: 
39
The experimental studies using various animal models have 
demonstrated that different parts of plant especially leaves possesses 
anti-inflammatory and anti-athritic activity. 
40
The leaves have anti-inflammatory and analgesic properties 
mediated via PG synthesis inhibition, membrane stabilizing and 
antioxidant activities. Vitex negundo which is known to act by 
prostaglandin inhibition, may be expected to cause gastric damage but 
on the contary it produced no histomorphological changes in the 
stomach even in toxic doses. This may be due to a selective COX-2 
inhibition that might be responsible for its NSAID’s like activity. 
 
  
                                                 
38
 Gupta and Tandon (2004) 
39 Chaturvedi & Singh, 1965; Ravishankar et al, 1985-86 
40 Dharmasiri et al & Tandon and Gupta, 2004 
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41
ANTIOXIDANT ACTIVITY: 
The antioxidant activity of the plant was studied using free radical 
scavenging activity effect on hydroxyl radical mediated damage to 
deoxyribose and in vivo lipid peroxidation assay but did not show any 
significant effect.  
42
INSECTICIDAL AND PESTICIDAL ACTIVITY: 
The plant products of Vitex negundo are variously reported to 
possess insecticidal activity against stored product pests, mosquito 
larvae, house flies and tobacco leaf eating larvae. Leaf oil of the plant is 
shown to have repellent action against stored product pests. 
          
  
                                                 
41 Munasinghe et al, 2001 
42 Deshmukh et al 1982, Prakash & Mathur 1985, Hebbalkar et al 1992.  
34 
 
MATERIALS AND METHOD FOR PREPARATION  
COLLECTION OF TEST DRUG: 
The green leaves of Vennochi of about 5 kilograms were collected 
from small trees at Nochodaiapatty village in Dindigul. The leaves were 
cleaned, free off impurities by hand picking method. Then leaves were 
dried under shadow for more than five days. After completing the 
process of drying, the running veins in the leaves were completely 
removed. 
AUTHENTICATION:  
Gunapadam experts of the Gunapadm department of Siddha 
medical college, Palayamkottai, authenticated the trial drug. The 
preparation method was collected from Pathaartha Guna Vilakkam (Pg. 
no 478). 
PREPARATION: 
The tattered leaves were ground into fine powder and the powder 
was again sieved with a white cloth (Vasthirakayam). The powder 
content thus obtained was weighed about 1 Kg and it was kept ready for 
analysis  in a clean and uncontaminated container.    
Administration of the Drug: 
Form of Medicine               : CHOORANAM 
Route of Administration   : ORAL 
Dose                                     :           1 gms  
Anubanam (Vehicle)         : Luke warm water 
Times of Administration  : Two times per day before food 
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STANDARDISATION OF THE DRUG 
PHYSICO-CHEMICAL ANALYSIS 
PROCEDURES: 
Total ash 
Two grams of grounded air-dried Vennochi Ilai Chooranam was 
accurately weighed in a previously ignited and tared silica crucible. The 
drug was gradually ignited by raising the temperature to 450°C until it 
was white. The sample was cooled in a desiccator and weighed. The 
percentage of total ash was calculated with reference to air-dried drug. 
Acid Insoluble ash 
The ash was boiled with 25 ml of 2 M hydrochloric acid for 5 
minutes, the insoluble matter was collected on an ash less filter paper, 
washed with hot water, ignited, cooled in a desiccator, and weighed. The 
percentage of acid insoluble ash was calculated with reference to the air-
dried drug. 
Water Soluble ash 
The ash was boiled with 25 ml of water for 5 minutes, the insoluble 
matter on ash less filter paper collected, washed with hot water, ignited, 
cooled in a desiccator, and weighed. The weight of the insoluble matter 
from the weight of the total ash was subtracted; the difference 
represents the water soluble ash. The percentage of water insoluble ash 
was calculated with reference to the air-dried drug. 
Moisture content: 
The shade-dried Vennochi Ilai Chooranam was grounded in a mixer 
grinder. The powder passed through #40 and retained on #120. 
Accurately weighed 10 g of # 40/120 drug powder was kept in a tared 
evaporating dish. This was dried at 105°C for 5 hours in tray drier and 
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weighed. The drying was continued and weighing was done at one-hour 
interval until difference between two successive weighings corresponds 
to not more than 0.25 percent. Drying was continued until a constant 
weight was reached with two successiveweighings after drying for 30 
minutes and cooling for 30 minutes in a desiccator wasshowing not more 
than 0.01 g difference. 
Potential of Hydrogen (pH): 
The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 
being neutral. 
Readings less than 7.0 indicate acidic solutions, while higher 
readings indicate alkalineor base solutions. 
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43
BIO-CHEMICAL ANALYSIS OF VENNOCHI ILAI CHOORANAM  
PREPARATION OF EXTRACT:- 
5gms of the drug “Vennochi ilai Chooranam” is weighed accurately 
and placed in a 250ml clean beaker. Then 50ml of the distilled water is 
added to it and dissolved it well. Then it is boiled well for 10 minutes. It is 
cooled and filtered in a 100ml volumetric flask and then it is made up to 
100ml with distilled water. Then the fluid is taken for analysis. 
QUALITATIVE ANALYSIS:- 
S.No EXPERIMENT OBSERVATION INFERENCE 
1 
TEST FOR CALCIUM:                          
2ml of the above-prepared 
extract is taken in a clean test 
tube. 2ml of 4% Ammonium 
oxalate solution is added to it.            
No white 
precipitate is 
formed 
Indicates the 
absence of 
calcium 
2 
TEST FOR SULPHATE:                          
2ml of the extract is added to 
5% of barium chloride 
solution 
No white 
precipitate is 
formed 
Indicates the 
absence of 
sulphate 
3 
TEST FOR CHLORIDE:                          
The extract is treated with 
silver nitrate solution 
No white 
precipitate is 
formed 
Indicates the 
absence of 
chloride 
4 
TEST FOR CARBONATE:                          
The extract is treated with 
concentrated HCL 
No brisk 
effervescences 
formed 
Indicates the 
absence of 
carbonate 
  
                                                 
43 Done at Govt. Siddha Medical College Palayamkottai 
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5 
TEST FOR STARCH:                           
The extract is added with 
weak iodine solution. 
Blue colour is 
developed 
Indicates the 
presence of starch 
6 
TEST FOR IRON FERRIC:                                 
The extract is treated with 
glacial acetic acid and 
potassium ferro cyanide. 
No blue colour 
is formed 
Indicates the 
absence of ferric 
iron 
7 
TEST FOR IRON FERROUS:                                 
The extract is treated with 
concentrated Nitirc acid and 
ammonium thio cyanate. 
Blood red 
colour is 
formed 
Indicates the 
presence of 
ferrous iron 
8 
TEST FOR PHOSPHATE:                                 
The extract is treated with 
ammonium molybdate and 
concentrated Nitirc acid. 
Yellow 
precipitate is 
formed 
Indicates the 
presence of 
phosphate 
9 
TEST FOR ALBUMIN:                                 
The extract is treated with 
Esbach's reagent. 
No yellow 
precipitate is 
formed 
Indicates the 
absence of 
Albumin 
10 
TEST FOR TANNIC ACID:                                 
The extract is treated with 
ferric chloride. 
No blue black 
precipitate is 
formed 
Indicates the 
absence of Tannic 
acid 
11 
TEST FOR UNSATURATION:                                 
Potassium permanganate 
solution is added to the 
extract. 
It gets 
decolorized 
Indicates the 
presence of 
unsaturated 
compound 
39 
 
12 
TEST FOR REDUCING SUGAR:                                 
5ml of Benedict's qualitative 
solution is taken in a test tube 
and allowed to boil for 2 
minutes and added 8 - 10 
drops of the extract and 
again boil it for 2 minutes. 
Colour change 
occurs 
Indicates the 
presence of 
reducing sugar 
13 
TEST FOR AMINO ACID:                                 
One or two drops of the 
extract is placed on a filter 
paper and dried it well. After 
drying, 1% Ninhydrin is 
sprayed over the same and 
dried it well. 
Violet colour is 
formed 
Indicates the 
presence of 
Amino acid 
14 
TEST FOR ZINC:                                 
The extract is treated with 
potassium ferro cyanide. 
No white 
precipitate is 
formed 
Indicates the 
absence of zinc 
 
INFERENCE:- 
 The given sample of VENNOCHI ILAI CHOORANAM contains  
 STARCH 
  FERROUS IRON 
  PHOSPHATE 
 UNSATURATED COMPOUNDS  
 REDUCING SUGAR 
 AMINO ACID 
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PHARMACOLOGICAL ANALYSIS 
ANTI-SPASMODIC EFFECT OF VENNOCHI ILAI CHOORANAM ON 
ISOLATED RABBIT JEJUNUM 
AIM: 
To find out the Anti-spasmodic effect of VENNOCHI ILAI 
CHOORANAM on isolated Rabbit jejunum (Burn - 1952) 
PREPARATION OF THE TEST DRUG: 
1 gram of VENNOCHI ILAI CHOORANAM was dissolved in 10ml of 
water. Then it was used for the experiment. 
SOLUTIONS REQUIRED: 
 Acetyl choline -  10µg/ml 
 Test drug  -   VENNOCHI ILAI CHOORANAM 100mg/ml 
NUTRIENT SOLUTION: 
Tyrode solution - 1 to 2 litres 
Tyrode solution (1 litre) 
 NaCl  -  8 gms 
 KCl  -  0.2 gms 
 CaCl2  -  0.2 gms 
 MgSO4 -  0.26 gms 
 NaH2PO4 -  0.05 gms 
 NaHCO3 -  1 gms 
 Glucose -  1 gms 
TISSUE USED: 
 Rabbit jejunum 
  
                                                 
44 Done at Govt. Siddha Medical College Palayamkottai 
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APPARATUS REQUIRED: 
Student’s organ bath, Sherrington rotating drum, scissors, cotton 
thread etc. 
PROCEDURE: 
A rabbit was starved for 48 hours and was allowed only water ad-
libitum. It was sacrificed by a blow on the head and by carotid bleeding. 
The abdomen was quickly opened and the ileocaecal junction was found 
out. A small piece of jejunum portion was cut, removed and placed in a 
dish, containing warm aerated Tyrode solution. The contents of lumen of 
the jejunum was gently rinsed out by pushing the tyrode solution into it. 
3 cm length segment was cut from this part of ileum and was tied with 
thread on both ends separately without closing the lumen and the tissue 
was mounted in an organ bath, containing Tyrode solution maintained at 
37
o
C, bubbled with air by an oxygen tube. 
First the rotating drum was allowed to run for 1 minute to record 
the baseline. Drugs were given to study the inhibiting effect of Acetyl 
Choline. 0.2 ml of Acetyl Choline was added and the drum was allowed to 
run for 30 seconds. Thus the tissue was standardized and then the drum 
was stopped and the Acetyl Choline was washed out. 
Again Tyrode solution was added to the organ bath till the level 
comes to the baseline. The drum was allowed to run for 1 minute. To the 
organ-bath, 1 ml of test drug was added, waited for one minute and 0.2 
ml of Acetyl Choline was added and the drum was allowed to run for 30 
seconds to record the inhibitory action of the test drug. Then 0.2 ml of 
Acetyl Choline was added to standardize the tissue. Then the tracing was 
labeled and fixed. 
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INFERENCE: 
From the graph it is inferred that the test drug antagonize the 
effect of Acetyl Choline when added together. So, the drug VENNOCHI 
ILAI CHOORANAM has got significant Anti-spasmodic activity. 
 
ANTI-HISTAMINE STUDY OF VENNOCHI ILAI CHOORANAM ON 
ISOLATED GUINEA PIG ILEUM 
AIM: 
To study the Anti-histamine effect of VENNOCHI ILAI CHOORANAM 
on isolated Guinea Pig ileum (Burn - 1952) 
PREPARATION OF THE TEST DRUG: 
  1 gram of VENNOCHI ILAI CHOORANAM was dissolved in 10ml of 
water. Then it was used for the experiment. 
SOLUTIONS REQUIRED: 
 Histamine  - 1 in 100000 strength 
 Anti-histamine - (PheniramineMaleate) 2.5 mg/ml 
 Test drug  - VENNOCHI ILAI 100mg/ml 
NUTRIENT SOLUTION: 
Tyrode solution - 1 to 2 litres 
Tyrodesolution(1 litre) 
 NaCl  -  8 gms 
 KCl  -  0.2 gms 
 CaCl2  -  0.2 gms 
 MgSO4 -  0.26 gms 
 NaH2PO4 -  0.05 gms 
 NaHCO3 -  1 gms 
 Glucose -  1 gms 
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TISSUE USED: 
Guinea Pig ileum 
APPARATUS REQUIRED: 
 Student’s organ bath, Sherrington rotating drum, scissors, cotton 
thread etc. 
PROCEDURE: 
 An overnight fasted Guinea Pig weighing about 400 grams was 
sacrificed by a blow on the head and by carotid bleeding. The abdomen 
was suddenly opened and ileo-caecaljunction was found out. A small 
piece of ideal portion was cut and removed and placed in a dish 
containing warm aerated tyrode solution. The contents of lumen of ileum 
was gently rinsed by pushing tyrode solution into it. 3 cm length segment 
was cut from this part of ileum, and was tied with thread on both ends 
separately without closing the lumen and the tissue was mounted in an 
organ bath containing Tyrode solution maintained at 37
o
C and bubbled 
with air by oxygen tube. 
First the rotating drum was allowed to run for 1 minute to record 
the baseline. Drugs were given to study the inhibiting effect of 
Histamine. 0.2 ml of Histamine was added and the drum was allowed to 
run for 30 seconds. Thus the tissue was standardized and then the drum 
was stopped and the Histamine was washed out. 
Again Tyrode solution was added to the organ bath till the level 
comes to the baseline. The drum was allowed to run for 1 minute. To the 
organ-bath, 1 ml of test drug was added, waited for one minute and 0.2 
ml of Histamine was added to it and the drum was allowed to run for 30 
seconds to record the inhibitory action of the test drug. Again the 
recordings were repeated by adding 0.2 ml of Anti- histamine and 0.2 ml 
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Histamine and the drum was allowed to run for 30 seconds to record the 
antagonistic action of Anti- histamine 
There was an elevation in the graph from the baseline. Then 0.2 ml 
of Histamine was added to standardize the tissue. Then the baseline was 
labeled and fixed. 
INFERENCE: 
 From the graph it is inferred that the test drug antagonize the 
effect of Histamine when added together. So, the drug VENNOCHI ILAI 
CHOORANAM has got significant Anti-histamine activity. 
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ANTI - MICROBIAL ACTIVITY 
- By KIRBY BAUER METHOD 
AIM: 
To determine the anti - microbial sensitivity of Vennochi ilai 
Chooranam by disc diffusion method – Kirby Bauer method. 
PROCEDURE: 
INOCULUM PREPARATION: 
The microorganisms were inoculated in 10 ml of peptone water 
under sterile condition. The inoculum is incubated at 37’C for two hours. 
Then the turbidity of the inoculum is adjusted to 0.5 micro C farland 
standard. The inoculum was poured in a Muller Hington agar plate and 
uniformly spreaded over the plate. Staphylococcus aureus, Streptococcus 
pneumoniae, Pseudomonas aeruginosa are inoculated separately. 
COMPONENTS OF MULLER HINGTON AGAR MEDIUM: 
Beef Extract                  : 300 gms / lit 
Agar     :  17 gms / lit      
Starch                           : 1.5 gms / lit 
Casein Hydroxylate   : 17.5 gms / lit 
Distilled water           : 1000 ml. 
PH                              :          7.6 
DISC PREPARATION: 
Vennochi ilai Chooranam is impregnated in a 6 mm diameter filter 
paper disc and applied over the inoculum. Then the Muller Hington agar 
plate is incubated at 37’C for overnight. The zone of clearance is 
measured with a scale and the sensitivity of the organism to the 
                                                 
45 Done at Malar Microbiological Laboratory, Palayamkottai 
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Vennochi ilai Chooranam is assessed. Antimicrobial susceptibility is 
proportional to the diameter of the inhibitory zone around the disc.  
 The plates after 24 hrs incubation are observed for the zone of 
inhibition. 
RESULT: 
S.NO TEST DRUG 
ORGANISMS 
(Culture) 
SUSCEPTIBILITY 
ZONE SIZE (mm) 
Control Test Drug 
1 
VENNOCHI ILAI 
CHOORANAM 
Staphylococcus 
aureus 
Sensitive 23 21 
2 
Streptococcus 
pnemoniae 
Moderate 21 14 
3 
Pseudomonas 
aeruginosa 
Resistive - - 
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S E M –
 Scanning Electron Microscope (SEM) have been widely used for the 
characterization of surface topography, bulk chemical composition and 
the structure of thin specimens. SEM has facility for detecting secondary 
and back-scattered electrons. The use of incident electron beams with 
energybetween 2 & 40keV. The secondary electrons and orbital knocked 
out of sample atoms by collision with the incident electron beam. When 
the electron beam impinges on this specimen induce seconda
Rutherford back scattered, Auger electrons, and various energies were 
produced. These energies provide information about the surface 
topography, crystallography, grain size etc. The escape depth of 
secondary electrons is low due to their low 
electrons are generated at a specimen depth of few nanometers in metal 
to a few tens of nanometer in insulator. If the specimen is not a 
conductor, it is necessary to provide a conducting surface to deposit gold 
or some other metal. 
                                                
46 Done at Anna University, Chennai
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 SCANNING ELECTRON MICROSCOPE
energy. Consequently these 
 
 
 
 
ry electrons, 
 47
F T I R – FOURIER 
The infrared spectrum originates from the vibrational motion of 
the molecule. The vibrational frequencies are a kind of fingerprint of the 
compounds. This property is used for characterization of organic and 
inorganic compounds. The band intensities are pr
concentration of the compound and hence qualitative estimations are 
possible. The IR spectroscopy is also carried out by using Fourier 
transform technique. The interference pattern obtained from a two 
beam  interferometer as the path diff
altered, when Fourier transformed, gives rise to the spectrum. The 
transformation of the interferogram into spectrum is carried out 
mathematically with adedicated on
consists of globar and
interferometer chamber comprising of KBr and mylar beam splitters 
followed by a sample chamber and detector. Entire region of 450
                                                
47 Done at Anna University, Chennai
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TRANSFORM INFRARED SPECTROMETRY
oportional to the 
erence between the two beams is 
-line computer. The FT-IR instrument 
 mercury vapour lamp as sources, an 
 
 
 
 
 
-4000 
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cm-1 is covered by this instrument. The spectrometer works under 
purged conditions. Solid samples are dispersed in KBr or polyethylene 
pellets depending on the region of interest. This instrument has a typical 
resolution of 1.0 cm-1. Signal averaging, signalenhancement, base line 
correction and other spectral manipulations are possible. Infrared 
spectrum is useful in identifying the functional groups like -OH, -CN, -CO, 
-CH, -NH2, etc. Also quantitative estimation is possible in certain cases 
for chemicals, pharmaceuticals etc. 
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CLINICAL ASSESSMENT 
The main objective of this clinical study is to evaluate the efficacy 
of the trial drug Vennochi ilai chooranam on Eraippu erumal.  There is a 
growing interest regarding the pharmacological evaluation of various 
herbal drugs used in traditional system of medicine. The revival of 
interest in natural drugs started in last decade mainly because of the 
wide spread belief that green medicine is healthier than synthetic 
products.  The number of individuals suffering with allergic illnesses is 
increasing in the industrialized, as well as in developing countries. This 
study is aimed to evaluate the efficacy of Vennochi ilai chooranam on 
such allergic disease as bronchial asthma.   
Objectives:  
 To evaluate the Broncho dilator and anti-histaminic activity of 
Vennochi ilai chooranam. 
 To explore the efficacy of Vennochi ilai chooranam in OP patients 
with bronchial asthma.  
Design of the Study:  
 The Open clinical trial phase-2B  
Study Centre:  
Govt. Siddha medical college and hospital, Palayamkottai. 
Study Participants:  
Both men and women and members of all races and ethnic groups 
were eligible for this trial. Treatment was being administered on an 
inpatient/outpatient basis. The patients were selected from the In-
patient and Out-patient department of Govt Siddha medical college and 
hospital, Palayamkottai.  
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Number of Subjects:  
Number of participants will be 35 - 40.  
Registration Process: 
To register a patient, the following documents should be 
completed by the investigator.  
 Copy of required laboratory tests  
 Signed patient consent form  
 Other appropriate forms (e.g., Trial profoma).  
This Clinical trial is an ethical and scientific quality standard for 
designing, conducting and recording trials that involve the participation 
of human subjects. Compliance with this standard provides assurance to 
public that the rights, safety and well being of trial subjects are 
protected, consistent with the principles enshrined in the Declaration of 
Helsinki and ensures that clinical trial data are credible  
Selection of patients:  
The Clinical trial is usually focus on asthma control as measured by 
pulmonary function test, symptom scores and medication requirement. 
After taking the short history of patient, all the selected cases were 
carefully examined and records were maintained. To arrive at the 
diagnosis along with the history taking and the following investigations 
were done. The patients were selected for clinical trials as per the 
following criterias, which are listed below  
 Recurrent wheezing  
 Coughing  
 Trouble in breathing  
 Chest tightness  
 Symptoms that occurs or worsen at night  
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 Symptoms that are triggered by cold air,exercise or exposure to 
dust,smoke and pollens  
 Family history also taken.  
Consent form:  
Patients were included in this clinical study only after getting the 
concern form accordance of ‗Helsinki‘. Voluntary written assent of a 
subject‘s willing to participate in this study and in its documentation. The 
confirmation is sought only after information about the trial including an 
explanation of its status as research, its objectives, potential benefits, 
risks and inconveniences, alternative treatment that may be available 
and of the subject‘s rights and responsibilities have been provided to the 
potential subject. The patients were selected for clinical trials as per the 
following criteria, which are listed below  
Inclusion criteria: 
 Co operative patient  
 Cough with expectoration  
 Expiratory wheeze  
 Tightness of the chest  
 Positive allergic history  
 History of previous attack  
Exclusion criteria:  
 Infectious disease patient  
 Pulmonary tuberculosis  
 Malignancy  
 Renal diseases  
 Cardio vascular diseases  
 Cardiac Asthma 
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 Renal Asthma 
 Status asthmaticus 
 Urenic Asthma 
Withdrawal criteria:  
 Exacerbations of symptoms  
 Unacceptable adverse events  
 Patient decided to withdraw from the study  
 Irregular visit  
 Irregular Medications  
 Alcohol intake  
Investigations criteria:  
Blood: TC, DC, ESR, Hb, blood sugar PP.  
Urine: Routine examination  
Chest: X-ray  
Sputum for AFB 
P F M – PEAK FLOW METER: 
 
“PEAK FLOW METER FOR ASTHMA IS LIKE THERMOMETER FOR FEVER” 
 PFM indicates what happens and how much air moves in lungs.  
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USAGE: 
 Insert the mouth piece into the meter and reset the indicator of 
PFM by shaking the meter until the yellow indicator is resting with the 
diamond shape near the mouth piece. Do not obstruct the holes at the 
end of PFM, stand up if possible & take a deep breath place the meter in 
mouth and close lips around the mouth piece. Blow out as hard and fast 
as possible. 
Note the number on the scale indicated by pointer & repeat the 
procedure twice & take the highest reading. 
Green zone: 
 PEFR 80 to 100% of personal best. Indicates free of symptoms and 
can maintain current Asthma management program.  
Yellow zone: 
 PEFR 50 to 80% of personal best. Indicates that Asthma is 
worsening & medication to be taken. 
Red zone: 
 PEFR below 50% of personal best. Indicates the Danger situation. 
Spirometry:  
The spirometry is an important tool used for generating 
pneumotachographs, which are helpful in assessing asthma.  
Procedure:  
The basic forced volume vital capacity (FVC) test varies slightly 
depending on the equipment used. Generally, the patient is asked to take 
the deepest breath they can, and then exhale into the sensor as hard as 
possible, for as long as possible, preferably at least 6 seconds. It is 
sometimes directly followed by a rapid inhalation (inspiration), in 
particular when assessing possible upper airway obstruction. 
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Sometimes, the test will be preceded by a period of quiet breathing in 
and out from the sensor (tidal volume), or the rapid breath in (forced 
inspiratory part) will come before the forced exhalation.  
During the test, soft nose clips may be used to prevent air escaping 
through the nose. Filter mouthpieces may be used to prevent the spread 
of microorganisms.  
Parameters: 
The most common parameters measured in spirometry are Vital 
capacity, forced vital capacity, Forced expiratory volume and Maximal 
voluntary ventilation.   
Drug and dosage: 
Drug :Vennochi ilai chooranam 
Route : Enternal  
Dose : 1 gmtwice a day (After food)  
Vehicle : Luke warm water 
Dietery advice:  
Therapeutic foods or nutrients that help controlling asthma are: 
Omega-3 and omega-6 fatty acids, foods high in flavonoids and beta 
carotene, Vitamin B12, Vitamin B6 (Vitamin B6 deficiency is common in 
asthmatics), high amounts of vitamin B12 supplements (1,500 mcg per 
day) have been found to reduce the tendency for asthmatics to react to 
sulfites, Selenium, Vitamin E, Vitamin C, and Magnesium (magnesium 
can prevent spasms of the bronchial passages).  
Medical advice:  
 Patients are advised to avoid known offending allergen which is 
identified either by experience or by skin sensitivity test.  
 Take light meals at night and try to sleep early  
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 Drink plenty of water  
 Try to avoid dust, cigarette smoke and smoky surroundings.  
 Avoid cold water bath.Avoid cold, deep fried food.  
 Avoid keeping pets such as dogs, cats.  
 Avoid alcohol, lime and bananas.  
 Advice to do breathing exercise  
Criteria for assessment of response to therapy:  
 Marked Relief: 75%-90% relief in the presenting signs and 
symptoms marked normality pathological investigation.  
 Moderate Relief: 60%– 75% relief signs and symptoms, moderate 
normality of pathological investigation.  
 Mild Relief: 50%-60% relief of signs and symptoms no marked 
changes in pathological investigations.  
 Poor: Below 50% relief of signs and symptoms  
Observation:  
 The duration of the treatment ranged between 45-90 days.  
 At the time of treatment, no adverse effects were observed.  
 The drug was well accepted by all the patients.  
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BIO – STATISTICAL ANALYSIS 
ANALYSIS OF DATA: 
The Eraippu Erumal clinical trials in respect of the drug Vennochi 
ilai chooranam are described according to their demographic characters 
such as sex and age in terms of percentages and averages. The 
effectiveness of the drug in controlling the Eraippu Erumal is analysed 
and interpreted by the student’s paired ‘t’ test. The p- values <0.05 are 
considered as significant. 
RESULTS AND OBSERVATION: 
Description of the clinical trials of Vennochi ilai chooranamwas 
described according to their sex and age as follows. 
Age group 
(years) 
Male Female Total 
No % No % No % 
20 -29 - - 1 4.34% 1 2.50% 
30 – 39 1 5.88% 3 13.04% 4 10% 
40 -49 7 41.17% 13 56.52% 20 50% 
50 -59 7 41.17% 4 17.39% 11 27.50% 
60 – 69 1 5.88% 2 8.69% 3 7.50% 
70 – 79 1 5.88% - - 1 2.50% 
Total 17 42.50% 23 57.50% 40  
 
The age and sex wise distribution was shown in the above table. 
The male participation was 42.50% and the female participation was 
57.50% 
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Comparison of Male and Female according to their age distribution: 
Sex 
Age (years) 
Difference 
of means 
‘t’ Significance 
Mean 
Standard 
Deviation 
Male 50.71 9.80 
5.44 3.5 P < 0.01 
Female 45.26 8.04 
 
 This table reveals the difference of age between the male and 
female clinical trials. The mean age of the males was 50.71 ± 9.80 years 
and the same of the females was 45.26 ± 8.04 years. The difference 
between the mean ages was statistically significant (p<0.01). 
Assessment of related variables: 
The variables which were related to the diseases such as E.S.R ½ 
hour,E.S.R one hour and respiratory rate, PEFR were assessed before 
administration of the drug and after completion of the course of the 
drug. 
Assessment of E.S.R ½ hr before and after administration of the drug: 
Level of E.S.R  
at half an  
hour (mm) 
Before treatment After treatment 
Frequency % Frequency % 
0 -10 32 80.0 39 97.5 
10-20 8 20.0 1 2.5 
20-30 - - - _ 
Total 40 100.0 40 100.0 
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 The above table states that the E.S.R level at ½ hr for the patients 
before undergoing the course of the drug after completion of the course. 
Before the course of the drug 90.24% of the patients had E.S.R ½ hr level 
in between 0 – 10mm. The remaining 9.76% had their level above 10 
mm. After the course of the drug 95.12% of the subjects had  0- 10mm 
and the remaining 4.88% had that level above 10 mm. 
Assessment of E.S.R for 1 hr before and after taken the drug. 
Level of E.S.R at 
one hour (mm) 
Before treatment After treatment 
Frequency % Frequency % 
0 -10 15 37.5 33 82.5 
10-20 19 47.5 7 17.5 
20-30 3 7.5 - - 
30- 40 3 7.5 - - 
40-50 - - - - 
Total 40 100.0 40 100.0 
 
 The before and after administration of the drug, the level of E.S.R. 
at 1 hour was shown in the above table. Majority (47.5%) of the cases 
had their E.S.R level between 10 – 20 mm and 37.5% of them had 0-10 
mm. The level  20-30 mm was 7.5%. The remaining had their E.S.R at one 
hour is above 30 mm.  
 After the drug administration, 82.5% of  the cases had their level 
of E.S.R between 0 -10 mm. Then the level of E.S.R at one hour between 
10-20 mm is 17.5%.  
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Assessment of Respiratory Rate before and after the drug 
administration: 
 The respiratory rate of the study subjects before and after 
administration of the drug as follows. 
Assessment of RR before and after the drug administration: 
Level of 
Respiratory 
Rate 
Before After 
Frequency % Frequency % 
15-20 9 22.5 36 90.0 
20-25 26 65.0 4 10.0 
25-30 5 12.5 - - 
30-35 - - - - 
35-40 - - - - 
Total 40 100.0 40 100.0 
 
The respiratory level of the study subjects before and after the 
drug administration was shown in the above table. The respiratory level 
15 – 20 before and after were 22.5% and 90.0% respectively. The level 20 
– 25 of before and after were 65.0% and 10.0%, respectively. The level 
25 – 30 before and after were 12.5% and 0% respectively. And there is no 
repiratory rates were complained on 30-35 and 35-40 levels. 
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Assessment of PEFR before and after the drug administration: 
Level of 
PEFR 
Before Treatment After Treatment 
Frequency % Frequency % 
50-100 5 12.5 - - 
100-150 8 20.0 - - 
150-200 16 40.0 5 12.5 
200-250 4 10.0 4 10.0 
250-300 7 17.5 - - 
300-350 - - 27 67.5 
350-400 - - 4 10.0 
Total 40 100.0 40 100.0 
 
 The PEFR value of the study subjects before and after the drug 
administration was shown in the above table. The PEFR value was 
maximum 40% between 150-200 before treatment and was maximum 
67.5% between 300-350 after treatment. 
Effectiveness of the drug Vennochi ilai chooranam 
 The effectiveness of the drug Vennochi ilai chooranam was 
analysed by comparing the averages before and after administration of 
the drug in respectof E.S.R at ½ hr, 1 hr and RR, PEFR. 
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Effectiveness of the drug Vennochi ilai chooranam 
Variables 
Before 
Treatment 
After 
treatment 
Difference  
‘t’ 
 
Significance 
Mean S.D Mean S.D Mean S.D 
E.S.R ½ an 
hour(mm) 
8.30 4.14 4.68 2.36 3.62 1.78 6.373 p<0.01 
E.S.R 1 
hour(mm) 
14.48 7.53 8.25 3.47 6.23 4.06 3.62 p<0.001 
RR 23.65 2.81 17.05 2.09 6.60 0.72 3.59 P<0.001 
PEFR 181 58.60 309.50 57.84 128.5 0.76 0.757 P<0.01 
 
 The above table shows the effectiveness of the drug. The mean 
E.S.R. ½ hr before and after the drugs were 8.30 ± 4.14 and 4.68 ± 2.36 
mm. The difference of mean was statistically significant (p<0.01). 
Similarly the E.S.R at 1 hr before and after the drug were 14.48 ± 7.53 
and 8.25 ± 3.47 mm. The mean difference was statistically highly 
significant (p<0.001). Before administration of the drug the mean RR 
level was 23.65 ± 2.81 and the  same after administration was 17.05 ± 
2.09. The difference between the means was statistically very significant 
(p<0.001). The mean PEFR value before and after the drugs were 181 ± 
58.06 and 309.50 ± 57.84. The difference between the means was 
statistically very significant (p<0.01). 
 
 
 
 
63 
 
S. No: 
Category of 
prognosis 
No: of 
Subjects 
Percentage 
1. Good 33 82.5 
2. Fair 6 15 
3. Poor 1 2.5 
Total 40 100.0 
 
Prognosis of the drug: 
 The above table shows the response of the drug was good among 
the 73% of the subjects. The remaining 19% and 8% of the subjects were 
fair and poor response of the drugs respectively. 
INFERENCE: 
The drug Vennochi ilai chooranam was effective and showed 
good response to Eraippu Erumal clinical trials. 
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RESULTS AND DISCUSSIONS 
Diversified studies were carried out on the trial drug Vennochi ilai 
chooranam to prove its pre clinical safety and clinical efficiency. The 
study includes literature collections, Physico chemical analysis, 
Pharmacological analysis, Microbiological analysis and Clinical analysis. 
The therapeutical efficiency of the drug in treating Bronchial 
Asthma is put on many literature in different formulations. 
From the literatures, the trial drug Vennochi ilai chooranam has 
got Astringent, Pungent, Bitter taste, hot potency and Acid 
biotransformation. 
As per Siddha concept, the derangement of Kabha humour is the 
basic abnormality in Eraippu Erumal (BA). 
48‘fgj;jpidad;wpf; fhrRthrq;-fhzhJ”. 
 The properties of the trial drug – Pungent, Bitter & Astringent 
taste has the tendency to mitigate the harmful effects of the vitiated 
kabha humour. 
‘49.   ..................fpspnkhopNa 
fhh;g;gpdpg;G tpQ;rpw; fgk;tpQ;RQ; rl;bujr;  
Nrug;Gzh; NehaZ fhNj”. 
PHYSICO CHEMICAL ANALYSIS 
The colour of the Vennochi Ilai Chooranam  sample is same in both 
the ordinary and the UV light. The total ash value is 6.65%, acid insoluble 
ash is 0.41%, so acid insoluble ash is very low denoting that it gets 
digested fully in our GI track without provoking any ill effects. So this 
study helps to standardize the preparatory method of this herbal 
formulations. 
                                                 
48 Njiuah; - gpzpfspd; Kjw;fhuzk;  - Neha; Kjdhly; jpul;L ghfk; - 1 gf;fk; 363 
49 Neha; Kjdhly; jpul;L ghfk; - 1 gf;fk; 23 
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BIOCHEMICAL ANALYSIS: 
Bio chemical analysis reveal the presence of starch, ferrous iron, 
phosphate, unsaturated compound, reducing sugars and Amino acids. 
Presence of ferrous iron increase the haemoglobin concentration 
in the blood, enhancing the oxygen availability of the cells. The drug 
prevent hypoxaemia. 
Phosphate is the most abundant intracellular anion and is 
essential for membrane structure, energy storage and transport in cells. 
Phosphate is also necessary in red blood cells for production of 2 – 3 
diphosphoglycerate which facilitates release of oxygen from 
haemoglobin. Thus increases the oxygen availability of the cells. 
The presence of amino acid promotes the immune system of the 
body. The ferrous iron is also associated with effective immune 
competence of the body. 
S E M – PICTURE OF VENNOCHI ILAI CHOORANAM: 
 
The SEM images of the powdered vennochi ilai chooranam showed 
a fluffy and wavy structure. It looks like flowers petal. The structure is not 
uniform in shape and it is agglomerated. The average size of the particle 
37 nm. 
                                                 
50
 Ambika Shanmugam, Fundamental of Bio chemistry – Pg. 690, Emedicine medscape.com – Devon. 
J. Moore 
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FTIR - SPECTRUM OF VENNOCHI ILAI CHOORANAM : 
 
~2.SP  3601  4000.0  400.0  3.1  100.0  4.0  %T  4  2.0 
PT 
REF 4000 98.5 2000 98.2 600 
3406.0  3.1    2919.5  9.7    2851.0  22.7   2366.1  75.1   2345.5  79.5    
1646.4  27.5   1430.0  50.6   1271.5  51.0   1052.2  41.4   619.0   84.5    
 
END 10 PEAK(S) FOUND 
The peak at 3406 cm-1 indicates the presence of hydroxyl group. 
The peaks of 2919 and 2851 cm - 1 indicates the alkane group in the 
compound. The peaks at 1271 and 1052 cm-1 represent the 
unsymmetrical ether group in the compound. The peak of 619 cm-1 
showed the availability of halidegroup. The peaks at 1646 and 1430 cm-1 
corresponds to the presence of alkene and amide groups, respectively. 
Pharmacological study:     
 Greater than 50 different mediators have been implicated in 
bronchial asthma, among these histamine is the major targeting 
mediator in the treatment of Asthma. The trial drug Vennochi ilai 
Chooranam excerted antagonistic effect on histamine induced 
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contraction, manifesting the marked anti histaminic activity in isolated 
guinea pig ileum. 
The trial drug Vennochi ilai chooranam  also excerted significant 
anti spasmodic activity by antagonizing the effect of a acetyl choline  in 
isolated rabbit jejunam. 
Microbiological activity: 
 The microbial activity shows test drug is sensitive for 
staphylococcus aures and moderately sensitive for streptococcus 
pneumoniae. 
Statistical Analysis:  
 The effectiveness of the drug in controlling the Eraippu Erumal is 
analysed and interpreted by students paired ‘t’ test. P values less than 
0.05 were considered as significant. 
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SUMMARY 
The test drug Vennochi ilai chooranam is selected from the text 
PATHAARTHA GUNA VILAKKAM (Pg. No. 478)  for the evaluation of 
safety, efficacy and theraupeutical potency on Bronchial Asthma 
patients. 
A brief description pertaining to its Botanical aspect has been 
referred. 
A review of the literatures about the Vitex negundo and its 
significance in Gunapadam aspect since ancient period has been done. 
Bio chemical analysis shows the presence of starch, ferrous iron, 
phosphate, unsaturated compounds, reducing sugar and amino acid. 
Pharmacological analysis shows that the drug has got significant 
Anti – spasmodic activity and good Anti – Histaminic activity. 
Hence it can be concluded that this drug may inhibit the tone of 
tracheal and bronchial muscles and thus has a good bronchodilator 
action. 
After the above evaluation, the drug Vennochi ilai chooranam is 
subjected to clinical trial. The open clinical trial results that 82.50% of 
patient were having goodimprovement and 15% were having fair 
improvement.  
From the above pre clinical & clinical observation, it is inferred that 
Vennochi ilai Chooranam, which is a simple cost effective medicine has 
got significant effect on Bronchial Asthma.  
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CONCLUSION 
Vennochi ilai Chooranam was selected for the elaborate study of 
its efficacy on Eraippu Erumal (BA). 
From the literature review physico-chemical,pharmacological, 
microbiological, biochemical, instrumental analysis it has been concluded 
that Vennochi ilai Chooranam has got a good Anti spasmodic and Anti 
histaminic activity and hence effective for Eraippu Erumal.  
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INTRODUCTION 
Siddha comes from the word “Siddhi” which means perfection or 
eternal bliss. These are referred as the supernatural power, which gave 
the ancient saints the designation of Siddhars. By the virtue of these 
powers, Siddhars employed their knowledge for the benefit of the 
mankind.    
According to Siddha, medical science the world is made up of five 
basic material elements i.e. Panchabootham (Prithvi, Appu, Theyu, 
Vaayu and Aagayam) and the worldly objects are classified into two 
categories namely movable & immovable. This concept has been rightly 
declared by an old saying  
“CLASSIFYING ALL MOVABLE AND IMMOVABLE THINGSWITHIN THE 
CLASSIFICATION OF FIVE MATERIAL ELEMENTS” 
According to this, the human body is the replica of universe and so 
similar are the food & drug to man as explained in ANDAPINDA 
THATHUVAM. The thathuvam explains the relationship between the 
universe and human body. These two are interlinked and vividly 
explained through the five basic principles “PANCHABOOTHAAS”. The 
structural aspect of human body is said to be “UDAL THATHUS” (i.e. the 
physical component of the human body) and the functional units of the 
human body is said to be “UYIR THATHUS” (the physiological units i.e. 
Vatham, Pitham and Kapham). The functional co-operation of these two 
are essential for the maintenance of health.  
In Siddha system, thousands of drugs are used. These drugs are 
categorized into three groups, namely herbal products, metal-mineral 
products and animal products. In this, the herbal products formulate 
more than 80% of the Siddha medicines. However, in certain life 
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threatening diseases and in many chronic diseases the herbal medicines 
alone are not much effective. In such conditions, Siddha enumerated 
some herbo-metal and herbo-mineral formulations. Minerals are 
classified as metals metals, salts (karasarangal), arsenic compounds and 
secondary minerals. 
Among karasarangal, Vediuppu (Potassium nitrate) one such 
karasaram, a fire based salt element with demulcent, diuretic action was 
depicted for Kalladaippu i.e. Urolithiasis as emphasized in the literature 
Kannusamy parambarai vaithiyam (Pg. no. 371). 
Urinary stones have afflicted humans since the dawn of history. 
The first known stones have been discovered in Egyptian mummies. In 
1901, the English archeologist E. Smith found a bladder stone from a 
4500 – 5000 year old mummy in El. Amrah, Egypt.  
Such a historical disease Kalladaippu has become as a very 
common ailment nowadays due to modern food habits and work nature. 
Therefore, I have chosen the Vediuppu Chendhuram to prove its efficacy 
on Kalladaippu by pre-clinical and clinical studies.  
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AIM AND OBJECTIVES 
AIM: 
Urolithiasis constitutes one of the commonest diseases in our 
country and it is mostly known that the pain due to kidney stones is 
worse than that of labour pain. In India, approximately 5 – 7 million 
patients suffer from stone disease and at least 1/1000 of Indian 
population needs hospitalization due to kidney stone disease and 
sometimes many of them are subjected to unwarranted surgical 
intervention. But in Siddha system of medicine affords treatment for all 
kinds of diseases with simple preparations. One of such simple 
medication is Vediuppu Chendhuram from the treasury of Siddhars. The 
aim is to evaluate the safety and efficacy of Vediuppu Chendhuram on 
Urolithiasis by pre-clinical and clinical trial. 
OBJECTIVES: 
The main objectives of the study are  
 To collect the literature evidence regarding the trial medicine. 
 To get proper authentication. 
 To prepare the trial medicine as per the text. 
 To standardize the trial drug. 
 To evaluate the lithotriptic, diuretic and anti-spasmodic activity of 
the trial drug pre-clinically. 
 To evaluate the therapeutical efficacy of the drug through open 
clinical trial.  
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REVIEW OF LITERATURE 
GEO-CHEMICAL ASPECT 
POTASSIUM NITRATE:[Nitre or Indian Saltpeter KNO3 or Fullers earth] 
1Telugu  –  Patlu-uppu 
Mal   –  Vetii-uppu 
Can   –  Patluppu 
Malay  –  Sundawa 
Hindi   -  Shora 
Potassium nitrate is a chemical compound with the formula KNO3. 
It is an ionic salt of potassium ions K+ and nitrate ions NO3 −. It occurs as 
mineral nitre and is a natural solid source of nitrogen. Potassium nitrate 
is one of several nitrogen-containing compounds collectively referred to 
as saltpeter.  
Occurance -  In India it occurs in Haryana and Bengal  
PROPERTIES: 
Molecular formula  –  KNO3 
Molar mass    -  101.1032 g/mol 
Appearance   -  white solid 
Odour    -  odourless 
Density    -  2.109 g/cm3 (16 °C) 
Melting point   -  334 °C 
Boiling point   -  400 °C decomp. 
Solubility in water   -  133 g/L (0 °C) 
   383 g/L (25 °C) 
Solubility    -  slightly soluble in ethanol, soluble in  
glycerol, ammonia 
Acidity     -  ~7 
                                                 
1 Indian material Medica 91 
74 
 
Refractive index     -  1.5056 
Crystal structure           -  Orthorhombic  
OCCURANCE: 
Crude nitre occurs as an efflorescence on the surface of the earth 
in tropical countries like India. 
2
PRODUCTION: 
Potassium nitrate can be made by combining ammonium nitrate 
and potassium hydroxide. 
NH4NO3 (aq) + KOH (aq) → NH3 (g) + KNO3 (aq) + H2O (l) 
Potassium nitrate can also be produced by neutralizing nitric acid 
with potassium hydroxide.  
KOH (aq) + HNO3 → KNO3 (aq) + H2O (l) 
On industrial scale it is prepared by the double decomposition 
reaction between sodium nitrate and potassium chloride. 
NaNO3 (aq) + KCl (aq) → NaCl (aq) + KNO3 (aq) 
3
USES:          
 Fertilizer - Potassium nitrate is mainly used in fertilizers, as a 
source of nitrogen and potassium – two of the macronutrients for plants. 
When used by itself, it has an NPK rating of 13-0-44.  
Oxidizer - Potassium nitrate is an efficient oxidizer, producing a 
lilac-colored flame upon burning due to the presence of potassium. It is 
also used in fireworks such as smoke bombs, made with a mixture of 
sucrose and potassium nitrate. It is also added to pre-rolled cigarettes to 
maintain an even burn of the tobacco and is used to ensure complete 
combustion of paper cartridges for cap and ball revolvers. 
                                                 
2
 Text book of inorganic chemistry  -P.L.Soni 2.132 
3
 Text book of inorganic chemistry  -P.L.Soni 2.132 
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Food preservation - In the process of food preservation, potassium 
nitrate has been a common ingredient of salted meat it is also approved 
for use as a food additive in European Union. 
Food preparation - In West African cuisine, potassium nitrate (salt 
petre) is widely used as a thickening agent in soups and stews.  It is also 
used to soften food and reduce cooking time when boiling beans and 
tough meat. Salt petre is also an essential ingredient in making special 
porridges. 
Pharmacology - Used in some toothpastes for sensitive teeth. 
Used in some toothpastes to relieve asthma symptoms. Used historically 
to treat asthma.  
Other uses – In the manufacture of gun powder. As an oxidizing 
agent in laboratory and industries. 
4
Medicinal Uses – Potassium nitrate in solution is used as 
refrigerant as well as  efficient diuretic.   
In weak  solutions, 1 to 2 drachiams in a quart of thin warm rice 
kanji. It is an excellent refrigerant drink in fevers with hot and dry skin, 
parched tongue with great thirst and scanty high coloured urine. It is also 
useful in early stages of small pox. Drop C acute rheumatism.  
In colic a powder containing nitre, black pepper and sanchala salt. 
In equal parts is recommended to be given in doses of 10 grains in lime 
juice. 
A mixture of niter 2 parts and leave juice of radish, 1 part is given 
in doses of 80 grains tp releave scalding and retention of urine and also 
scantinuous of urine. 
 
                                                 
4 Indian Materia Medica 91,92&93 
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MUSA PARADISIACA, Linn 
TAXONOMICAL CLASSIFICATION: 
Kingdom                - Plantae 
Subkingdom             - Tracheobionta 
Superdivision - Spermatophyta 
Division  -  Magnoliophyta 
Class                        - Liliopsida 
Subclass  -      Zingiberidae 
Order                       -       Zingiberales 
Family  -   Musaceae 
Genus                    -  Musa 
Species                   -   Paradisiaca 
DISTRIBUTION: 
 The plant is widely distributed throughout the tropical regions. It is 
native to India and Burma. 
HABIT: 
 The plants have a large herbaceous growth habit with leaves with 
overlapping basal sheath  often mistaken for trees, but their upright 
stem is actually a pseudostem that grows 6 to 7.6 metres  tall, growing 
from a corm. 
LEAVES: 
 The new leaves originated from the corm that grow  up 
continuously through the centre of the pseudostem with their laminas 
tightly rolled in a spiral manner. 
INFLORESCENCE: 
 One terminal inflorescence arises from each corm with peduncle 
extending    through the centre of the pseudostem and bending down 
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when exserted, being a compound spike (BANANA HEART). 
FRUIT: 
The fruit has been described as a “leathery berry” 
ACTIVE INGREDIENT: 
 Tannins, eugenol , tyramine. High tannin content in the plant and  
unripe fruits has antibiotic activity. Serotonin, levarterenol, and 
dopamine are available in the ripe fruit and peel. Other chemical 
constituents are alkaloids, steroidal lactones, and iron 
Bananas are naturally slightly radioactive more so than most other 
fruits, because of their potassium (499mg/100gm) content and the small  
amounts of the isotope potassium-40 found in naturally. 
Bananas promote an overall improvement of the functional 
efficiency of kidneys. Benefits to the kidneys are again due to the high 
potassium content, a normal intake of potassium  suppresses calcium 
excretion in the urine and minimize the risk of kidney stone. 
As banana is a best source of potassium,it  reduces the risk of high 
blood pressure and also helps to maintain normal fluid and electrolyte 
balance in the cell. 
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PIPER BETLE, Linn 
VERNACULAR NAMES: 
English  : betle leaf 
Gujarati  : paan 
Hindi   : pan 
Kannada  : panu 
Malay  : se keh 
Tamil   : vettrilai 
5
TAXONOMICAL CLASSIFICATION: 
Kingdom  : Plantae 
Subkingdom  :  Tracheobionta 
Superdivision  : Spermatophyta 
Division   : Magnoliophyta 
Class    : Magnoliopsida 
Subclass   : Magnoliidae 
Order   : Piperales 
Family   : Piperaceae 
Genus   : Piper 
Species   : betle 
HABIT – The betle plant is an evergreen and perennial creeper, 
with glossy heart-shapedleaves and white catkin. 
HABITAT – Mostly found in moist and hot climatic condition. In 
India, it is in found in Bihar, Bengal and South India.  
Parts used: 
Leaves - Cordate, alternate ,Aromatic, dark green with entire 
margin, acuminate apex and unequal base with stout petiole.The leaves 
                                                 
5
 A handbook to the flora of Natal / by J. Medley Wood 
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are stimulant, antiseptic and sialogogue. Essential oil from leaves— 
antispasmodic, antiseptic. 
The Ayurvedics claim that the leaves are anthelminthic, 
aphrodisiac, carminative and laxative. They are also known to be 
stomachic and tonic. 
The Yunani regard the leaves as a styptic and a vulnerary. They 
prescribe it to improve the appetite and taste, to strengthen teeth and as 
tonic for the brain, heart and liver. 
6
CHEMICAL CONSTITUENTS: 
Leaves contain protein 3.1 %, carbohydrate 6.9 %, minerals 2.3 %, 
and tannins 2 %. It contains calcium, phosphorus, iron, iodine and 
potassium is also present. Vitamin B, vitamin c and vitamin A. leaves 
contains bitter compounds that are about 0.7 to 2.6 %. It also contains 
an aromatic compound and stable oils like phenol and terpene. Besides 
this it contains eugenol, chavibetol and hydroxychavicol.,Allyl 
pyrocatecol,piper betol 
7
Effects of the active substance: 
 The juice of betle leaves is credited with diuretic properties. Its 
juice mixed with diluted milk and sweetend, slightly help in easing 
urination.  
The juice of a few betle leaves, with a teaspoon of honey will serve 
as a good tonic.Thebetle leaf has analgesic and cooling properties 
A mixture of onion and betle leaves juice can cure fungal infection.  
Eugenol in leaves prevent deadly fungus Candida albicans, anti-
convulsive, analgesic, anesthetic, relieving spasms in smooth muscles. 
Tannin  Present  in leaf is a astringent it is liver protective . 
                                                 
6
 International Journal of Pharmaceutical Research & Development, Vol 4,Chandra Vikash 
7
 International Journal of Pharmaceutical Research & Development, Vol 4,Chandra Vikash 
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RAPHANUS SATIVUS, Linn 
TAXANOMICAL HIERARCHY: 
Kingdom   -  Plantae 
Subkingdom  -  Viridaeplantae  
Infrakingdom  -  Streptophyta  
Division   -  Tracheophyta phytes 
Subdivision   -  Spermatophytina  
Infradivision  -  Angiospermae  
Class    -  Magnoliopsida 
Superorder   -  Rosanae 
Order   -  Brassicales 
Family   -  Brassicaceae  
Genus   -  Raphanus L. 
Species   -  Raphanus sativus L. 
VERNACULAR NAMES: 
English : Radish, cultivated radish 
Tribal  : Mulwa (Chakma), Mala (Marma)  
Sanskrit : Kuttoowmbi 
Telugu : Darbuje 
Hindi  : Jamanka 
Kannada : Tharbooza 
Malayalam : Mandeki  
Greek name of the genus Raphanus means "quickly appearing" 
and refers to the rapid germination of these plants. The common name 
"radish" is derived from Latin (Radix = root). Four botanical varieties are 
recognised within the species, R. sativus L., namely radicula, Niger, 
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mougri and oleifera, the first two of which are grown for their tuberous 
roots, while oleifera is grown primarily for the oil in its seeds. 
HABIT  
Annual or Biennial Herb  
MORPHOLOGICAL CHARACTERS: 
LEAVES 
The leaves are roughly hairy. The basal leaves are long, often 
pinnately lobed and coarsely toothed, but sometimes are not serrated, 
while the cauline leaves are simple and linear. 
FLOWERS  
The flowers are in long terminal racemes, usually white or lilac 
with purple veins. 
FRUITS AND SEEDS  
The fruit are narrow, indehiscent, 2.5-7.5 cm long and about 1.25 
cm in diameter, with a long tapering beak. There are usually 6-12 
globose seeds, yellow to chocolate-brown in colour. Seeds are separated 
by pith. 
ROOT 
 The tap root is swollen, fleshy and normally white and in some 
may be pink to red.  
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MEDICINAL USES: 
 LEAVES - The juice of the fresh leaves is diuretic and laxative and used 
treatment of Asthma.  
 SEED - The seed is carminative, diuretic, expectorant, laxative and 
stomachic. It is taken internally in the treatment of , abdominal 
bloating, wind, acid regurgitation, diarrhoea and bronchitis.  
 ROOT - The root is antiscorbutic, antispasmodic, astringent, 
cholagogue, and diuretic. It is crushed and used as a poultice for 
burns, bruises and smelly feet.  
 The roots are said to be useful in urinary complaints, piles and in  
gastrodynia, Liver dysfunction and poor digestion 
 The plant contains raphanin, which is antibacterial and antifungal. It 
inhibits the growth of Staphylococcus aureus, E. coli, streptococci, 
Pneumococci etc.Radish preparations are useful in liver and gall 
bladder troubles. The roots are said to be useful in urinary complaints, 
piles and in gastrodynia. 
PHYTOCHEMICAL PROFILE: 
Coumarins isolated from Radish root 
 Aesculetin – Anti fungal activity 
 Scopoletin – Anti spasmodic activity 
Organic acid isolated from Radish leaves and roots 
 Para-hydroxy benzoic acid – Anti microbial activity 
 Salicylic acid – Anti fungal activity 
 Vanillic acid – Anti microbial activity 
Phenolic compounds isolated from Radish leaves and roots 
 Cyanidin – Antiulcer activity 
Kampherol – Diuretic, anti-inflammatory and anti-oxidant activities 
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rpj;j kUj;Jt Nehf;F ; ; ;; ; ;; ; ; - GUNAPADAM ASPECT 
ntbAg;G;;;  - POTASSIUM NITRATE 
8ruf;F tif :;;; - 
“cq;fe;jh Dg;Gtif ,Ugj;ije;J” 
,aw;if cg;G -10 
nraw;if cg;G -15 
ntbAg;G - Xh; nraw;if cg;G MFk;. 
9NtW ngah;fs; :; ;; ;; ; - 
 nghl;bYg;G 
 ,zq;fd; 
 giluhrd; 
 G+kp$h;kd; 
 etr;rhukpj;U 
 
10G+ehjd;> fk;gp> mzq;fd;> jPr;Rlh;> Nghl;biy> Ntij tsh;g;gp 
 
11Glytzk;> fUthk;Kg;G> Couhtzk;> mf;fpdpj;jP> Mz;ikAs;Nshd;> 
Grq;frj;JU> etr;rhu kpj;U 
12itg;G Kiw:;;; - 
Xub fdj;j kl;ghz;lj;jpy;> cg;G cjph;e;j kz;izf; nfhl;b> ePh;tpl;Lf; 
fyf;fp> gpwF FUJ fl;b> jkhpl;L> itf;Nfhy; nrhUfp Nkw;gb ePiu tpl;Lj; 
njspntLj;J> mjid fha;r;r cg;ghFk;. 
 
,t;Tg;G 1 gq;Ff;F ePh; 4 gq;F tpl;Lf; fha;r;Rk;NghJ> Kg;gjpw;F 1 gq;F 
Gspj;j Nkhh;> gor;rhW ,tw;iw tpl;Lf; fha;r;rp> cg;ngLf;fTk;. ,g;gb 4 
my;yJ 5 Kiw fha;r;rp vLf;f> cg;G fk;gpaha; epw;Fk;.  ,J thjj;Jf;F Nth;> 
fha;> ,iy> G+ vd;gh;. 
 
  
                                                 
8
 Nghfh; ,uz;lhtJ Mapuf; fhg;G nra;As; 
 
9 Fzghlk; jhJ - rPt tFg;G - 331 
10 thj itj;jpaj;Jf;fhjp ghfk; - I  gf;fk; 129 
11
 Nghfh; epfz;L ml;ltiz -3 
 
12
 Fzghlk; jhJ rPt tFg;G - gf;fk; 331 gjhh;j;j Fz tpsf;fk; jhJ rPtth;fk; gf;fk; -18 
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13rj;JU ;;; - kpj;JU :;;; - 
‘Nfskh jhuq; nfbrpiy nfe;jpAk; 
thslh tPuk; tsh; ntb fhuKk; 
ehSld; ypq;fk; ey;y nfshpAk; 
NrYk ehfKQ; nrg;g epkpisNa 
 
epkpis fhhpak; epd;w fy;ehUld; 
Fkpis mtj;jq; nfhbaey kpj;JU 
jkpio awpe;J jdjha; tifAld; 
ckpog; glhky; cfe;jeP  ghUNk 
 
ghu ntbAg;Gg; gzpAk; ey; rj;JU 
fhhpak; nuz;Lq; fbaNjhh; #lDQ; 
rhur; rTL Fspg;gr;ir nts;spAq; 
Nfhuf; FUk;G $h;fhe;jj; njhl;bNa 
 
njhl;ba nrk;G #urpiy nfe;jp 
fl;ba fhe;jk; fLQ;rpq;fp uhrh 
nfhl;ba fhe;jq; nfhLRiu nfe;jpAk; 
tpl;ljP KUfy; Ntz;LQ; rj;JUNt.” 
14gQ;r G+j $W:;;; - 
gQ;rG+j cg;gpy; ntbAg;G NjAtpd; $W MFk;. 
15ehj-tpe;J $W:;;; - 
‘ntbAg;G ehj ruf;F> ,jw;F tpe;J ruf;F rTf;fhuk; MFk; 
Gsp ehj ruf;F> ,jw;F tpe;J ruf;F ntbAg;G MFk;. 
16ntbAg;G Mz; ruf;F> ,jw;F ngz; ruf;F gbfhuk;” 
  
                                                 
13 kr;rKdp ehadhh; - gf;fk; 54> 55.  gjhh;j;j Fztpsf;fk; jhJrPt (th;f;fk;) gf;fk; 294 
14
 Fzghlk; jhJ rPttFg;G - gf;fk; 333> gyuhikah; thjitj;jpaj;Jf;fhjp - gf;fk; 10> kr;rKdp ruf;F itg;G 
jpUke;jpuk; - gf;fk; 87 
 
15
 ghyuhika;ah; thj itj;jpaJ;Jf;fhjp gf;fk; - 29>  
 
 
16 gjhh;j;j Fz tpsf;fk; - 18 
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17Rj;jp Kiwfs;; ;; ;; ; 
 ntbAg;G xU gq;F> fly; ePh; my;yJ fpzw;W ePh; ,uz;L gq;F> 
ntbAg;igf; fy;tj;jpypl;L Ez;ikahfg; nghbj;J Nkw;gb ePhpy; fiuj;Jf; 
nfhQ;r Neuk; itj;jhy>; NkNy njsptpUf;Fk;.  me;jj; njspitapWj;J> 
,Uk;Gr; rl;bapy; tpl;Lf; fha;r;r> cg;ghFk;.  me;j cg;ig Kd;Nghw; 
nghbj;J kPz;Lk; ,uz;L gq;F ePhpy; fiuj;Jf; fha;r;rp cg;ghf;fp 
Kd;Nghy; ,uz;L gq;F ePhpy; fiuj;Jf; fha;r;rp vLj;Jf; nfhs;s> 
ntbAg;ghdJ Rj;jpahapUf;Fk;.   
 Nkw;fz;l ghfg;gbNa thiof; fpoq;Fr; rhw;wpy; %d;W jlit nra;jhy; 
jpwkhd Rj;jpahFk;. VO jlit nra;jhy; jpwkhd Rj;jpahtJld; 
ntbAg;Gf; fl;lhFk;. 
 ,e;j cg;G xU gq;fpw;F ehd;F gq;F jz;zPh; tpl;L mLg;Ngw;wpr; rpW 
jPahy; vhpj;Jf; nfhjp fpsk;Gk; NghJ Nkw;gbahd xU tPir (1400 fpuhk;) 
cg;Gf;F ehd;F Nfhop Kl;il ntz; fUitr; Nrh;f;f Ntz;Lk;. Nkny 
mOf;F jpuSk;.  mjid mfg;igahy; topj;J ePf;fp> ciwAk; gjj;jpy; 
kWrl;bapy; rPiy fl;b mjpy; tbj;Jf; fhw;wpy;yh tplj;jpy; itj;J kWehs; 
vQ;rpa ePiu tbj;Jtpl;L> #hpanthspapy; cg;ig cyh;j;jTk;.  ,t;thW 
VOKiw nra;ar; Rj;jpahk;.  Kl;il ntz; fUtpw;Fg; gjpy; ghYf;F Giu 
,LtJ Nghy;.  vYkpr;rk; gor;rhw;iwahtJ> Gspj;j NkhiuahtJ Nrh;j;J 
mOf;if ePf;fyhk;. 
Organoleptic characters: 
 
18TASTE (Rit)    -   frg;G(Bitter), tpWtpWg;G  
POTENCY(tPhpak;)    -  ntg;gk; (Hot) 
BIO TRANSFORMATION (tpghfk;) -  frg;G(Bitter) 
19DOSAGE (msT)    -  5 - 10 Fd;wpnail 
20DOSAGE (msT) : 
5 - 15 fpNud; [yj;jpy; nfhLf;fyhk;. 
20 - 30 fpNud; tpah;tpf;f nfhLf;fyhk;.  
1 - 8 fpuhk; mjpf [yj;jpy; fiuj;J ,jd; Ntfj;ij Fiwj;J gpuNkfk;> 
fPy;thjk; ,itfSf;F nfhLf;fyhk;.  
                                                 
17 Fzghlk; jhJ rPt tFg;G - gf;fk; 332> mDNghf itj;jpa etePjk; - gf;fk; 83> ruf;F Rj;jp nra;Kiwfs; - gf;fk; 
87 
18
 gpuhz u~hkph;j rpe;J 
 
19
 Fzghlk; jhJrPt tFg;G - gf;fk; 333 
20 gpuhz u~hkph;j rpe;J 
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21ACTION (nra;if);;;  
Refrigerent (Fsph;r;rp cz;lhf;fp)  
Diaphoretic (tpah;it ngUf;fp)  
Diuretic (rpWePHngUf;fp) 
22GENERAL CHARACTERS (nghJ Fzk;);;;  
 ‘ky;yhU kl;lFzk; khjUj uf;fl;b 
 fy;yh kijg;GePHf; fl;lUf - nyy;yhNk  
 fk;gpfk;gp nad;Wq; fUTz;lh kq;fpepd;w 
 fk;gpfk;gp nad;Wiuf;Fq; fhy;.  
 
 #jf thAnthL Nrhzpjj;jpd; thjKk; Nghk;  
 thjtyp Fd;kkpit khWq;fhz; - kPjhq;  
 nfhba tapwpopAq; Nfhiofg NkFk;  
 ntbAg;Gj; jd;id tpsk;G.” 
 
vz;tpj Fd;kk;> fUg;ghraf; fl;b> Nrhig> %j;jpuf;fphPr;ruk;> 
ePHRUf;F> #jpfhthjk;> thj Nrhzpjk;> rhkhdpathj gpj;j fg 
Fd;kq;fs;> ngUtapW><is> fgNjhlk; xopAk;. Nghpsk; ngz;> gUtq; 
fle;j khjh;fl;Fk; fUg;gk; cz;lhFk;.  
23kUj;Jt gad;fs; : ; ; ;; ; ;; ; ;  
 nghl;bYg;G 4 tuhfd;> ethr;rhuk; 4 tuhfd;>¾ Mohf;F ePhpy; 
fiuj;J rPiyapy; eidj;J cyu cyu new;wpapypl epidT 
jLkhw;wk;> jiytyp ,itfSld; $ba Ruj;jpw;F Fzj;ij 
nfhLf;Fk;.  
 nghl;bYg;G 2 tuhfid 1 NrH fQ;rpapypl;L Ritf;fhf Njd; 
my;yJ fw;fz;L NrHj;J mUe;j ehtwl;rp> jhfk;> ePHfLg;G> Njhy; 
twl;rp> mk;ikahy; fhZk; Ruk;> ePHf;NfhitAld; $ba Ruk;> 
Nky;Nehf;F fPo;Nehf;F Mfpa ,uj;j gpj;j NehapYk; toq;fyhk;.  
 Muk;g njhz;ilg;Gz;> neQ;R tpuzk; ,itfSf;Fr; rpwpJ 
nghl;bYg;ig thapypl;Lr; Ritf;f Fzj;ij jUk;.  
                                                 
21 Fzghlk; jhJrPt tFg;G - gf;fk; 332 
22
 gjhh;j;j Fz tpsf;fk; - gf;fk; 407> Fzghlk; jhJrPt tFg;G - gf;fk; 333 
 
23 Fzghlk; jhJrPt tFg;G - gf;fk; 333 
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 CWq;  fhfpjq;fisg; nghl;bYg;G ePhpy; Cw itj;j cyh;j;jpr; 
RUl;bf; nfhSj;jpg; Gifgpbf;fr; Rthrfhrk;> ,Uky; jzpAk;.  
 2 Fd;wpnailnghl;bYg;ig xU mTd;]; ePhpy; fye;J fz;typf;Fr; 
fpNyjkhfTk; cgNahfpf;fyhk;. 
 1 gyk; ntbAg;ig 2 Mohf;F ePhpypl;Lf; fye;J> mjpy; rPiyia 
eidj;J %l;L tPf;fk;> %l;Ltyp ,itfSf;F NkNy Nghl 
FzkhFk;.  
 nghl;bYg;G jpuhtfk; (Acidum nitricum) jf;f msT ePhpy; fye;J 
nfhLf;f rpWePiu mjpfg;gLj;Jk;.  goQ;Ruj;jpw;Fg; gpd; fhZk; 
gyf;FiwT ePq;Fk;.  
 Jspf;fzf;fpy; ePhpy; fye;J Foe;ijfl;Ff; nfhLj;J tuf; fy;yPuy;> 
kz;zPuy; tPf;fk; FzkhFk;.  
 ntbAg;Gr; nraePH - jhsfk; Kjypa gh\hzq;fSk; cgurq;fSk; 
ePWk;.  
 ntbAg;Gr; Rz;zk;  -1 Fd;wp Ks;sq;fpr; rhW> ,sePH my;yJ 
rpWgPisr; rhw;wpy; nfhLf;f ePHfl;L> ePuilg;G> ePH vhpr;ry; ePq;Fk;.  
eQ;R FwpFzk; :; ;; ;; ;  
fl;baha; cl;nfhz;lhy; vhpr;riy cz;Lgz;Zk;.  mjpf 
mstpy; gad;gLj;j gpuhzgak; NehpLk;.  
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ntbAg;G NrUk; fy;yilg;gpw;fhd gpw kUe;Jfs;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
 
24rhu gw;gk;; ;; ;; ; 
 
msT  :  2 - 3 Fd;wpnail 
mDghdk;  :  rPuff; FbePh; 
jPUk; Neha;  : fy;yilg;;G> rijailg;G Fly;thjk;> fw;whio  
ehw;wk; 
 
25rhuytz gw;gk;; ;; ;; ; 
msT  :  1 - 1½  Fd;wpnail 
mDghdk;  :  ,sePh;> rPuffpahok;> md;d nfhjp ryk; 
jPUk; Neha;  : ePh; milg;G> ePh;fl;L> gf;f#iy 
 
26rJh;Kf gw;gk;; ; ;; ; ;; ; ; 
msT  :  1 - 2  Fd;wpnail 
jPUk; Neha;  : fy;yilg;;G> ePuilg;G> rijailg;G> gpuNkfk; 
 
27Mwhjhu gw;gk;; ;; ;; ; 
msT  :  Fd;wpnail 
mDghdk;  :  ,sePh;> ntq;fha rhW> ePiu ngUf;Fk; FbePh; 
jPUk; Neha;  : fy;yilg;;G> ePuilg;G> rijailg;G> ePh; vhpr;ry; 
 
 
28A+jf;fy; gw;gk;; ; ; ;; ; ; ;; ; ; ; 
msT  :  1-2 Fd;wpnail 
mDghdk;  : neUQ;rp Kl;J}s;> fhrpdp tpijj;J}s; 
tiff;F 16 Fd;wpnail> Njd; 1 ½ tuhfndil 
jPUk; Neha;  : fy;yilg;;G> rijailg;G> ePh;g;ig fy;yilg;G>  
ehl;gl;l gpuNkf Neha; 
  
                                                 
24 gjhh;j;j Fz tpsf;fk; jhJ rPt th;f;fk; gf;fk; 139 
25
 gjhh;j;j Fz tpsf;fk; jhJ rPt th;f;fk; gf;fk; 139 
26
 gjhh;j;j Fz tpsf;fk; jhJ rPt tFg;G gf;fk; 174 
27
 fz;Zrhkp guk;giu itj;jpak; gf;fk; 397 
28
 mDNghf itj;jpa etePjk; ghfk; - III gf;fk; 169 
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 
29fhsNkf ehuhaz nre;J}uk;; ;; ;; ; 
msT  :  ½ gdntil 
mDghdk;  :  KUq;ifg;gl;il Rurk; 
jPUk; Neha;  : fy;yilg;;G> ePuilg;G> rijailg;G 
 
30v0F nre;J}uk;; ;; ;; ; 
msT  :  gdntil 
mDghdk;  :  nea;> Njd; 
jPUk; Neha;  : fy;yilg;;G> rijailg;G> ePh;f;fl;L> ePuilg;G 
 
31ntbAg;Gr; Rz;zk;; ; ; ;; ; ; ;; ; ; ; 
msT  :  Jtuk; gUg;gsT 
mDghdk;  :  ,sePh;> ePiu ngUf;Fk; FbePh; 
jPUk; Neha;  : fy;yilg;;G> rijailg;G> ePh;f;fl;L 
 
32ntbAg;Gr; Rz;zk;; ; ; ;; ; ; ;; ; ; ; 
msT  :  Fd;wpnail 
mDghdk;  :  ,sePh;  
jPUk; Neha; : ePuilg;G> fy;yilg;G 
 
33[ykQ;rhp;;;  
msT  :  ¼ Kjy; ½ tuhfndil 
mDghdk;  :  ,sePh;> Ks;sq;fpr;rhW> Nrhk;Gj;jPePh;> fhrpdpj;jPePh; 
jPUk; Neha;  : fy;yilg;;G> rijailg;G> ePh;f;fl;L> ePuUfy; 
 
34ntbAg;G nra;ePh; ; ; P ;; ; P ;; ; P ;  
msT   :  4 Kjy; 10 Jspfs; 
Jiz kUe;J : vYkpr;rk; gor;rhW> neUQ;rpNth;f; 
FbePh;>,sePh;> nts;shpf;fhia mdypy; thl;bg; 
 gpope;j rhW 
                                                 
29
 Mj;k ul;rhkph;jnkd;Dk; itj;jpa rhurq;fpufk; gf;fk; 496 
30
 fz;Zrhkpak; vd;Dk; guk;giu itj;jpa Nrfuk;gf;fk; 141 
31
 fz;Zrhkp guk;giu itj;jpak; gf;fk; 400 
32
 fz;Zrhkp vd;Dk; itj;jpa Nrfuk; gf;fk; 86 
33
 mDNghf itj;jpa etePjk; ghfk; - VII gf;fk; 98 
34
 mDNghf itj;jpa etePjk; ghfk; III gf;fk; 78 
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jPUk; Neha;   : ePh; mUfy;> ePhp vhpf;fy;> ePh;f;fl;L> fy;yilg;G> 
rijailg;G 
 
35etr;rhuf;fl;L; ; ; ; ;; ; ; ;; ; ; ;  
msT  :   ¼  tuhfndil 
mDghdk; : Ks;sq;fpf; fpoq;Fr;rhW -2gyk; Njd; -1gyk;  
,uz;ilAk; fye;J gad;gLj;jTk; 
jPUk; Neha;  : ePh; mUfy;> ePuilg;G> fy;yilg;G> rijailg;G 
 
36ntbAg;Gf;fl;L; ; ; ; ;; ; ; ;; ; ; ;  
msT  :    2 Kjy; 4 Fd;wpnail 
mDghdk; : neUQ;rp Nth; FbePh;> ahid neUQ;rpiaf;  
fyf;fp jz;zphpy; vLj;j Nfhio> Ks;sq;fpr;rhW 
nts;shl;Lg;ghy; 
jPUk; Neha;  : ePuilg;G> fy;yilg;G> rijailg;G>tapw;Wtyp> thA 
 
  
                                                 
35
 mDNghf itj;jpa etePjk; ghfk; III gf;fk; 57 
36
 mDNghf itj;jpa etePjk; ghfk; III gf;fk; 71 
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37thio 
MUSA PARADISIACA, Linn 
 
NtW ngah; :;;;  
 mk;gzk;  
 muk;ig 
 Xir 
 fjyp 
 fth; 
 Nrfpyp 
 jpuzgjp 
38thioAlg; Ngh;jidNa tOjjf;NfS 
kfj;jhd uk;gh thq;fjyp Nkhrh 
tPioafk; tphpe;j G\;g kw;gyhth  
kpiuahd fh\;bth thA jhdP 
jhioahQ; RFkhue; jPuz ge;jpue;  
Jhpjkhk; a];jp tp\h;zp fhyhFk;  
ehioahk; uj;j gpj;jdh rdpAkhFk; 
ehbaNjhh; thioAlg; NgUkhNk” 
,J ,e;jpahtpd; vy;yhg; ghfq;fspYk; itj;Jg; 
gaph;nra;ag;gLfpwJ. ,jpy; gy tifAz;L.  mfj;jpah; Fzghlj;jpy; 
vz; tif thiog; goj;jpd; Fzk; $wg;gl;bUf;fpd;wJ.  
gad;gLk; cWg;Gfs; :; ; ; ;; ; ; ;; ; ; ;   ,iy> G+> gpQ;R> fha;> gok;> gl;il> fl;il> jz;L> ePH  
ePH> fl;il> jz;L P ; ;P ; ;P ; ;  
Organoleptic Characters  
Taste (Rit)   -  Jth;g;G 
 Potency (jd;ik)  -  ntg;gk; 
 Bio transformation (gphpT) -  ,dpg;G 
 
Action (nra;if) ;;;  
 G+> gpQ;R> fha;   Astringent (Jth;g;gp) 
 ePH    Styptic  (FUjpg; Nghf;flf;fp) 
 fl;il> jz;L   Antipitha (gpj;jklf;fp) 
     Diuretic (rpWePH ngUf;fp)    
                                                 
37 Fzghlk; %ypif tFg;G 810 
38 Nghfh; epfz;L 1200 
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,iy> gl;il   Refrigerant (FspHr;rpAz;lhf;fp)  
gok;     Demulcent (cs;soyhw;wp)   
     Laxative (kykpsf;fp)     
     nutritive (clYukhf;fp)    
thiof; fpoq;F :; ;; ;; ; -  
 fpoq;if ,bj;Jg; gpope;j ,urj;jpw;F %j;jpuj;ijg; ngUf;Fk; 
nra;if cs;sJ.  
 ,jpy; ntbAg;gpd; rj;J Nrh;e;jpUg;gjhy; ePHf;fl;L> ePH vhpT> 
,uj;jf;fphpr;ruk; ,itfisg; Nghf;f gad;gLj;jyhk;.  
 fpoq;fpd; ,urj;jpdhy; ntbAg;G Nkyhd Rj;jpahFk; ;; ;; ; ;.  
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39ntw;wpiy;;;  
PIPER  BETLE,  Linn 
 
 
NtW ngah; :;;;  
 jhk;G+yk; 
 nts;spiy 
 jhk;G+yty;yp 
 jpiuay;  
 ehfty;yp 
 nky;ypiy 
 nky;ylF  
 40ntj;jpiyapd; Ngh;jidNa tpsk;gf; NfS 
  Ntz;baNjhh; jhk;G+y khjhthFk;.  
 rpj;jpiyapd; rhjf yl;Rkp ahFk; 
  jhk;G+yf; fz;zp ey ehfty;yp  
 xj;jpiuNthk; Gyf;fd;dpahFk; 
  cWgy;Yf;fofp jhd; Njf u~fpahk;  
 ej;jiy ehfj;ij #uzkhf;fp 
  eyq;fpaNjhh; ntw;wpiyap ehkkhNk.  
 ,J ,e;jpahtpy; ntg;g ghfj;jpYk;> rJg;Gs;s ,lq;fspYk; 
gapuhf;fg;gLk;.  kuNkWq;nfhb.  ,J ,iyapd; nghUl;Nl gaphplg;gLfpwJ.  
,J ,iyapd; epwj;jhYk;> kzj;jhYk;> fhh;g;Gr; RitahYk; 
tifg;gLk;.  fUikAk;> fhuKk; kpFe;jJ ‘fk;khW ntw;wpiy”.  fUg;G+u 
kzKk; rpWfhuKKilaJ ‘fUg;G+u ntw;wpiy”.  
gad;gLk; cWg;G : ; ; ;; ; ;; ; ;  ,iy 
Taste (Rit)    tpWtpWg;G  
Potency (jd;ik)   ntg;gk; 
Bio-transformation (gphpT)  fhh;g;G 
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Action (nra;if) :;;;  
Stimulant  (ntg;gKz;lhf;fp) 
Carminative (mfl;Ltha;tfw;wp) 
Astringent (Jth;g;gp) 
Aphrodisiac (fhkk; ngUf;fp) 
Antiseptic (mOfyfw;wp)  
Febrifuge (ntg;gfw;wp) 
Stomachic (grpj;jPj;J}z;b)  
Galactagogue (ghw;ngUf;fp) 
Sialogogue (ckpo;ePHg;ngUf;fp) 
Fzk; :;;;  
ntw;wpiyapd; ,urj;ijg; gUfpy;> Iak;> rapj;jpak;> Kg;gpzp 
,itfs; xopAk;.  
 Iak; mWq;fhz; mjd;rhuq; nfhz;lf;fhw; 
  igar; rapj;jpak;Nghk; ige;njhbNa - nka;apd;  
 fbapd; Fzk; NghFq; fhuntw;wp iyf;Fg;  
  gbAKj; Njhlkpijg; ghh;.  
fk;khW ntw;wpiy; ;; ;; ;  
 ,jw;F ePNuw;wk;> jiyghuk;> Kg;gpzp> khe;jk;> Fuw; fk;ky;> tapw;W typ> 
tapw;Wg;gprk; MfpaitNghk;.  
 vl;bnyhd;W fpl;bdP Nuw;wQ; rpNuhghu  
  khl;b tpLrd;dp khe;jnkhL - ehl;bw;  
 ghpaFuw; fk;ky;typ  gz;bAg;gp rk;Ngh  
  khpafk; khW ntw;wp iy.  
41kUj;Jtg; gad;ghL :; ; ;; ; ;; ; ;  
 njhz;ilailg;G> Fuw;fk;kypy; ntw;wpiyiaAk;> rhkpga 
gjq;fj;ijAk nkd;W Ritf;Fk;gb nra;ayhk;.  
 ghw;Ruf;fTk;> ghy; fl;b cz;lhFk; Kiy tPf;fj;ijf; fiuf;f 
ntw;wpiyiaj; jzypy; thl;b mLf;fLf;fhf itj;Jf; fl;lyhk;.  
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 jiyg; gSTf;F %f;fpYk;> fhJ Fj;jYf;Ff; fhjpYk;> ntw;wpiyr;; 
rhw;wpy; 2 -3 Jsp tplyhk;.  
 ntw;wpiyia vz;nzapy; eidj;J> tpsf;fpy; thl;b khh;gpd; Nky; 
Nghl ,Uky;> %r;R%l;ly;> fbd Rthrk;> Foe;ijfSf;Fz;lhFk; 
,Uky; tpyFk;. ,itfl;Nf ntw;wpiyr; rhw;Wld; Rz;zhk;Gf; 
$l;b njhz;ilf; Fopapy; jltyhk;.  
 ntw;wpiyr; rhWld; ,Q;rpr; rhWk; NrHj;J EiuaPuy; rk;ge;jkhd 
Nehapy; toq;fyhk;.  
 jPg;gl;l Gz;zpd; kPJ ntw;wpiyia itj;Jf; fl;lyhk;.  
 ,sk; ntw;wpiyf; nfhb NtUk;> kpsFQ; NrHj;J rhg;gpl;L kyl;il 
cz;lhf;Fk;. 
 Ntiur; Ritj;J tu ghlfh;fspd; njhz;il xyp ngUFk;.  
 rpWgps;isfSf;Fz;lhFk; tapw;Wg; nghUky;> kyr;rpf;fy;         
,itfis Nghf;f ntw;wpiyf; fhk;ig Mkzf;F nea;apy; eidj;J 
fPo;thapy; itf;fyhk;.  
 ntw;wpiyr; rhw;wpy; nfhQ;rk; NfhNuhrdQ; NrHj;J Gfl;bdhy; 
Nfhiof; fl;L> ,Uky;> %r;Rj; jpzwy; FzkhFk;.  
 2 - 3 ntw;wpiyAld; 4 - 5 kpsF NrHj;Jf; FbePhpl;Lg; Gfl;l 
rpWth;fSf;Fz;lhFk; nrhpahik tpyFk;.  
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42Ks;sq;fp; ;; ;; ;  
Raphanus sativus, Linn. 
 
NtW ngah; : Ks;sq;fp> %ygk;; ; ; ;; ; ; ;; ; ; ; 
,/J ,e;jpahtpd; vy;yhtplq;fspYk; gaphplg;gl;L tUfpwJ.  
,jpy; nts;is> rptg;G> kQ;rs; vd %d;W tif cz;L.  Mdhy; gz;G 
xd;NwahFk;.  
gad;gLk; cWg;G :; ; ;; ; ;; ; ;   ,iy> fpoq;F> tpij 
Organoleptic Characters  
 
,iy - fpoq;F;;;  tpij 
Taste  (Rit) fhh;g;G ,dpg;G 
Potency (jd;ik);;;  jl;gk; jl;gk; 
Bio-Transformation (gphpT) fhh;g;G ,dpg;G 
Action (nra;if;;; ) :  
Aphrodisiac Mz;ikg; ngUf;fp 
Diuretic rpWePHg;ngUf;fp 
Laxative kykpsf;fp 
Stimulant  ntg;gKz;lhf;fp 
Stomachic  grpj;jPj;J}z;b  
fpoq;F :;;;  
,jdhy; ‘tsp Neha;” fug;ghd;> tapw;nwhpr;ry;> Fj;jy;> Fly; 
gUkd;> ,Uky;> Ia Neha;> jiytyp> ePNuw;wk;> gy;Neha;> gy; rpye;jp> 
Fd;kk;> ,iug;G> %yf;fLg;G ,it Nghk;.  
 thjq; fug;ghd; tapw;nwhpT #iyFly;  
 thjq;fh rikak; td;jiyNeha; - NkhJePHf; 
 Nfhitgd;Ndha; gy;rpye;jp Fd;kkpiug; Gf;fLg;GQ; 
 rhTKs;sq; fpf;fe;jj; jhy;.  
tof;F Kiw : ;;;  
Ks;sq;fp el;L ,uz;L %d;W ,iyfs; te;j cld;> 
mt;tpiyfspy; xU gpb vLj;J> 2-4 fpuhk; Nrhw;Wg;Gr; NrHj;J> fhiy - 
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khiy ,U NtisAk; rhg;gpl;L tu> nts;isapdhy; cz;lhFk; 
ePuilg;G ePq;Fk;>ntspf;Fg;Nghk;.  
fpoq;if eRf;fpr; rhW gpope;J 34-100 fpuhk; tiuapYk; Fbj;J tu 
rpWePiu ed;wha;g; Nghf;Fk;.  
fpoq;ifr; rikj;Jz;gJ ehl;L tof;fk;.  rpyh; gr;irahfj; 
jpd;gJk; cz;L. Ritapd;ikia ePf;fpg; grpia cz;L gz;Zk;.  
czitr; nrhpg;gpf;Fk;.  
tpijiaf; FbePhpl;Lf; Fbf;f> Nkw;$wpa gz;Gfisj; jUk;.  
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SIDDHA ASPECTS 
fy;yilg;G ; ;; ;; ;  
43NtW ngah; ;;;  - mr;khp Neha;  
    mr;rkhp Neha;  
Neha; ,ay; :; ;; ;; ; -  
rpWePHfopf;Fq;fhy; m‡J ,wq;fpf; nfhz;bUf;Fk; NghNj  
• jpBnud ePuilj;jy;> FwpKid Nehjy;  
• ePHGio vhpjy;  
• ,Lg;gpd; gpd;Gwj;Jk;> KJFj; jz;bd; gf;fj;Jk; Nehjy;  
• kziynahj;j rpWfw;fs; fye;jpUj;jy;.  
Mfpa ,ay;GfisAilajhFk;.  
44Neha; tUk; top :; ;; ;; ; - 
fyq;fpdNjhh; jz;zPHjhd;  Fbj;j Ngh;f;Ff; 
 fy;nyYk;G kaph;kz;jhd; fye;jd;dj;jpy;  
myq;fpdNjh ud;dq;fsUe;jyhYk; 
 mOfNyhL %j;jgz;l kUe;jyhYk;  
kyq;fpdNjhh; khg;gz;l kUe;jyhYk; 
 ke;jj;jpy; tha;thd gjhh;j;e;jd;id   
Jyq;fpdNjhh; Urp jd;dpw; Ritj;jyhYk; 
 RUf;fha;f; fy;yilg;G; ;; ;; ;  te;J Njhd;We;jhNd  
 
,jdhy; fy;yilg;G ; ; ;; ; ;; ; ;  
 
 RidePH> gd;dhl;fs; Njq;fpa ePH> RUF Cwpa ePH mRj;jkhd 
ePiu gUFtjhYk; 
 mOfy;> Crpa gz;lk;> khg;gz;lk;> Crpa gz;lk; tsp> moy; 
Fw;wj;ij kpFjpg;gLj;Jk; czT cz;gjhYk;  
 kz;> fy;> vYk;G fye;j md;dj;ij cz;gjhYk;> mjpf Gspg;ghd 
japh; mUe;JtjhYk;  
 tpe;JthdJ fl;Lg;gLtjhYk; tUk; vd;W $wg;gl;Ls;sJ. 
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45‘njspe;jNjhh; fy;yilg;G cw;gj;jp Nfsha;  
 rpwpJ ehl;nlhlq;fpNa Nkfe;jd;dhy;  
jspe;jNjhh; ryg;igap Yjpue; Njha;e;J  
 re;jrj;jhfNt gUj;Jf; nfhs;Sk;  
tspe;jNjhh; thj gpj;j Nfhgpj;jf;fhy;  
 te;J ngUq;fy;yha; ePH topailj;J  
espe;jNjhh; ehYtpjf; fy;yilg;G  
 ez;ghd tuyhW ehl;lf;NfNs” 
 
 46fdyJ kPWk; ghf;F ntw;wpiyAk;  
  fw;Rz;z kpitaDgtpj;jhw; 
 GdYk; NtwhFe; jDntDq; Nfhrk; 
  nghhpA Kz;lhf;Fk; ePH fLf;Fk;  
 GJikaha;r; Rf;fhd; fy;nfhz;lilf;Fk;  
 
ghf;F ntw;wpiyNahL fy; Rz;zk;> mjpfkhf NrHj;Jz;lhy; 
Rz;zhk;G fw;fs; ePHj;jiuia milj;J tpLk; vd;W $wpAs;shh;.  
Neha; vz; :; ;; ;; ; -  
Fw;w mstha; ehd;F  
 tsp fy;yilg;G 
 moy; fy;yilg;G 
 Ia fy;yilg;G 
 Kf;Fw;w fy;yilg;G  
jPUk; jPuhjit :P ; PP ; PP ; P -  
jdpf;Fw;wj;jhy; tUtd jPUk; 
Kf;Fw;wj;jhy; cz;lhtJ jPuhJ.  
nghJ FwpFzq;fs;  :; ;; ;; ; -  
 mbf;fb rpWePhpopAk;> Kw;Wk; ntspahfhky; rpWePH ,wq;fp 
nfhz;bUf;Fk; NghNj jpBnud milf;Fk;.  
 vUthapd; Nkw;Gwk; typAz;lhFk;.  
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 fy; fuL KulhNaDk;> $HikahNaDkpUg;gpd; fPo; tapw;wpYk;> 
ePHGioapYk; jhq;f Kbahj vhpr;riyAk;> typiaAk; je;J 
FUjpia ntspahf;Fk;.  
Fw;w Kjypa NtWghLfs; ; :; ; ;; ; ;; ; ; -  
czT> ePH Kjypaitfshy; jPf;Fw;wk; kpFe;J cly; ePiur; 
Rz;lr; nra;J> rpWePH tw;wp> ePhpd; cg;ig ciwar; nra;J> 
fPo;Nehf;Ff;fhy; td;ikapoe;jhy;> cg;ig ntspahf;fhJ jq;fr; 
nra;tNjhL ,e;Nehiag; gpwg;gpf;Fk;.  
ePHFwp :PPP -  
njspaitf;fpd; rpWkzy; NghYk;> rpWfw;fs; NghYk; 
fhzg;gLk;.   
 
 
 
 
 
 
101 
 
   MODERN ASPECT OF THE DISAESE 
UROLITHIASIS 
ETYMOLOGY: 
The term  Uro  came from Greek word “ ouron” means urine and 
lithos means stone 
Renal calculus came from Latin “Ren – kidney”, “calculus – 
pebble” 
Renal calculus is a stone-like aggregation of urinary salts bound 
together by a colloid matrix or organic materials. It consists of a nucleus 
around which concentric layers of urinary salts are deposited. 
AETIOLOGY: 
 Hyper excretion of relatively insoluble urinary constituents. 
 Physiological changes in urine such as Urinary Ph. 
 Altered urinary crystalloids and colloids. 
 Decreased urinary output of citrate. 
 Vitamin A deficiency. 
 Urinary infection. 
 Urinary stasis. 
 Hyperparathyroidism. 
 Prolonged immobilization. 
 Nidus of stone formation. 
Occurance –More in male than female earlier but now the ratio is almost 
same as per WHO. 
PREDISPOSING FACTORS AND CONDITIONS: 
 Environmental and dietary factors. 
• Low urine volumes. 
• High ambient temperatures. 
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• Low fluid intake. 
• Diet. 
• High protein intake. 
• High Sodium. 
• Low calcium. 
• High sodium excretion. 
• High oxalate excretion. 
• Low citrate excretion. 
 Other medical conditions 
• Hypercalcemia of any cause 
• Ileal disease or resection (leading to increased oxalate 
absorption and urinary excretion) 
• Renal tubular acidosis type. 
 Congenital and inherited conditions 
• Familial hypercalciuria 
• Medullary sponge kidney 
• Cystinuria 
• Renal tubular acidosis type I 
TYPES OF REAEL CALCULI: 
Basically the renal stones can be divided into two major groups 
 PRIMARY STONES 
They appear in apparently healthy urinary tract without any 
antecedent inflammation. 
• Calcium oxalate 
• Uric acid calculi 
• Cystine calculi 
• Xanthine calculi 
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• Indigo calculi 
 SECONDARY STONES 
They are usually formed as the result of inflammation. 
• Triple phosphate calculus or infectious stones, triple phosphate 
stones. 
• Mixed stones 
 DRUG INDUCED CALCULI 
• Crixivan (Indinavix) stones – Critical to differentiate these 
stones from uric acid syones. 
• Triamterene stones – Direct crystallization by seeding calcium 
oxalate stones. 
EFFECTS OF STONE: 
The size and position of the stone usually govern the development 
of secondary pathologic changes in the urinary tract. 
 SAME KIDNEY 
• Obstruction. 
• Infection 
• The epithelium of the pelvis and calyces in relation to the stone 
gradually loses lustre, becomes rough and thickened.  
• Metaplasia 
 OPPOSITE KIDNEY 
• Compensatory hypertrophy 
• Stone formation may be bilateral 
• Infection of the opposite kidney 
• Calculus anuria 
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CLINICAL FEATURES: 
 SYMPTOMS 
• Quiescent calculus 
• Pain 
- Fixed renal pain 
- Ureteric colic 
- Referred pain 
• Hydronephrosis (a lump in the loin and a dull ache) 
• Haematuria 
• Pyuria 
 PHYSICAL SIGNS 
• Tenderness at the 'renal angle' posteriorly. 
• Muscle rigidity over the kidney 
• Swelling in the flank when there is hydronephrosis or 
pyonephrosis associated with renal calculus. 
• Abdominal distension and diminished peristalsis may 
accompany ureteric colic. 
SPECIAL INVESTIGATIONS: 
 Blood examination 
 Urinalysis 
 Radiography 
- Straight X-ray 
- Excretory urogram 
 Ultrasonography 
 Computed tomography 
 Renal Scan 
 Cystoscopy 
 stone analysis 
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RECURRENCE: 
Recurrence may be classified into two varieties 
 False recurrence  
 True recurrence 
PREVENTION: 
General measures. 
The general measures or advises which should be given to the 
patient regardless of the type of stone are: 
 Fluid intake should he high at all times 
 Avoidance of milk, cheese and great deal of calcium  
 Alkalies should be prohibited or used in lesser quantities.  
 Vitamin D should be stopped or used in very low quantity. 
 Patients with hyperuricemia should avoid red meats, offal and fish. 
 Eggs, meat and fish are high in sulphur containing proteins and 
should be restricted in patients with cystinuria. 
The following investigations are appropriate in bilateral and 
recurrent stone formers: 
 Serum calcium, measured fasting on three occasions to exclude 
hyperparathyroidism. 
 Serum uric acid  
 Urinary urate, calcium and phosphate in a 24 hour collection. The 
urine should also be screened for cystine.  
 Analysis of any stone passed. 
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Specific measures. 
 Calcium stone disease 
• Non-idiopathic Calcium stone disease 
• Idiopathic Calcium stone disease 
- Low urinary volume, hypercalciuria, hyperoxaluria, 
hyperuricosuria .and hypocitraturia and low urinary 
magnesium. 
- Fluid intake - · A low urinary volume will increase the risk 
of crystal formation.  
- Diet 
- Western diet with increased intake of animal protein 
and carbohydrate.  
- Dietary intake of calcium should also be restricted. 
- A mega dose of vitamin C should be avoided. 
• Infection stones 
- Infection stones consist of magnesium ammonium     
phosphate (Struvite) with varying admixtures of calcium 
phosphate (apatite). 
- In general, Struvite stones may partially dissolve in the   
presence of sterile urine, so long term low-dose 
treatment with antibiotics is appropriate even when 
urine culture is initially sterile. 
• Oxalate stones 
- Foods high in oxalate should be eliminated from the diet.   
These are strawberrys, plums, spinach, asparagus etc. 
- Pyridoxine in large doses may be helpful. 
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- Thiazides are useful agents which decrease both urinary 
calcium and oxalate. 
• Uric acid calculi 
- A low-purine diet should be prescribed for the uric acid 
stone former.  
• Cystine calculi  
- Sulphur containing proteins such as meat, fish and eggs 
should be restricted. 
- Intake of fluids must be increased to dilute cystine in the 
urine. 
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LATERAL RESEARCH WORK 
Musa paradisiacal, Linn 
47
Diuretic effect of methanolic extract of Musa paradisiaca Root stock 
Methanolic extracts of root stocks of Musa paradisiaca L (MEMP) 
was evaluated for its diuretic activity using modified method of Rao. The 
extracts showed increase in total urine volume and electrolytes excretion 
(sodium Na+, potassium K+ and chloride Clּ). the metanol extract (500 
mg/kg) significantly and markedly increased the urine output (p < 0.01). 
The pattern of diuresis induced by the methanol extract was almost 
similar to that produced by the furosemide. These findings suggest the 
possible traditional use of this plant as diuretics. 
48
Effect of MUSA Tablet on Ethylene Glycol-Induced Urolithiasis in Rats 
 Treatment with Musa tablet restored the phosphate level, thus 
reducing the risk of stone formation. In urolithiasis, the glomerular 
filtration rate(GFR) decreases due to the obstruction to the outflow of 
urine by stones in the urinary system because of that waste products, 
particularly nitrogenous substances such as urea, creatinine and uric acid 
get accumulated in blood. However, the curative treatment with product 
Musa tablet caused diuresis and hastened the process of dissolving the 
preformed stones and prevention of new stone formation in the urinary 
system. The diuretic effect of Musa tablet was evident from urine 
volumes collected when compared to the model control group. 
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49
ANTIDIABETIC AND ANTIOXIDANT ACTIVITIES OF STEM JUICE OF 
MUSA PARADISIACA ON ALLOXAN INDUCED DIABETIC RATS 
Phytochemical screening on the stem juice of M. paradisiaca 
reveals that the extract contained various pharmacologically active 
compounds such as tannins and alkaloids. In alloxan--treated diabetic 
rats receiving stem juice of musa decrease of blood glucose levels in 
comparision to diabetic control and this could be due to the possibility 
that some ß--cells are still surviving to act upon by M. paradisiaca to 
exert its insulin releasing effect. This suggests that the mode of action of 
the active ingredients of M. paradisiaca is probably mediated by an 
enhanced secretion of insulin, like sulphonyl ureas.          
PIPER BETLE, Linn 
50
Radio protective activity 
Mammalian systems if exposed to radiation can cause damaging 
effects leading to cell death and an increased risk of degenerative 
diseases. Recently the radioprotective property of ethanolic extract of 
P.betle leaves was studied as alternative low cost preventive medicine to 
synthetic radioprotectants which are reported to be toxic. The capacity of 
the extract in preventing g-ray induced lipid peroxidation and 
DNA damage in rat liver mitochondria were assessed and evaluated to 
establish the mechanism of its radioprotective action. The study revealed 
significant immunomodulatory and superior radical scavenging activities 
which may be due to the presence of phenolic bioactives such as 
chavibetol and allyl pyrocatechol 
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 Available online on www.ijprd.com 
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51
Protective and healing activity 
Most recently, a study was undertaken to evaluate the protective 
and healing effects of allylpyrocatechol against the indomethacin- 
induced stomach ulceration in rat model. Results showed that 
allylpyrocatechol can protect indomethacin-induced gastric ulceration 
due to its antioxidative and mucin protecting properties. 
52
Antibacterial activity: 
 The bioactive molecule thought to be responsible for antibacterial 
activity is sterol which has been obtained in large quantities  in piper 
betle extract .The mode of action is surface interaction of sterol  with the  
primary structure of cell  wall membrane, ultimately leading to pore 
formation and degradation of bacterial component 
53
Anti inflammatory activity: 
Eugenol, one of the principal constituent of betle  shows to possess  
anti inflammatory effects in various animal models of studies with 
various inflamogens. 
54
DIURETIC ACTIVITY OF AQUEOUS EXTRACT OF RAPHANUS SATIVUS  
Diuretic activity of aqueous extract of Raphanus sativus using 
Albino Wistar rats. Phytochemical screening showed that positive tests 
for the presence of triterpenes, alkaloids, flavanoids, saponins and 
coumarins glycoside . Results revealed that the cumulative urine volume 
collected at 5 hrs after the treatment of extracted drug exceeds 
Furosemide, the increase in urine volume with marked increase in 
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excretion of sodium, potassium and chloride  clearly indicated and 
confirmed the diuretic activity of aqueous exract of Raphanus sativus. 
55
ANTILITHIASIC AND HYPOLIPIDAEMIC EFFECT OF RAPHANUS SATIVUS 
The compound glucoraphanin is responsible for lowering 
cholesterol and triglyceride in the serum of the mice in the study. A 
hypolipidaemic effect is directly related to prevention of Gallstones. The 
reduction in plasma cholesterol is a direct consequence of decrease in 
intestinal absorption.      
56
HEPATOPROTECTIVE ACTIVITY OF RAPHANUS SATIVUS  
The methanol extract of Raphanus sativus root extract showed a 
protective effect on paracetamol induced hepatotoxicity in a dose-
dependent manner. This study indicates the involvement of Raphanus 
sativus root extract with antioxidants like glutathione and catalase in 
rendering protection against paracetamol-induced hepatotoxicity. 
57
ANTI-MICROBIAL ACTIVITY OF RAPHANUS SATIVUS 
The plant contains raphanin, which is antibacterial and antifungal. 
It also has been found to be strongly active on Escherichiacoli, 
Pseudomonas pyocyaneus, Salmonella typhi and Bacillus subtilis. 
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112 
 
MATERIALS AND METHODS FOR PREPARATION  
COLLECTION OF TEST DRUG: 
 The raw drug Vediuppu (Potassium nitrate) was purchased from a 
raw drug trader at Madurai.  
 The raw drugs Vetrilai (Betle leaves) were purchased from the 
local trader. 
AUTHENTICATION:  
Gunapadam experts of the Gunapadm department of Siddha 
medical college, Palayamkottai, authenticated the trial drug. The 
method of preparation was collected from Kannusamy parambarai 
vaithiyam (Pg. no. 371). 
PURIFICATION: 
 One part weight of powdered Vediyuppu was mixed with two parts 
weight extract of the tuber of Musa paradisiaca and kept 
undisturbed. Then clear upper portion was taken and heated in an 
iron pan. Once the water contents got evaporated the sediments 
were kept for condensation in a copper pan. Likewise 2 part extract of 
tuber of Musa paradisiaca was added to the same Vediuppu and 
heated again. The process was repeated for five to seven times. 
 The leaves of Piper betle were cleaned thoroughly and juice was 
extracted.   
PREPARATION: 
A quantity of 5 palams (175 gms) of purified Vediuppu (Nitrate of 
Potassium) was taken accurately weighed and put into a mud pot. The 
pot was placed on a fire of kiln. When the salt in the pot got melted, an 
alakku (168 ml) extract of Nagavalli leaves (vetrilai) was added to it and 
the content of pot was well stirred and heated till the water portion got 
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reduced with the sound ending of chidu chidu. Then the content of the 
pot was poured on a clean kalvam. After cooling the content, it was 
transferred from the kalvam to the mud pot along with the Nagavalli 
leaves extract added again and then it was burnt to the extent that the 
content to appear as if it was cooked food. 
The process was repeated for three times until the content of the 
pot become red in colour. Then the content was cooled and ground into 
fine powder and stored in a clean and dry containers. 
Administration of the Drug: 
Form of Medicine               : CHENDHURAM 
Route of Administration : ORAL 
Dose                                   :           130 milli gms 
Anubanam (Vehicle)      : Juice of Raphanus sativus 
Times of Administration : Two times per day before food 
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STANDARDISATION OF THE DRUG  
PHYSICO-CHEMICAL ANALYSIS 
PROCEDURES: 
Total ash 
Two grams of grounded air-dried Vediuppu chendhuram was 
accurately weighed in a previously ignited and tared silica crucible. The 
drug was gradually ignited by raising the temperature to 450°C until it 
was white. The sample was cooled in a desiccator and weighed. The 
percentage of total ash was calculated with reference to air-dried drug. 
Acid Insoluble ash 
The ash was boiled with 25 ml of 2 M hydrochloric acid for 5 
minutes, the insoluble matter was collected on an ash less filter paper, 
washed with hot water, ignited, cooled in a desiccator, and weighed. The 
percentage of acid insoluble ash was calculated with reference to the air-
dried drug. 
Water Soluble ash 
The ash was boiled with 25 ml of water for 5 minutes, the insoluble 
matter on ash less filter paper collected, washed with hot water, ignited, 
cooled in a desiccator, and weighed. The weight of the insoluble matter 
from the weight of the total ash was subtracted; the difference 
represents the water soluble ash. The percentage of water insoluble ash 
was calculated with reference to the air-dried drug. 
Moisture content: 
The shade-dried Vediuppu chendhuram was grounded in a mixer 
grinder. The powder passed through #40 and retained on #120. 
Accurately weighed 10 g of # 40/120 Vediuppu chendhuram powder was 
kept in a tared evaporating dish. This was dried at 105°C for 5 hours in 
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tray drier and weighed. The drying was continued and weighing was 
done at one-hour interval until difference between two successive 
weighings corresponds to not more than 0.25 percent. Drying was 
continued until a constant weight was reached with two 
successiveweighings after drying for 30 minutes and cooling for 30 
minutes in a desiccator wasshowing not more than 0.01 g difference. 
Potential of Hydrogen (pH): 
The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 
being neutral. 
Readings less than 7.0 indicate acidic solutions, while higher 
readings indicate alkalineor base solutions. 
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BIO-CHEMICAL ANALYSIS OF VEDIUPPU CHENDHURAM 
PREPARATION OF EXTRACT: 
100mgs of Vediuppu Chendhuram is weighed accurately and 
placed into a clean beaker, few drops of Hydrochloric acid added to it 
and evaporated well. After evaporating, the content is allowed to cool 
and then a few drops of nitric acid added and evaporated well. After 
cooling the content add 20ml of distilled water and is allowed to dissolve 
well. Then it is transferred to 100ml volumetric flask and made up to 
100ml with distilled water. The content is mixed and filtered well. Then 
the extract is taken for analysis. 
QUALITATIVE ANALYSIS:- 
S.No EXPERIMENT OBSERVATION INFERENCE 
1 
TEST FOR CALCIUM:                          
2ml of the above-prepared extract 
is taken in a clean test tube. 2ml 
of 4% Ammonium oxalate solution 
is added to it.             
A white 
precipitate is 
formed 
Indicates the 
presence of 
calcium 
2 
TEST FOR SULPHATE:                          
2ml of the extract is added to 5% 
of     barium chloride solution 
A white 
precipitate is 
formed 
Indicates the 
presence of 
sulphate 
3 
TEST FOR CHLORIDE:                          
The extract is treated with silver 
nitrate solution 
A white 
precipitate is 
formed 
Indicates the 
presence of 
chloride 
4 
TEST FOR CARBONATE:                          
The extract is treated with 
concentrated HCL 
No brisk 
effervescences 
formed 
Indicates the 
absence of 
carbonate 
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5 
TEST FOR STARCH:                           
The extract is added with weak 
iodine solution. 
No blue colour 
developed 
Indicates the 
absence of 
starch 
6 
TEST FOR ZINC:                                 
The extract is treated with 
potassium Ferro cyanide. 
No white 
precipitate is 
formed 
Indicates the 
absence of zinc 
7 
TEST FOR IRON FERRIC:                                 
The extract is treated with glacial 
acetic acid and potassium Ferro 
cyanide. 
Blue colour is 
formed 
Indicates the 
presence of 
ferric iron 
8 
TEST FOR IRON FERROUS:                                 
The extract is treated with 
concentrated Nitric acid and 
ammonium thio cyanate. 
Blood red colour 
is formed 
Indicates the 
presence of 
ferrous iron 
9 
TEST FOR PHOSPHATE:                                 
The extract is treated with 
ammonium molybdate and 
concentrated Nitric acid. 
No yellow 
precipitate is 
formed 
Indicates the 
absence of 
phosphate 
10 
TEST FOR ALBUMIN:                                 
The extract is treated with 
Esbach's reagent. 
No yellow 
precipitate is 
formed 
Indicates the 
absence of 
Albumin 
11 
TEST FOR TANNIC ACID:                                 
The extract is treated with ferric 
chloride. 
No blue 
precipitate is 
formed 
Indicates the 
absence of 
Tannic acid 
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12 
TEST FOR UNSATURATION:                                 
Potassium permanganate solution 
is added to the extract. 
It doesn’t get 
decolorized 
Indicates the 
absence of 
unsaturated 
compound 
13 
TEST FOR REDUCING SUGAR:                                 
5ml of Benedict's qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 - 10 drops of the extract 
and again boil it for 2 minutes. 
No colour 
change occurs 
Indicates the 
absence of 
reducing sugar 
14 
TEST FOR AMINO ACID:                                 
One or two drops of the extract is 
placed on a filter paper and dried 
it well. After drying, 1% Ninhydrin 
is sprayed over the same and 
dried it well. 
No violet colour 
is formed 
Indicates the 
absence of 
Amino acid 
 
 
INFERENCE: 
 The given sample of VEDIUPPU CHENDHURAM contains  
 CALCIUM  
 SULPHATE  
 CHLORIDE 
 FERRIC IRON  
 FERROUS IRON 
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58
PRECLINICAL   PHARMACOLOGICAL STUDY OF VEDIUPPU  
CHENDHURAM (VC) ON ETHYLENE GLYCOL INDUCED 
UROLITHIASIS IN RATS 
Test Drugs: 
The medicineVediuppu chendhuram(VC)  used in the study was 
processed by the methods prescribed in standard textbooks of Siddha 
medicine. 
Preparation of drug for dosing: 
 All drugs used for the study was suspended each time with 1% 
(w/v) solution of sodium carboxy methylcellulose before administration. 
Drugs and chemicals: 
 Fine chemicals used in these experiments were obtained from 
Sigma Chemicals Company, U.S.A. Other analytical grade chemicals were 
obtained from S.d. Fine Chemicals Ltd., Mumbai. Standard drug Cystone 
(Himalya Drug Company product) procured from market. 
Experimental animals: 
Male albino rats of wistar strain weighing between 200-250gm 
were used. The animals were fed with commercial rat feed 
pellets(Tanuvas,Chennai) and water ad libitum.  
Animals were housed in plastic cages with filter tops under 
controlled conditions of 12:12  light dark cycle, 50 humidity and 28 c. All 
animal experiments and maintenance were carried out according to the 
ethical guidelines suggested by the IAEC. (IAEC/XXXV/61/CLBMCP/2012). 
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Urolithiatic activity: 
Animals were divided in to five groups containing six animals in 
each group and received the following regimen of treatment. 
Group I -       Served as normal control received 1%CMC  
10ml/kg/po. 
Group II -      Received Ethylene glycol (0.75%) in drinking water for  
28 days and served as   negative control.  
Groups III - Rreceived EG  (0.75%) in drinking water for 28 days  
and also received the test drug VC(25mg/kg/po 
simultaneously  for 28 days 
Group IV -  Animals received EG in the same dose and period  
mentioned for  group III and simultaneously received  
Standard drug Cystone(500mg/kg/po) 
Group V - Animals received VC at the dose of 25mg/kg/po for 28  
days and used for the 28 days chronic toxicity study to  
assess the toxicity, if any in comparison to the normal 
control(Group-1) 
All drugs were given once daily by oral route using blunt metal 
needle fitted with PVC tube .24 hrs urine samples were collected and 
analysed for  calcium, magnesium, oxalate, inorganic phosphate,   using 
standard  procedures . 
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ASSESSMENT OF ANTIUROLITHIATIC ACTIVITY: 
Collection and analysis of urine: 
All the animals were kept in individual metabolic cages and urine 
samples of 24 h were collected on the 28th day. Animals had free access 
to drinking water during the urine collection period. A drop of 
concentrated hydrochloric acid was added to the urine before being 
stored at 4°C. Urine was analyzed for calcium, phosphate, and oxalate 
content using the method of Bahuguna et al. 
Serum analysis: 
After the experimental period, blood was collected from the retro-
orbital under anesthetic condition and animals were sacrificed by cervical 
decapitation. Serum was separated by centrifugation at 10 000 × g for 10 
min and analyzed for creatinine, uricacid, and urea nitrogen . 
Urine volume: 
Animals were placed in separate metabolic cages for 24 h and 
total urinary volume was measured using the measuring cylinder and 
reported in ml. 
Urine pH: 
Uric acid crystals were found to deposit most frequently in the 
concentrated acid urine. Thus, the acidity of the urine was tested using 
the pH meter. 
Statistical Analysis: 
Statistical evaluation was done using  Student “t’test. Statistical 
significant was set at P < 0.05. Results are presented as mean ± standard 
error of mean (SEM). 
 
 
122 
 
ANALYSIS OF DIURETIC EFFECT OF VEDIUPPU CHENDHURAM 
AIM: 
To evaluate the diuretic effect of Vediuppu chendhuram. 
PREPARATION OF TEST DRUG: 
 100 mg of Vediuppu chendhuram extract was dissolved in 5 ml of 
distilled water, thus 1 ml contains 20 mg of Vediuppu chendhuram 
extract. 
PROCEDURE: 
 The method of lipschitiz et.al was employed for the assessment of 
diuretic activity. Groups of 9 male albino rats, each weighing 80-120 gm 
were fasted and deprived of water for 18 hours prior to the experiments. 
They are divided into 3 equal groups of rats each and put into 3 different 
metallic cages. On the day experiment all the animals were given normal 
saline orally 2.5 ml / 100 gm body weight. Group I served as the negative 
control which received only normal saline 2.5 ml / 100 gm. Group II 
received Frusemide 2 mg / 100 gm as reference diuretic and Group III 
received least drug at a dose at a dose of 20 mg / 100 gm orally, 1  hour 
prior to the administration of normal saline. 
 Immediately after dosing, the animals were placed in metabolic 
cages specially designed to separate urine and faeces and kept at room 
temperature of 25* ± 0.5* C. The urine was collected in measuring 
cylinder upto 5 hours after dosing. During this period no water and food 
was made available to the animals. The total volume of urine collected 
was measured for the control and treated groups .The results are 
evaluated in the forthcoming coming chapter(S.no-). 
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ANTI-SPASMODIC EFFECT OF VEDIUPPU CHENDHURAM ON ISOLATED 
RABBIT JEJUNUM 
AIM: 
To find out the Anti-spasmodic effect of VEDIUPPU CHENDHURAM 
on isolated Rabbit jejunum (Burn - 1952) 
PREPARATION OF THE TEST DRUG: 
 100mg of VEDIUPPU CHENDHURAM was dissolved in 10ml of 
water. Then it was used for the experiment. 
SOLUTIONS REQUIRED: 
 Acetyl choline - 10µg/ml 
 Test drug  - VEDIUPPU CHENDHURAM100mg/ml 
NUTRIENT SOLUTION: 
 Tyrode solution - 1 to 2 litres 
 Tyrode solution (1 litre) 
• NaCl  -  8 gms 
• KCl  -  0.2 gms 
• CaCl2  -  0.2 gms 
• MgSO4 -  0.26 gms 
• NaH2PO4 -  0.05 gms 
• NaHCO3 -  1 gms 
• Glucose -  1 gms 
TISSUE USED: 
 Rabbit jejunum 
APPARATUS REQUIRED: 
 Student’s organ bath, Sherrington rotating drum, scissors, cotton 
thread etc. 
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PROCEDURE: 
 A rabbit was starved for 48 hours and was allowed only water ad-
libitum. It was sacrificed by a blow on the head and by carotid bleeding. 
The abdomen was quickly opened and the ileocaecal junction was found 
out. A small piece of ileal portion was cut, removed and placed in a dish, 
containing warm aerated Tyrode solution. The contents of lumen of the 
ileum was gently rinsed out by pushing the tyrode solution into it. 3 cm 
length segment was cut from this part of ileum and was tied with thread 
on both ends separately without closing the lumen and the tissue was 
mounted in an organ bath, containing Tyrode solution maintained at 
37oC, bubbled with air by an oxygen tube. 
First the rotating drum was allowed to run for 1 minute to record 
the baseline. Drugs were given to study the inhibiting effect of Acetyl 
Chlorine. 0.2 ml of Acetyl Chlorine was added and the drum was allowed 
to run for 30 seconds. Thus the tissue was standardized and then the 
drum was stopped and the Acetyl Chlorine was washed out. 
Again Tyrode solution was added to the organ bath till the level 
comes to the baseline. The drum was allowed to run for 1 minute. To the 
organ-bath, 1 ml of test drug was added, waited for one minute and 0.2 
ml of Acetyl Chlorine was added and the drum was allowed to run for 30 
seconds to record the inhibitory action of the test drug. Then 0.2 ml of 
Acetyl Chlorine was added to standardize the tissue. Then the tracing 
was labeled and fixed. 
INFERENCE: 
 From the graph it is inferred that the test drug antagonize the 
effect of Acetyl Chlorine when added together. So, the drug VEDIUPPU 
CHENDHURAM has got significant Anti-spasmodic activity. 
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ANTI - MICROBIAL ACTIVITY 
- By KIRBY BAUER METHOD 
AIM: 
 To determine the anti - microbial sensitivity of Vediuppu 
Chendhuram by disc diffusion method – Kirby Bauer method. 
PROCEDURE: 
INOCULUM PREPARATION: 
 The microorganisms were inoculated in 10 ml of peptone water 
under sterile condition. The inoculum is incubated at 37’C for two hours. 
Then the turbidity of the inoculum is adjusted to 0.5 micro C farland 
standard. The inoculum was poured in a Muller Hington agar plate and 
uniformly spreaded over the  plate. Esherichia coli  and  Klebsiella 
pneumoniae inoculated separately. 
COMPONENTS OF MULLER HINGTON AGAR MEDIUM: 
Beef Extract                  :         300 gms / lit 
Agar     :   17 gms / lit      
Starch                           :        1.5 gms / lit 
Casein Hydroxylate   :         17.5 gms / lit 
Distilled water           :         1000 ml. 
PH                               :          7.6 
DISC PREPARATION: 
Vediuppu Chendhuram is impregnated in a 6 mm diameter filter 
paper disc and applied over the inoculum. Then the Muller Hington agar 
plate is incubated at 37’C for over night. The zone of clearance is 
measured with a scale and the sensitivity of the organism to the  
Vediuppu Chendhuram  is assessed. Antimicrobial susceptibility is 
proportional to the diameter of the inhibitory zone around the disc.  
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The plates after 24 hrs incubation are observed for the zone of 
inhibition. 
RESULT: 
S.NO TEST DRUG 
ORGANISMS 
(Culture) 
SUSCEPTIBILITY 
ZONE SIZE (mm) 
CONTROL TEST DRUG 
1 
VEDIUPPU 
CHENDHURAM 
Escherichia 
coli 
Moderate 22 15 
2 
Klebsiella 
pneumoniae 
Sensitive 25 22 
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  S E M – SCANNING ELECTRON MICROSCOPE 
 
 In a typical SEM, an electron beam is thermionically emitted from 
an electron gun fitted with a tungsten filament cathode. Tungsten is 
normally used in thermionic electron guns because it has the highest 
melting point and lowest vapour pressure of all metals, thereby allowing 
it to be heated for electron emission.. The electron beam, which typically 
has an energy ranging from 0.2 keV to 40 keV, is focused by one or two 
condenser lenses to a spot about 0.4 nm to 5 nm in diameter. The beam 
passes through pairs of scanning coils or pairs of deflector plates in the 
electron column, typically in the final lens, which deflect the beam in 
the x and y axes so that it scans in a raster fashion over a rectangular 
area of the sample surface. The beam current absorbed by the specimen 
can also be detected and used to create images of the distribution of 
specimen current. Each pixel of computer video memory is synchronized 
with the position of the beam on the specimen in the microscope, and 
the resulting image is therefore a distribution map of the intensity of the 
signal being emitted from the scanned area of the specimen. In older 
microscopes image may be captured by photography from a high-
resolution cathode ray tube, but in modern machines image is saved to 
a computer data storage. 
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F T I R – FOURIER TRANSMISSION INFRARED SPECTROSCOPY: 
 
 
In infrared spectroscopy, IR radiation is passed through a sample. 
Some of the infrared radiation is absorbed by the sample and some of it 
is passed through (transmitted). The resulting spectrum represents the 
molecular absorption and transmission, creating a molecular fingerprint 
of the sample. Like a fingerprint no two unique molecular structures 
produce the same infrared spectrum. This makes infrared spectroscopy 
useful for several types of analysis. 
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INDUCTIVELY COUPLED PLASMA OPTIC EMISSION  
SPECTROSCOPY (ICP – OES) 
 
 
 
 
 
Inductively coupled plasma optic emission spectroscopy                       
(ICP-OES), also referred to as inductively coupled plasma optical emission 
spectrometry (ICPOES), is an analytical technique used for the detection 
of trace metals. It is a type of emission spectroscopy that uses the 
inductively coupled plasma to produce excited atoms and ions that emit 
electromagnetic radiation at wavelengths characteristic of a particular 
element. The intensity of this emission is indicative of the concentration 
of the element within thesample. 
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59
PRECLINICAL TOXICOLOGICAL STUDY OF VEDIUPPU  
CHENDHURAM (VC)  
MATERIALS AND METHODS: 
Test Drugs: 
 The medicineVediuppu chendhuram (VC)  used in the study was 
processed by the methods prescribed in standard textbooks of Siddha 
medicine. 
Preparation of drug for dosing: 
 All drugs used for the study was suspended each time with 1% 
(w/v) solution of sodium carboxy methylcellulose before administration. 
Experimental animals:  
Colony inbred wistar rats of either sex weighing 200 - 250 g were 
used for the pharmacological and toxicological studies. The animals were 
kept under standard conditions 12:12 (day/night cycles) at 220C room 
temperature, in polypropylene cages. The animals were fed on standard 
pelleted diet (Hindustan Lever Pvt Ltd., Bangalore) and tap water ad 
libitum. The animals were housed for one week in polypropylene cages 
prior to the experiments to acclimatize to laboratory conditions. The 
experimental protocol was approved by the Institutional Animal Ethical 
Committee (IAEC)(IAEC/XXXV/61/CLBMCP/2012). 
Acute oral toxicity study:     
Acute oral toxicity was conducted as per the OECD guidelines 
(Organization of Economic Cooperation and Development) 423 (Acute 
Toxic Class Method). The acute toxic class method is a stepwise 
procedure with 3 animals of a single sex per step. Depending on the 
mortality and /or moribund status of the animals, on the average 2-4 
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steps may be necessary to allow judgment on the acute toxicity of the 
test substance. This procedure results in the use of a minimal number of 
animals while allowing for acceptable data based scientific conclusion. 
The method uses defined doses (5, 50, 300, 2000 mg/kg body 
weight) and the results allow a substance to be ranked and classified 
according to the Globally Harmonized System (GHS) for the classification 
of chemicals which cause acute toxicity 
Female Wistar albino rats weighing 200-250 g were fasted 
overnight, but allowed water ad libitum. Wistar albino rats of either sex 
weighing 200-250 g were fasted overnight, but allowed water ad libitum. 
Since the formulation is relatively nontoxic in clinical practice the highest 
dose of 2000 mg/kg/p.o (as per OECD guidelines “Unclassified”) was 
used in the acute toxicity study.   
The animals were observed closely for behavioral toxicity, if any by 
using FOB (Functional observation battery). 
Repeated oral toxicity study: 
Repeated oral toxicity studies can be used to get additional 
information regarding the toxicity profile of a chemical. Repeated oral 
toxicity studies are defined as those studies where the chemical is 
administered to the animal for a period covering approximately 10% of 
the expected life of the animal. Usually, the dose levels are lower than 
for acute studies and allow chemicals to accumulate in the body before 
lethality occurs, if the chemical possess this ability. 
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Experimental procedure: 
The following experimental procedure was followed to evaluate 
the repeated oral toxicity study of VC 
Group I:* Control animals received 1%CMC, 2 ml/kg/p.o. for 28 days  
Group II:* Received VC at the dose of 23mg/kg/po in 1%CMC for 28 days 
Dose calculation:  
The dose for rats was calculated by multiplying the daily dose used 
in the   clinical practice( i.e.130mg BID=260mg/day) divided by a factor 
0.018 corresponding to the body surface area  of man weighing 70kg to 
rat weighing 200g. 
Single dose 130mg, Daily dose 260mg x 0.018 =4.6mg for a rat 
weighing 200g.  Multiply the rat dose for a rat weighing 200g x5 to get 
the dose for kg/body weight of rat (i.e.4.6mg x 5=23mg/kg/po) The dose 
is rounded off to 25mg/kg/po 
* Group I and II animals were used for the chronic toxicity study for 
28 days and part of the animals were used in the experimental protocol 
for the urolithitic study of VC (Table- 3 ). Blood samples were collected at 
the end of 28 days from the respective groups to study the biochemical 
and hematological parameters 
Body weight, food intake and water intake was recorded at two 
intervals with simultaneous observation for toxic manifestation and 
mortality, if any. At the end of 28 days treatment blood samples were 
collected by retro orbital puncture and used for hematological studies 
and serum was used for biochemical studies  
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BIO CHEMICAL STUDIES 
60
Aspartate aminotransferase(AST): 
Aspartate aminotransferase was estimated using commercial AST 
kit (Span Diagnostics) by the method of Reitman and Frankel. 
Alanine aminotransferase (ALT): 
Alanine aminotransferase was estimated using commercial AST kit 
(Span Diagnostics) by the method of Reitman and Frankel . 
61
Alkaline phosphatase (ALP): 
Alkaline phosphatase was assayed using commercial ALP kit (Span 
Diagnostics)  by the method of King. 
HEMATOLOGICAL STUDIES: 
Erythrocyte count 
 Erythrocytes count was estimated by Hem cytometer method of   
Ghai. 
Total Leukocyte Count (WBC)  
Total Leukocyte Count was estimated by Hemo cytometer method 
of John . 
62
Hemoglobin 
 Hemoglobin was estimated by method of Ghai . 
 
 
 
 
 
 
                                                 
60 Reitman S Frankel AMJ Clinical Pathology 28 
61 King E.J. Can. Med. AssJ. 
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CLINICAL ASSESSMENT 
The main objective of this clinical study is to evaluate the efficacy 
of the trial drug Vediuppu chedhuram on Urolithiasis.   
Objectives:  
 To evaluate the lithotriptic, anti-spasmodic and diueretic activity 
of Vediuppu chendhuram. 
 To explore the efficacy of Vediuppu chendhuram in OP patients 
with Urolithiasis (Kalladaippu).  
Design of the Study:  
 The Open clinical trial phase-2B  
Study Centre:  
Govt. Siddha medical college and hospital, Palayamkottai.  
Study Participants:  
Both men and women members of all races and ethnic groups 
were eligible for this trial. Treatment was being administered on an 
outpatient basis. The patients were selected from the Out-patient 
department of Govt Siddha medical college and hospital, Palayamkottai.  
Number of Subjects:  
Number of participants will be 35 - 40.  
Registration Process: 
To register a patient, the following documents should be 
completed by the investigator.   
 Copy of required laboratory tests  
 Signed patient consent form  
 Other appropriate forms (e.g., Trial profoma).  
This Clinical trial is an ethical and scientific quality standard for 
designing, conducting and recording trials that involve the participation 
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of human subjects. Compliance with this standard provides assurance to 
public that the rights, safety and well being of trial subjects are 
protected, consistent with the principles enshrined in the Declaration of 
Helsinki and ensures that clinical trial data are credible  
Selection of patients:  
The patients were selected for clinical trials as per the following 
criterias, which are listed below  
 Loin pain 
 Groin pain  
 Difficulty in micurination 
 Back pain 
Consent form:  
Patients were included in this clinical study only after getting the 
concern form accordance of ‗Helsinki‘. Voluntary written assent of a 
subject‘s willing to participate in this study and in its documentation. The 
confirmation is sought only after information about the trial including an 
explanation of its status as research, its objectives, potential benefits, 
risks and inconveniences, alternative treatment that may be available 
and of the subject‘s rights and responsibilities has been provided to the 
potential subject. The patients were selected for clinical trials as per the 
following criterias, which are listed below  
Inclusion criteria: 
 Pain abdomen 
 Pain in the loin radiating to groin 
 Intermittent dull pain in the loin 
 Burning micturition 
 Dysuria 
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 Haematuria 
 Increased frequency of micturition 
 Nausea 
 Vomiting 
 Presence of crystals in the urine 
 Ultrasonogram of abdomen and pelvis with positive results for 
Kalladaippu Noi. 
Exclusion criteria:  
 Renal calculus with renal failure. 
 Renal calculus with acute sever colic pain associated with 
severe vomiting 
 Renal calculus found along wth malignancy of kidney 
 Uretric calculus with urethral obstruction. 
Withdrawal criteria:  
 Exacerbations of symptoms  
 Unacceptable adverse events  
 Patient decided to withdraw from the study  
 Irregular visit  
 Irregular Medications  
Investigations criteria:  
Blood: TC, DC, ESR, Hb, blood sugar PP.  
Urine: Albumin, Sugar and Deposits 
X- Ray: Abdomen and pelvis 
 USG: Abdomen, KUB  
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LINE OF TREATMENT: 
The patients were orally administered Vediuppu chendhuram in a 
dose of 130 mg along with juice of Raphanus sativus twice a day.  
Ultrasonogram abdomen and pelvis, clinical pathological 
examination were carried out before and after treatment. The clinical 
improvements were recorded for every seven days.  
Drug and dosage: 
Drug   :  Vediuppu chendhuram  
Route  :  Enternal  
Dose   :  130 mg twice a day 
Vehicle  :  Water 
Dietery advice:  
Therapeutic foods or nutrients that help controlling asthma are: 
Omega-3 and omega-6 fatty acids, foods high in flavonoids and beta 
carotene, Vitamin B12, Vitamin B6 (Vitamin B6 deficiency is common in 
asthmatics), high amounts of vitamin B12 supplements (1,500 mcg per 
day) have been found to reduce the tendency for asthmatics to react to 
sulfites, Selenium, Vitamin E, Vitamin C, and Magnesium (magnesium 
can prevent spasms of the bronchial passages).  
Medical advice:  
 Patients are advised to avoid known offending allergen which is 
identified either by experience or by skin sensitivity test.  
 Take light meals at night and try to sleep early  
 Drink plenty of water  
 Try to avoid dust, cigarette smoke and smoky surroundings.  
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 Avoid cold water bath.Avoid cold, deep fried food.  
 Avoid keeping pets such as dogs, cats.  
 Avoid alcohol, lime and bananas.  
 Advice to do breathing exercise  
Criteria for assessment of response to therapy:  
1. Marked Relief: 75%-90% relief in the presenting signs and 
symptoms marked normality pathological investigation.  
2. Moderate Relief: 60%– 75% relief signs and symptoms, moderate 
normality of pathological investigation.  
3. Mild Relief: 50%-60% relief of signs and symptoms no marked 
changes in pathological investigations.  
4. Poor: Below 50% relief of signs and symptoms  
Observation:  
 The duration of the treatment ranged between 45-90 days.  
 At the time of treatment, no adverse effects were observed.  
 The drug was well accepted by all the patients.  
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BIO STATISTICAL ANALYSIS 
AIM: 
The study subjects and the effectiveness of the drugs were 
analyzed as Mean, Standard deviation and Percentages. The 
interpretations were made on the basis of student, ‘t’ test.  
RESULT AND DISCUSSIONS: 
The study subjects were analyzed based on their age and sex. Since 
the age and sex were independent variable. 
AGE AND SEX: 
 The study subjects from the study are 40 in numbers. Among them 
32 are male and 8 are female. They were described by their age and sex 
as follows 
Age and Sex wise distribution of study subjects shown in Table – 1 
S. 
No 
Sex n 
Age 
‘t test’ Significance 
Mean 
Std. 
Deviation 
1 Male 32 42.84 14.28 
0.0097 P < 0.01 
2 Female 8 30.88 10.67 
3 Total 40 40.45 14.35   
 
The above study clearly shows the mean age of male clinical trial is 
42.84 ± 14.28 and the mean age of female clinical trial is 30.88 ± 10.67. 
The difference in the mean ages are statistically significant with the ‘t’ 
test value as 0.0097 which means P<0.01. 
The mean age of total study subject is 40.45 ± 14.35 years.  
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EFFECTIVENESS OF DRUG: 
Among 40 clinical trials, 13 were affected by Kalladaippu in both 
the kidneys. The remaining were affected in either of the kidneys. The 
analysis were made by taking the un affected kidney as normal since no 
calculus was found. After treatment also the calculus was not found in 
the kidney, it is also taken as normal and response is good.  
Distribution of calculus of the study subjects in right and left kidneys of 
before and after treatment shown in Table - 2 
S. 
No 
Kidney N 
Calculus 
before 
treatment 
Calculus 
after 
treatment 
Mean 
difference 
‘t’ 
test 
value 
Significance 
Mean S.D Mean S. D 
1 
Right 
Kidney 
29 8.18 8.61 3.47 9.28 4.71 2.50 P<0.05 
2 
Left 
Kidney 
23 5.88 2.30 0.87 1.47 5.01 0.17 P<0.001 
 
The above table clearly shows the effectiveness of Vediuppu 
chendhuram in curing Kalladaippu. The right kidney had a mean size of 
8.18 mm calculus before under going treatment. After the treatment the 
mean calculus size is 3.47 mm. The mean reduction is 4.71. The reduction 
is the effect of the drug, since the reduction is statistically significant. 
Similarly, the left kidneys of the study subjects are also 5.01  of mean 
reduction observed. This is also very statistically significant. 
The above interpretation of the effectiveness of the drug was 
supported by the analysis of response. Among the 40 affected clinical 
trials 30 were cured with 75% percentage of curing and they are treated 
as good response. Out of this only 7 cases (17.5%) were partially cured 
which were treated as fair responses and 3 cases (7.5%) were treated as 
poor responses.  
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OBSERVATION AND RESULTS 
 This study has been done to establish the role of Vediuppu 
chendhuram as a Lithotriptic agent and assess that how far it can help in 
the management of Kalladaippu.  
Among the symptoms of Kalladaippu noi burning micturition, 
dysuria, radiating pain from loin to groin were reduced significantly 
within 7 days, other symptoms gradually subsided during the remaining 
course of treatment.  
The treatment was given from 28 to 48 days, graduation of result 
and clinical assessment are tabulated. Among 40 cases, 30 cases (75%) 
showed good response in the gradual relief of signs and symptoms. 7 
cases (17.5%) showed fair response and 3 cases (7.5%) showed poor 
response. 
The age and sex incidence of these cases are shown in Table – 1 
S. No 
Age in  
Years 
Sex 
Total 
Male Female 
1 11 – 20 1 - 1 
2 21 – 30 7 2 9 
3 31 – 40 8 5 13 
4 41 – 50 10 2 12 
5 51 – 60 2 - 2 
6 61 – 70 2 - 2 
7 Above 70 1 - 1 
TOTAL 40 
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The drug efficacy on Renal calculus, ureteric calculus and vesicle 
calculus are shown in Table – 2 
S. No Site of Calculus 
No. of cases 
treated 
No. of cases 
cured 
Percentage 
of cured 
1 Renel calculus 28 26 92.8% 
2 Ureteric calculus  5 3 60.0% 
3 Vesicle calculus 1 0 0% 
4 
Ureteric calculus 
+ Renel calculus 
4 3 75.0% 
5 
Vesicle calculus + 
Renel calculus 
2 1 50.0% 
 
The drug efficacy is based on the size of the calculus are shown in  
Table – 3 
S. No Site of Calculus 
No. of cases 
treated 
No. of cases 
cured 
Percentage 
of cured 
1 5 mm and below 16 16 100% 
2 6 mm to 10 mm  18 13 72.20% 
3 Above 10 mm 6 4 66.67% 
 
Gradation of Results Table – 4 
S. No Results No. of cases Percentage 
1 Good  31 77.50% 
2 Fair  7 17.50% 
3 Poor 2 5.00% 
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RESULTS AND DISCUSSIONS 
 The study is to highlight the efficacy of the herbo mineral drug 
VEDIUPPU CHENDHURAM in the treatment of UROLITHIASIS 
(KALLADAIPPU) as given in the KANNUSAMY PARAMBARAI VAITHIYAM 
(Pg. No. 371). 
The study incorporates collection of literature evidences, scientific 
aspects of the drug, physico chemical analysis, chemical analysis, 
pharmacological analysis, microbiological analysis and clinical study. 
As per Siddha concept, the disease Urolithiasis (Kalladaippu) 
occurs due to the vitated pithaa humour, so the trial drug which has got 
refrigerant activity helps in bringing down the pithaa humour. From the 
text Gunapadam Thaathu Jeeva Vaguppu (Pg. No. 332) the trial drug 
Vediuppu Chendhuram has got significant Diuretic property which 
hastens the property of dissolving the preformed stones and the 
prevention of the new stone formation in the urinary system. In the 
Siddha Maruthuvam Pothu it is given that the derangement of Abaana 
Vaayu causes crystalisation of deposits in the urine due to stasis. The 
diuretic property of the Vediuppu Chendhuram ease the micturition of 
urine, thus preventing the stone formation.  
Physiochemical analysis: 
The physiochemical analysis shows the total ash value, acid 
insoluble ash (34.65%) which helps us to interpret the digestion and 
solubility of the drug. The bio-chemical analysis shows the presence of 
calcium sulphate, chloride, ferric iron and ferrous iron. 
63The ferric iron which is useful in the treatment of 
hyperphosphatemia in the same way helps in the prevention of 
                                                 
63
 execbeneifits.mworld.com – Keith Chan  
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phosphate stone formation. The ferric iron binds with the phosphate in 
the blood and the ferric phosphate precipitate in the gastro intestinal 
tract, resulting in effective removal of phosphate.The ferrous iron is 
associated with the immune competence of the body. 
64The anupanam i.e. extract of Raphanus sativus has the property 
of increasing the excretion of chloride and sodium which manages the 
elimination of the chloride in the trial drug. 
65In 1941, sulpha drugs were used successfully for curing Urinary 
tract infection. In this way the sulphate present in the trial drug helps to 
prevent infectious urinary calculi. 
The pharmacological analysis shows the significant antispasmodic 
activity by antagonizing the effect of acetyl chloride. The trial drug has 
significant diuretic property. 
S. No 
Name of 
Drugs / 
Groups 
Dose / 100 
gm body 
weight 
After Drug 
Administration Remarks 
1.5 hrs 3 hrs 4.5 hrs 
1 
Control 
(water) 
5 ml 3.0 ml 5.0 ml 6.0 ml Significant 
and 
Action 2 
Vediuppu 
chendhuram 
20 mg 3.0 ml 8.0 ml 12.0 ml 
 
Result: The lithotriptic activity of the trial Vediuppu Chenduram is 
significant 
 
 
                                                 
64
 European journal of biological sciences – IDOSI Publication, 2011 
65
 Text book of Organic Chemistry – PL Soni – Pg. No. 3.256  
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Lithotriptic effect of VC: 
Administration of 0.75% Ethylene glycol (EG) for 28 days in 
drinking water resulted in hyperoxaluria in rats as evidenced by the 
results of the study. Oxalate, calcium and phosphorous excretion were 
increased in EG treated rats. Serum creatinine and blood urea 
nitrogen(BUN levels were increased in rats treated with EG  
Administration of the test drug VC at the dose of 25mg/kg/po for 28 days 
concurrently with EG significantly lowered the levels of oxalate, calcium 
and phosphorous in urine when compared to EG alone treated rats. The 
results of test drug VC can be compared to that of standard drug 
Cystone. The treatment with VC  significantly(P<0.05) increased the level 
of serum creatinine but this cannot be considered as an adverse reaction 
since anupanam given during administration of Siddha drugs plays an 
important role in the drug absorption and half-life of the drug in the 
body. Histopathological study of kidney showed the lesser nucleation of 
oxalate crystals in VC treated animals when compared to untreated 
animals.  Urine volume was increased in animals treated with VC and 
cystone with an acidic pH and this may be accounted for the reduced 
crystallization of oxalate and expedited elimination from the urine 
The test drug (VC) alone at the dose of 25mg/kg/po administered 
for 28 days to evaluate the toxicity, if any per se on long term use did not 
show evidence of  liver injury and hematopoietic system toxicity. 
However a significant (p< 0.05) change in serum creatinine level was 
observed in rats treated with VC alone at the dose of 23mg/kg/po for 28 
days. In clinical practice the drug is usually administered with specific 
anupanam and the anupanam may have a specific role to adjust the 
urine pH and plays an important role in the elimination and maintains 
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the homeostasis of serum creatinine. This hypothesis may be premature 
and further study is required to establish the validity of the hypothesis, 
both experimentally and clinically.  
Ethylene glycol induced urolithiasis is a standard method practiced 
by pharmacologists to induce hyperoxaluric stones in rats. 
Hyperoxaluria is a significant risk factor in the pathogenesis of 
renal calculi than hypercalcuria.In the present study urinary oxalate was 
increased in the EG induced urolithiasis in rats. It has been reported that 
oxalate plays a important role in stone formation and has about 15 times 
greater effect than urinary calcium. 
The study with urinary biochemistry with respect to the stone 
forming minerals will provide a good indication of the risk stone 
formation. Hyperoxaluria in EG induced urolithic rats might be a factor 
favouring the nucleation and precipitation of calcium oxalate from urine 
and subsequent crystal growth .                                                                     
A gradual increase in urinary phosphorous excretion was observed  
in    EG induced urolithic rats. Increased phosphorous excretion has been 
reported in stone formation in clinical practice. 
Urinary magnesium was significantly reduced in EG induced 
urolithic rats Magnesium complexes with oxalate, thus reducing calcium 
oxalate supersaturating in urine and as a consequence the nucleation 
rate of calcium oxalate crystals is reduced . 
Uric acid is known to promote calcium oxalate crystal growth . 
In the present study, higher concentration of urinary uric acid was 
observed in EG induced rats. Test drug treatment restored the uric acid 
level to near normal thus reducing risk of stone formation. 
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HP slides of kidney: 
Microscopic examination of kidney section derived from EG 
induced urolithic rats showed irregular crystal deposits inside the tubules 
(plat-2) which causes dilation of the proximal tubules along with 
interstitial inflammation thus might be attributed to oxalate formation. 
The presence of such deposits  is an evidence of adhesion and 
retention of crystals with in renal tubules.  EG induced urolithic rats 
treated with Cystone (standard drug-Plate-3) and test drug (VC)(Plate-4) 
had increased the solubilisation of oxalate crystals and restored the 
normal architecture of kidney. 
In the present study an attempt has been made to evaluate the 
efficacy of Siddha formulation Vediuppu Chendhuram (VC) in Ethylene 
induced Urolithiasis in rats .Ethylene glycol induced urolithiasis is a 
standard test procedure to evaluate the drugs with antilithiatic effect. EG 
lithiasis is attributed to calcium oxalate crystal formation and has good 
correlation in kidney stones in humans, VC exhibited a significant 
pharmacological effect as an antiurolithitic drug which is established by 
biochemical and pathological parameters of urine, blood samples and 
histopathological studies. Now a correlation between the preclinical 
study and clinical outcome should be established to develop VC as a 
potential candidate for the treatment of kidney stones. 
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TABLE - 1 
Effect of Siddha Formulations (VC) on Hematological parameters after 
28 days repeated oral dosing (25 mg/kg) 
Groups Hb 
(gm/100
ml) 
RBC 
(millions/
cu.mm) 
WBC 
(cells/cu.m
m) 
Differential leucocyte count (%) 
Lympho 
cytes 
Mono 
cytes 
Granulo 
cytes 
Normal 13.23 ± 
0.56 
4.59 ± 
0.565 
5650.08 ± 
9.43 
76.06 ± 
3.27 
5.610 ± 
1.27 
19.84 ±  
4.647 
VC(mg/k
g/po) 
13.92 ± 
0.621 ns 
4.68 ± 
0.267 ns 
5786.66 ± 
3.823 
77.67 ± 
3.64 ns 
6.16 ± 
1.87 ns 
17.36 ± 
3.31 ns 
 
n=6; Values are expressed as mean ± S.E followed by Students Paired ‘T’ Test 
ns – non significant when compared to control groups  
n=6; Values are expressed as mean ± S.E followed by Students Paired ‘T’ Test 
ns – non significant when compared to control groups  
 
TABLE - 2 
Effect of Siddha formulation (VC) on Biochemical markers of liver and 
kidney after 28 days repeated oral dosing (25 mg/kg/po) in rats  
Groups AST(IU
/L) 
ALT(IU
/L) 
ALP(IU/L) BUN(mg
/dl) 
Creatinine(m
g/dl) 
Normal 72.64 ± 
0.349 
30.64 ± 
0.821 
158.45 ± 
0.64 
30.16±1.
45 
0.70±0.01 
VC(25mg/kg
/po) 
81.45 ± 
0.36ns 
28.81 ± 
0.664ns 
161.23±0.6
6ns 
29.5±0.1
7ns 
1.07±0.01* 
 
N=6; Values are expressed as mean ± S.E followed by Students Paired ‘T’ Test 
Ns – non significant when compared to control groups 
*p<0.05 
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TABLE - 3 
Effect of VC on Urinary level of Oxalate, calcium and phosphate after 
treatment with VC (25mg/kg/po) in EG induced Urolithiasis 
Group and dose Oxalate(mg/g) Calcium(mg/g) Phosphate(mg/g) 
Group-1 Normal 
control 
0.32±0.052 0.36±0.31 3.77±0.07 
Group-2 Urolithic 
control 
3.94±0.61***a 4.28±0.19***a 7.02±0.05***a 
Group-3 Cystone 
(500mg/kg/p) 
treated 
0.48±0.02***b 1.44±0.01***b 3.31±0.02***b 
Group-4 
VC(25mg/kg/po) 
treated 
0.79±0.01***b 1.45±0.03***b 4.35±0.19***b 
 
n= 6 animals values mean±SEM,** p<0.01 ***p<0.001 
a: Control(group-1) vs Ethylene glycol induced urolithitic rats(group-2) 
b: Goup-2 vs group 3 and 4 
TABLE - 4 
Effect of VC on BUN, Serum creatinine and Uric acid levels in ethylene 
glycol induced urolithiasis 
Groups Serum prameters(mg/dl) 
Blood urea 
nitrogen (BUN) 
Cretinine Uric acid 
Group-1 Control 30.16±1.45 0.70±0.01 1.42±0.031 
EG treated 
aniamls 
48.12±1.23***a 1.43±0.02***a 1.99±0.05***a 
Cystone  37.40±1.89***b 0.87±0.01**b 1.41±0.06***b 
VC 41.08±1.05***b 0.91±0.02**b 1.57±0.03**b 
 
n= 6 animals values mean±SEM,** p<0.01 ***p<0.001 
a: Control(group-1) vs Ethylene glycol induced urolithitic rats(group-2) 
b: Goup-2 vs group 3 and 4 
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TABLE - 5 
Effect of  VC on volume of urine and pH of urine 
 in  ethylene glycol induced urolithiasis 
Groups Total volume of urine(ml) pH of urine 
Group-1 Control 2.10±0.12 7.20±0.06 
EG treated  1.34±0.12***a 8.9±0.07***a 
cystone 4.05±0.31***b 7.21±0.32***b 
VC 4.36±012.***b 7.18±0.10***b 
 
n= 6 animals  values mean±SEM,** p<0.01 ***p<0.001 
a: Control(group-1) vs Ethylene glycol induced urolithitic rats(group-2) 
b: Goup-2 vs group 3 and 4 
Microbiological Analysis: 
Microbiological analysis shows the sensitivity of trial drug for 
Klebsiella pneumoniae and Esherichia coli which prevents the infection 
and avoid calculi formation. - Lab Report Attached For Reference 
 
Toxicological Analysis: 
Acute oral toxicity study: 
VC at the dose of 2000mg/kg/po did not exhibit mortality in rats. 
As per the OECD guidelines substances do not exhibit mortality at the 
dose of 2000mg/kg/po are rated as “unclassified “in the toxicity scale. 
Repeated oral toxicity for 28 days: 
Test drug VC at the dose of 25mg/kg/po when administered orally 
for 28 days in rats did not show significant toxicity in Hematological and  
liver  function tests (Tables, 1 and 2) briefed before. However the drug 
exhibited significant elevation of serum creatinine level (Table 2- briefed 
before). 
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S E M – PICTURE OF VEDIUPPU CHENDHURAM: 
 
The SEM images of the Vedippu Chendhuram showed a small 
particles embedded on a stone like material. The structure of the particle 
is not uniform in shape. The average particle size is approximately 33 
nm. 
FTIR - SPECTRUM OF VEDIUPPU CHENDHURAM  
 
Vediuppu Chendhuram 30.10.12.pk 
~1.SP  3601  4000.0  400.0  3.1  100.0  4.0  %T  4  2.0 
PT 
REF 4000 99.8 2000 99.5 600 
3854.4  90.4   3401.4  21.2   2395.8  85.9   2368.2  85.6   2345.6  89.1    
2266.0  97.4   2083.3  88.7   1632.5  71.7   1384.3  6.6    1115.8  3.1     
825.6   88.5   618.7   37.2    
END 12 PEAK(S) FOUND 
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
0.0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100.0
cm-1
%T 
3854.4
3401.4
2395.8
2368.2
2345.6
2266.0
2083.3
1632.5
1384.3
1115.8
825.6
618.7
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An olefinic bond showed weak absorption band at 1632 and 825 
cm-1 indicating the presence of unsaturation compounds such as alkene. 
Because of moisture the strong O-H peak (hydroxyl group) obtained at 
3401 cm-1. The peak at 1384 cm-1 represents the presence of alkane 
group in the compound. The peak of 618 corresponds to the halide 
group. The presence of carboxylate group (– COO –) in the compound is 
indicated by the peak at 1115 cm-1 . The peak at 2266 cm-1 represent 
the presence of alkyene group. Above results indicates the presence of 
maximum number of organic group in our materials.   
INDUCTIVELY COUPLED PLASMA OPTIC EMISSION SPECTROSCOPY           
(ICP – OES): 
 The result of ICP –OES revealed the absence of toxic elements like 
Arsenic,Cadmium,,Mercury,lead and the presence of 
Potassium(526.184mg/L)Which improves the functional efficacy of 
kidney and suppresses the calcium excretion in the urine  and minimize 
the risk of kidney stone formation. 
Statistical analysis: 
The effect of the drug in treating Urolithiasis is analysed and 
interpreted by student’s parity test (‘t’ test). P value less than 0.05 were 
considered as significant.  
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SAMPLE ID ANALYTE MEAN 
Vediuppu 
Chendhuram 
As193.696 BDL 
B 249.773 02.286 
Cd 226.502 mg/L BDL 
Cu 324.754 04.836 mg/L 
Co 228.616 02.284 mg/L 
Fe 238.204 14.158 mg/L 
Hg253.652 BDL 
K 766.490 526.184 mg/L 
Ni 58.693 BDL 
Pb 230.204 BDL 
Sb 206.833 12.184 mg/L 
Si 251.611 14.284 mg/L 
Zn 213.856 15.127 mg/L 
BDL – Below Detection Limit 
  
  
 
 
HISTO PATHOLOGICAL SLIDE 
 
 
         
Plate-1 Normal control animal                        Plate-2 Animals treated with EG x 28  
           (kidney section)                                           days (kidney section) 
 
 
 
 
 
 
        
Plate-3 Animals  treated with                              Plate-4 Animals treted with  
         EG + Cystone                                                              EG+VC 
for 28 days(kidney section)                                 for 28days(kidney section) 
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SUMMARY 
The study is to evaluate the efficacy of the herbo mineral drug 
Vediuppu Chendhuram given in the Siddha text, Kannusamy Parambarai 
Vaithyam (Pg. No. 371) for Lithotriptic, diuretic and anti-spasmodic 
activity. 
A review of literature about the Vediuppu and its significants in the 
Gunapadam aspect has been done.  
Biochemical  analysis shows the presence of ferric iron, sulphate, 
calcium, chloride, ferrous iron.  
Pharmacological analysis shows that the drug has got significant 
lithotriptic, diuretic and anti-spasmodic activity. After the above 
evaluation the Vediuppu chendhuram is subjected to clinical trail.  
The open clinical trial results that 77.50% of patients were having 
Good improvement and 17.50% were having the Fair improvements.  
From the pre-clinical and clinical observation, it is inferred that the 
Vedipuppu chendhuram has got significant effect on Urolithiasis. 
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CONCLUSION 
Vediuppu Chendhuram was selected for the elaborate study of its 
efficacy on Urolithiasis. 
From the literature review physico-chemical, pharmacological, 
microbiological, biochemical, instrumental analysis, it has been 
concluded that Vediuppu chendhuram has got a good Lithotriptic, 
diuretic and anti-spasmodic activities and hence effective for Urolithiasis. 
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O.P No: 38818 NAME: Mr. Palpandi AGE/SEX: 25 / M FROM: 24.05.2012 TO: 05.07.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition, Haematuria since 7 days 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 9200 cells ALBUMIN: NIL RIGHT KIDNEY: Normal TC: 9200 cells / cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 65% DEPOSITS: LEFT KIDNEY: A calculi size of 
4 mm seen 
P: 65% DEPOSITS: LEFT KIDNEY: Normal, No 
calculus L: 34% Few RBC cells L: 32% NAD 
E: 1% UB:  Normal E: 3% UB: Normal 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 11 mm 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 9 mm 
Hb: 80% IMPRESSION: Lt Renel 
Calculus 
Hb: 80% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 71 mgs%  SUGAR: 92 mgs% 
UREA: 19 mgs% UREA: 16 mgs% 
O.P No: 40681 NAME: Mr. Syed AGE/SEX: 27 / M FROM: 31.05.2012 TO: 12.07.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition since 1 month 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 7600 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 5.9 mm 
calculus is seen 
TC: 7700 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:58% DEPOSITS:  LEFT KIDNEY: 5.9 mm calculus 
is seen 
P: 60% DEPOSITS:  LEFT KIDNEY: Normal 
L: 38% NAD L: 38% NAD 
E: 4% UB: Normal E: 2% UB: Normal 
ESR: ½ hr – 2 mm      
ESR: 1 hr – 4 mm 
ESR: ½ hr – 2 mm      
ESR: 1 hr – 4 mm 
Hb: 72 mgs% IMPRESSION: Rt Renel 
calculus and Uretric Calculus 
Hb: 72 mgs% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 104 mgs% SUGAR: 79 mgs% 
UREA: 22 mgs% UREA: 22 mgs% 
 DRUG: VEDIUPPU CHENDHURAM DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 40805 NAME: Mr. Syed Ali AGE/SEX: 26 / M FROM: 31.05.2012 TO: 12.07.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition, low back pain for the past one month 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 9300 cells ALBUMIN: NIL RIGHT KIDNEY: A calculus size 
of 3.3 mm is seen 
TC: 9300 cells / cum ALBUMIN: NIL RIGHT KIDNEY: Normal. No 
calculus seen. DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 69% DEPOSITS: LEFT KIDNEY: Normal P: 65% DEPOSITS: LEFT KIDNEY: Normal 
L: 29% NAD L: 34% NAD 
E: 2% UB:  wall thickened E: 1% UB: Normal 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 10 mm 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
Hb: 82% IMPRESSION: Rt Renel 
Calculus 
Hb: 82% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 111 mgs%  SUGAR: 92 mgs% 
UREA: 18 mgs% UREA: 18 mgs% 
O.P No: 41262 NAME: Mr. Jeyaram AGE/SEX: 29 / M FROM: 02.06.2012 TO: 07.07.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition since 10 days 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 6900 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal TC: 6700 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:58% DEPOSITS:  LEFT KIDNEY: 10.2 mm 
calculus is seen 
P: 60% DEPOSITS:  LEFT KIDNEY: A calculus of 5 
mm is seen L: 36% 5-7 pus cells L: 38% NAD 
E: 6% UB: Normal E: 2% UB: Normal 
ESR: ½ hr – 15 mm      
ESR: 1 hr – 30 mm 
ESR: ½ hr –10 mm      
ESR: 1 hr – 20 mm 
Hb: 65 mgs% IMPRESSION: Lt Renel 
calculus  
Hb: 65 mgs% IMPRESSION: Normal study 
OBSERVATION: Fair response SUGAR: 101 mgs% SUGAR: 89 mgs% 
UREA: 191 mgs% UREA: 18 mgs% 
DRUG: VEDIUPPU CHENDHURAM DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 42496 NAME: Mr. 
Ramachandran 
AGE/SEX: 45 / M FROM: 07.06.2012 TO: 19.07.2012 
COMPAINTS AND DURATION: Loin pain to groin pain, burning micturition for the past 15 days 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8700 cells ALBUMIN: NIL RIGHT KIDNEY: A calculus size 
of 14 mm is seen 
TC: 8800 cells / cum ALBUMIN: NIL RIGHT KIDNEY: A calculus size 
of 8 mm is seen DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 65% DEPOSITS: LEFT KIDNEY: Normal P: 67% DEPOSITS: LEFT KIDNEY: Normal 
L: 32% 1-5 pus cells L: 30% NAD 
E: 3% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 20 mm 
ESR: ½ hr – 8 mm      
ESR: 1 hr – 16 mm 
Hb: 81% IMPRESSION: UC Hb: 82% IMPRESSION: UC 
OBSERVATION: Fair Response SUGAR: 96 mgs%  SUGAR: 111 mgs% 
UREA: 19 mgs% UREA: 17 mgs% 
O.P No: 42640 NAME: Mr. Mohideen Badusha AGE/SEX: 50 / M FROM: 08.06.2012 TO: 20.08.2012 
COMPAINTS AND DURATION: Abdominal pain, burning micturition since 10 days 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 7200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal TC: 7200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:62% DEPOSITS:  LEFT KIDNEY: 3 mm calculus 
is seen 
P: 62% DEPOSITS:  LEFT KIDNEY: Normal 
L: 34% NAD L: 34% NAD 
E: 4% UB: Normal E: 4% UB: Normal 
ESR: ½ hr – 20 mm      
ESR: 1 hr – 40 mm 
ESR: ½ hr –15 mm      
ESR: 1 hr – 30 mm 
Hb: 70 mgs% IMPRESSION: Lt UC  Hb: 70 mgs% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 79 mgs% SUGAR: 82 mgs% 
UREA: 15 mgs% UREA: 15 mgs% 
 DRUG: VEDIUPPU CHENDHURAM DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 42441 NAME: Mr. Boothapandi AGE/SEX: 58 / M FROM: 07.06.2012 TO: 12.07.2012 
COMPAINTS AND DURATION: Loin pain and radiating to groin, pain and burning during micturition 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 6700 cells ALBUMIN: Trace RIGHT KIDNEY: A calculus size 
of 9 mm is seen 
TC: 6800 cells / cum ALBUMIN: NIL RIGHT KIDNEY: Normal. No 
calculus seen. DC:  SUGAR: + DC:  SUGAR: + 
P: 60% DEPOSITS: LEFT KIDNEY:  A calculus size 
of 9 mm is seen 
P: 61% DEPOSITS: LEFT KIDNEY:  Normal. No 
calculus seen. L: 32% 1-2 pus cells L: 32% NAD 
E: 8% UB:  Normal E: 7% UB: Normal 
ESR: ½ hr – 9 mm      
ESR: 1 hr – 18 mm 
ESR: ½ hr – 6 mm      
ESR: 1 hr – 12 mm 
Hb: 62% IMPRESSION: Rt & Lt Renel 
Calculus and UC 
Hb: 62% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 190 mgs%  SUGAR: 289 mgs% 
UREA: 16 mgs% UREA: 16 mgs% 
O.P No: 48385 NAME: Mr. Raj AGE/SEX: 50 / M FROM: 28.06.2012 TO: 09.08.2012 
COMPAINTS AND DURATION: Pain in loin and radiating towards groin 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8800 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal TC: 8800 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:62% DEPOSITS:  LEFT KIDNEY: 7 mm calculus 
is seen 
P: 62% DEPOSITS:  LEFT KIDNEY:  Normal. No 
calculus seen. L: 32% NAD L: 34% NAD 
E: 6% UB: Normal E: 4% UB: Normal 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
ESR: ½ hr –4 mm      
ESR: 1 hr – 7 mm 
Hb: 87% IMPRESSION: Lt Renel 
calculus  
Hb: 87% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 78 mgs% SUGAR: 90 mgs% 
UREA: 17 mgs% UREA: 16 mgs% 
 DRUG: VEDIUPPU CHENDHURAM DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 51713 NAME: Mrs. Alagumayil AGE/SEX: 50 / F FROM: 09.07.2012 TO: 06.08.2012 
COMPAINTS AND DURATION: Pain in left groin, burning micturition since 3 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 7800 cells ALBUMIN: Trace RIGHT KIDNEY: Normal TC: 8000 cells / cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 62% DEPOSITS: LEFT KIDNEY: A calculi size of 
6.6 mm seen 
P: 62% DEPOSITS: LEFT KIDNEY:  A calculi size of 
2 mm seen L: 33% 3-7 pus cells L: 32% NAD 
E: 5% UB:  Normal E: 6% UB: Normal 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 20 mm 
ESR: ½ hr – 8 mm      
ESR: 1 hr – 16 mm 
Hb: 79% IMPRESSION: Lt Renel 
Calculus 
Hb: 78% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 82 mgs%  SUGAR: 98 mgs% 
UREA: 20 mgs% UREA: 19 mgs% 
O.P No: 54512 NAME: Mr. Selvakumar AGE/SEX: 40 / M FROM: 19.07.2012 TO: 30.08.2012 
COMPAINTS AND DURATION: Pain in both the loins since 45 days 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM – ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 7500 cells/cum ALBUMIN: Trace RIGHT KIDNEY: 4 mm calculus 
is seen 
TC: 7600 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: ++ DC:  SUGAR: NIL 
P:60% DEPOSITS:  LEFT KIDNEY: 4 mm calculus 
is seen 
P: 62% DEPOSITS:  LEFT KIDNEY: Normal 
L: 33% 10-12 pus cells L: 33% NAD 
E: 7% UB: Normal E: 5% UB: Normal 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 20 mm 
ESR: ½ hr – 6 mm      
ESR: 1 hr – 12 mm 
Hb: 75% IMPRESSION: Rt & Lt Renel 
calculus 
Hb: 76% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 252 mgs% SUGAR: 203 mgs% 
UREA: 22 mgs% UREA: 21 mgs% 
 DRUG: VEDIUPPU CHENDHURAM DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 54609 NAME: Mr. Ganesan AGE/SEX: 43 / M FROM: 19.07.2012 TO: 30.08.2012 
COMPAINTS AND DURATION: Pain in loin radiating towards groin since a week 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 8600 cells ALBUMIN: NIL RIGHT KIDNEY: Normal TC: 8700 cells / cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 67% DEPOSITS: LEFT KIDNEY: A calculi size of 
4 mm seen 
P: 65% DEPOSITS: LEFT KIDNEY: Normal, No 
calculus L: 30% Few 2-3 pus cells L: 32% NAD 
E: 3% UB:  Normal E: 3% UB: Normal 
ESR: ½ hr – 6 mm      
ESR: 1 hr – 12 mm 
ESR: ½ hr – 7 mm      
ESR: 1 hr – 12 mm 
Hb: 86% IMPRESSION: Lt Renel 
Calculus 
Hb: 86% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 122 mgs%  SUGAR: 72 mgs% 
UREA: 17 mgs% UREA: 17 mgs% 
O.P No: 55709 NAME: Mr. Murugaiah AGE/SEX: 38 / M FROM: 23.07.2012 TO: 20.08.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition  
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 9000 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 5.3 mm 
calculus is seen 
TC: 9100 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal, no 
calculus seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P:68% DEPOSITS:  LEFT KIDNEY: Normal P: 67% DEPOSITS:  LEFT KIDNEY: Normal 
L: 31% NAD L: 32% NAD 
E: 1% UB: Normal E: 1% UB: Normal 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 7 mm 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 6 mm 
Hb: 80 mgs% IMPRESSION: Rt Renel 
calculus and Uretric Calculus 
Hb: 80% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 86 mgs% SUGAR: 112 mgs% 
UREA: 19 mgs% UREA: 19 mgs% 
 DRUG: VEDIUPPU CHENDHURAM DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 56626 NAME: Mr. Sudalaimani AGE/SEX: 68 / M FROM: 26.07.2012 TO: 30.08.2012 
COMPAINTS AND DURATION: Burning micturition, low back pain since 2 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 7700 cells ALBUMIN: Trace RIGHT KIDNEY:  A calculi size 
of 14.8 mm seen 
TC: 7800 cells / cum ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 8 mm seen DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 64% DEPOSITS: LEFT KIDNEY: Normal P: 64% DEPOSITS: LEFT KIDNEY: Normal 
L: 34% 5-10 pus  cells L: 34% NAD 
E: 2% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 16 mm      
ESR: 1 hr – 30 mm 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 20 mm 
Hb: 76% IMPRESSION: Rt Renel 
Calculus 
Hb: 76% IMPRESSION: Normal study 
OBSERVATION: Fair Response SUGAR: 92 mgs%  SUGAR: 77 mgs% 
UREA: 21 mgs% UREA: 20 mgs% 
O.P No: 56732 NAME: Mr. Ravishankar AGE/SEX: 40 / M FROM: 26.07.2012 TO: 30.08.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 9200 cells/cum ALBUMIN: Trace RIGHT KIDNEY: 4 mm calculus 
is seen 
TC: 9200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:62% DEPOSITS:  LEFT KIDNEY: 4 mm calculus 
is seen 
P: 64% DEPOSITS:  LEFT KIDNEY: Normal 
L: 30% 10-15 pus cells L: 32% NAD 
E: 8% UB: Normal E: 4% UB: Normal 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 10 mm 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
Hb: 82% IMPRESSION: Bilateral  Renel 
calculus 
Hb: 72 mgs% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 91 mgs% SUGAR: 79 mgs% 
UREA: 24 mgs% UREA: 22 mgs% 
  DRUG: VEDIUPPU CHENDHURAM                                                DIAGNOSIS: KALLADIPPU         
 
 
O.P No: 57766 NAME: Mr.Mohideenpitchai AGE/SEX: 58 / M FROM: 30.07.2012 TO: 03.09.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micturition 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 7900 cells ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 3.7 mm seen 
TC: 8100 cells / cum ALBUMIN: NIL RIGHT KIDNEY: Normal, No 
calculus DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 65% DEPOSITS: LEFT KIDNEY: Normal P: 63% DEPOSITS: LEFT KIDNEY: Normal 
L: 32% 1-5 pus cells L: 35% NAD 
E: 3% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 11 mm 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 9 mm 
Hb: 74% IMPRESSION: Rt Renel 
Calculus 
Hb: 74% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 96 mgs%  SUGAR: 100 mgs% 
UREA: 17 mgs% UREA: 160 mgs% 
O.P No: 58727 NAME: Mr. Thandapani AGE/SEX: 50 / M FROM: 02.08.2012 TO: 06.09.2012 
COMPAINTS AND DURATION: Loin pain radiating towards groin in both sides for the past 6 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 7700 cells/cum ALBUMIN: Trace RIGHT KIDNEY: 6.2 mm 
calculus is seen 
TC: 7900 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 3.1 mm 
calculus is seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P: 60% DEPOSITS:  LEFT KIDNEY: 6.2 mm calculus 
is seen 
P: 60% DEPOSITS:  LEFT KIDNEY: 3.1 mm calculus 
is seen L: 38% 5-8 pus cells L: 39% NAD 
E: 3% UB: Normal E: 1% UB: Normal 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 6 mm 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
Hb: 74% IMPRESSION: Bilateral renel 
calculus  
Hb: 75% IMPRESSION: Normal study 
OBSERVATION: Fair response SUGAR: 83 mgs% SUGAR: 111 mgs% 
UREA: 18 mgs% UREA: 16 mgs% 
 DRUG: VEDIUPPU CHENDHURAM                                                DIAGNOSIS: KALLADIPPU         
 
 
O.P No: 60923 NAME: Mr. Mutharasu AGE/SEX: 31 / M FROM: 09.08.2012 TO: 13.09.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micturition since 4 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 8300 cells ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 5 mm seen 
TC: 8300 cells / cum ALBUMIN: NIL RIGHT KIDNEY:  Normal, No 
calculus DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 65% DEPOSITS: LEFT KIDNEY: A calculi size of 
5 mm seen 
P: 65% DEPOSITS: LEFT KIDNEY: Normal, No 
calculus L: 32% Few pus cells L: 33% NAD 
E: 3% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 11 mm 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
Hb: 82% IMPRESSION: Bilateral Renel 
Calculus 
Hb: 82% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 111 mgs%  SUGAR: 99 mgs% 
UREA: 16 mgs% UREA: 16 mgs% 
O.P No: 62867 NAME: Mr. Kanthan AGE/SEX: 65 / M FROM: 16.08.2012 TO: 27.09.2012 
COMPAINTS AND DURATION: Difficulty in micturition, burning micturition, loin pain radiating to groin 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 7900 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 50 mm 
calculus is seen 
TC: 7900 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 50 mm 
calculus is seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P:67% DEPOSITS:  LEFT KIDNEY: Normal P: 67% DEPOSITS:  LEFT KIDNEY: Normal 
L: 29% NAD L: 29% NAD 
E: 4% UB: Normal E: 4% UB: Normal 
ESR: ½ hr – 20 mm      
ESR: 1 hr – 40 mm 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 19 mm 
Hb: 65% IMPRESSION: Rt Renel 
calculus  
Hb: 65% IMPRESSION:  Rt Renel 
calculus 
OBSERVATION: Poor response 
SUGAR: 180 mgs% SUGAR: 78 mgs% 
UREA: 20 mgs% UREA: 20 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 63207 NAME: Mr. Krishnan AGE/SEX: 42 / M FROM: 17.08.2012 TO: 28.09.2012 
COMPAINTS AND DURATION: Pain in both loin regions since 2 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 8800 cells ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 3 mm seen 
TC: 8900 cells / cum ALBUMIN: NIL RIGHT KIDNEY:  Normal, No 
calculus DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 62% DEPOSITS: LEFT KIDNEY: A calculi size of 
3 mm seen 
P: 62% DEPOSITS: LEFT KIDNEY: Normal, No 
calculus L: 32% NAD L: 34% NAD 
E: 6% UB:  Normal E: 4% UB: Normal 
ESR: ½ hr – 7 mm      
ESR: 1 hr – 13 mm 
ESR: ½ hr – 9 mm      
ESR: 1 hr – 19 mm 
Hb: 78% IMPRESSION: Bilateral Renel 
Calculus 
Hb: 76% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 150 mgs%  SUGAR: 96 mgs% 
UREA: 19 mgs% UREA: 18 mgs% 
O.P No: 67274 NAME: Mr. Oli muthu AGE/SEX: 30 / M FROM: 31.08.2012 TO: 05.10.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micturition 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8800 cells/cum ALBUMIN: Trace RIGHT KIDNEY: 4 mm calculus 
is seen 
TC: 8000 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:60% DEPOSITS:  LEFT KIDNEY: Normal P: 60% DEPOSITS:  LEFT KIDNEY: Normal 
L: 37% Few pus cells L: 34% NAD 
E: 3% UB: Normal E: 6% UB: Normal 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 22 mm 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 20 mm 
Hb: 65% IMPRESSION: Rt UC is seen Hb: 65% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 97 mgs% SUGAR: 92 mgs% 
UREA: 22 mgs% UREA: 22 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 67273 NAME: Mr. Ananda perumal AGE/SEX: 21 / M FROM: 31.08.2012 TO: 05.10.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition, Haematuria since 7 days 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 8200 cells ALBUMIN: Trace RIGHT KIDNEY:  A calculi size 
of 5 mm seen 
TC: 8300 cells / cum ALBUMIN: NIL RIGHT KIDNEY: Normal, No 
calculus DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 50% DEPOSITS: LEFT KIDNEY: Normal P: 60% DEPOSITS: LEFT KIDNEY: Normal 
L: 48% 3-4 Epi cells L: 38% NAD 
E: 2% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 20 mm 
ESR: ½ hr – 12 mm      
ESR: 1 hr – 24 mm 
Hb: 70% IMPRESSION: Rt Renel 
Calculus 
Hb: 70% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 115 mgs%  SUGAR: 104 mgs% 
UREA: 20 mgs% UREA: 18 mgs% 
O.P No: 67106 NAME: Mr. Iyyapan AGE/SEX: 45 / M FROM: 30.08.2012 TO: 04.10.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition since 20 days 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 9100 cells/cum ALBUMIN: Trace RIGHT KIDNEY: 6 mm calculus 
is seen 
TC: 9200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 2 mm calculus 
is seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P:56% DEPOSITS:  LEFT KIDNEY: 6 mm calculus 
is seen 
P: 56% DEPOSITS:  LEFT KIDNEY: 2 mm calculus 
is seen L: 42% NAD L: 41% NAD 
E: 2% UB: Normal E: 3% UB: Normal 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 6 mm 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 6 mm 
Hb: 78% IMPRESSION: Bilateral Renel 
calculus  
Hb: 78% IMPRESSION: Bilateral RC 
OBSERVATION: Fair response SUGAR: 75 mgs% SUGAR: 97 mgs% 
UREA: 26 mgs% UREA: 26 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 71801 NAME: Miss. Fathima AGE/SEX: 21 / F FROM: 13.09.2012 TO: 18.10.2012 
COMPAINTS AND DURATION: Loin pain, burning micturition since 2 yrs 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 8700 cells ALBUMIN: NIL RIGHT KIDNEY: Normal TC: 8900 cells / cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 50% DEPOSITS: LEFT KIDNEY: A calculi size of 
6 mm seen 
P: 60% DEPOSITS: LEFT KIDNEY: Normal, No 
calculus L: 48% 3-5 pus cells L: 38% NAD 
E: 2% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 6 mm 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 7 mm 
Hb: 78% IMPRESSION: Lt Renel 
Calculus 
Hb: 79% IMPRESSION: Normal study 
OBSERVATION: Good 
Response 
SUGAR: 75 mgs%  SUGAR: 80 mgs% 
UREA: 26 mgs% UREA: 20 mgs% 
O.P No: 78333 NAME: Mrs. Gandhi AGE/SEX: 37 / F FROM: 03.10.2012 TO: 07.11.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micturition since 2 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 9200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 7 mm calculus 
is seen 
TC: 9300 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 7 mm calculus 
is seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P:48% DEPOSITS:  LEFT KIDNEY: Normal P: 56% DEPOSITS:  LEFT KIDNEY: Normal 
L: 48% NAD L: 42% NAD 
E: 2% UB: Normal E: 2% UB: Normal 
ESR: ½ hr – 16 mm      
ESR: 1 hr – 32 mm 
ESR: ½ hr – 10 mm      
ESR: 1 hr – 20 mm 
Hb: 78% IMPRESSION: Rt Urethral 
calculus 
Hb: 79% IMPRESSION:  Rt Urethral 
calculus 
OBSERVATION: Poor response 
SUGAR: 108 mgs% SUGAR: 99 mgs% 
UREA: 20 mgs% UREA: 19 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 78800 NAME: Mr. Krishnan AGE/SEX: 47 / M FROM: 04.10.2012 TO: 08.11.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micturition 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 8200 cells ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 10 mm seen 
TC: 8400 cells / cum ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 3 mm seen DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 62% DEPOSITS: LEFT KIDNEY: A calculi size of 
10 mm seen 
P: 64% DEPOSITS: LEFT KIDNEY:  A calculi size of 
3mm seen L: 36% 5-10 pus cells L: 34% NAD 
E: 2% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 12 mm      
ESR: 1 hr – 24 mm 
ESR: ½ hr – 15 mm      
ESR: 1 hr – 30 mm 
Hb: 64% IMPRESSION: Bilateral Renal 
Calculus 
Hb: 80% IMPRESSION:  Bilateral Renal 
Calculus 
OBSERVATION: Fair Response 
SUGAR: 110 mgs%  SUGAR: 92 mgs% 
UREA: 25 mgs% UREA: 16 mgs% 
O.P No: 79352 NAME: Mr. Chokkalingam AGE/SEX: 75 / M FROM: 06.10.2012 TO: 10.11.2012 
COMPAINTS AND DURATION: Loin pain in right region for 2 yrs, burning micturition 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 9000 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 4.8 mm 
calculus is seen 
TC: 9200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:60% DEPOSITS:  LEFT KIDNEY: Normal P: 62% DEPOSITS:  LEFT KIDNEY: Normal 
L: 36% 2-3 pus cells L: 34% NAD 
E: 4% UB: Normal E: 4% UB: Normal 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 48 mm 
Hb: 78% IMPRESSION: Rt Renel 
calculus  
Hb: 79% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 96 mgs% SUGAR: 100 mgs% 
UREA: 22 mgs% UREA: 20 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 84857 NAME: Mr.Murugesan AGE/SEX: 38 / M FROM: 24.10.2012 TO: 28.11.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micturition 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 9100 cells ALBUMIN: Trace RIGHT KIDNEY:  A calculi size 
of 4 mm seen 
TC: 9200 cells / cum ALBUMIN: NIL RIGHT KIDNEY:  Normal, no 
calculi seen DC:  SUGAR: + DC:  SUGAR: NIL 
P: 55% DEPOSITS: LEFT KIDNEY: A calculi size of 
4 mm seen 
P: 62% DEPOSITS: LEFT KIDNEY:   Normal, no 
calculi seen L: 42% 5-10 pus cells L: 35% NAD 
E: 3% UB:  Normal E: 3% UB: Normal 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 11 mm 
ESR: ½ hr – 8 mm      
ESR: 1 hr – 12 mm 
Hb: 73% IMPRESSION: Bilateral Renal 
Calculus 
Hb: 72% IMPRESSION:  Normal study 
OBSERVATION: Good 
Response 
SUGAR: 283 mgs%  SUGAR: 195 mgs% 
UREA: 24 mgs% UREA: 23 mgs% 
O.P No: 88386 NAME: Mr. Mahesh AGE/SEX: 18 / M FROM: 05.11.2012 TO: 10.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin since 25 days 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal TC: 8000 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:62% DEPOSITS:  LEFT KIDNEY: 3.2 mm calculus 
is seen 
P: 60% DEPOSITS:  LEFT KIDNEY: Normal 
L: 32% 2-3 epi cells L: 38% NAD 
E: 6% UB: Normal E: 2% UB: Normal 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 6 mm 
Hb: 76% IMPRESSION: Lt Renel 
calculus  
Hb: 76% IMPRESSION: Normal study 
OBSERVATION: Good 
response 
SUGAR: 90 mgs% SUGAR: 112 mgs% 
UREA: 23 mgs% UREA: 21 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 89043 NAME: Mrs.Shahilsa AGE/SEX: 40 / F FROM: 06.11.2012 TO: 12.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micturition since 3 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 8900 cells ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 9.4 mm seen 
TC: 8000 cells/cum ALBUMIN: NIL RIGHT KIDNEY:   A calculi size 
of 5 mm seen DC:  SUGAR: + DC:  SUGAR: NIL 
P: 49% DEPOSITS: LEFT KIDNEY: Normal P: 60% DEPOSITS: LEFT KIDNEY:   Normal 
L: 48% NAD L: 38% NAD 
E: 3% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 7 mm 
Hb: 61% IMPRESSION: Rt Urethral 
calculus 
Hb: 61% IMPRESSION:   Rt Urethral 
calculus 
OBSERVATION: FairResponse 
SUGAR: 278 mgs%  SUGAR: 242 mgs% 
UREA: 31 mgs% UREA: 31 mgs% 
O.P No: 89898 NAME: Mrs. Stella AGE/SEX: 38 / F FROM: 08.11.2012 TO: 13.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micurination since 8 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8500 cells/cum ALBUMIN: Trace RIGHT KIDNEY: 8 mm calculus 
is seen 
TC: 8600 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 2.4 mm 
calculus is seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P:62% DEPOSITS:  LEFT KIDNEY: Normal P: 64% DEPOSITS:  LEFT KIDNEY: Normal 
L: 34% 3-5 pus cells L: 34% NAD 
E: 4% UB: Normal E: 2% UB: Normal 
ESR: ½ hr – 12 mm      
ESR: 1 hr – 20 mm 
ESR: ½ hr – 8 mm      
ESR: 1 hr – 16 mm 
Hb: 72% IMPRESSION: Lt Renel 
calculus  
Hb: 72% IMPRESSION:  Lt Renel 
calculus 
OBSERVATION: Fair response 
SUGAR: 162 mgs% SUGAR: 143 mgs% 
UREA: 22 mgs% UREA: 21 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 90360 NAME: Mrs. Fathima AGE/SEX: 30 / F FROM: 09.11.2012 TO: 14.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, difficulty in  micturition since 6 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 9100 cells ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 6 mm seen 
TC: 9200 cells/cum ALBUMIN: NIL RIGHT KIDNEY:    Normal 
DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 68% DEPOSITS: LEFT KIDNEY:  A calculi size of 
6 mm seen 
P: 65% DEPOSITS: LEFT KIDNEY:   Normal 
L: 30% 5-7 pus cells L: 33% NAD 
E: 2% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 10 mm 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
Hb: 82% IMPRESSION: Bilateral renal 
calculus 
Hb: 83% IMPRESSION:   Normal study 
OBSERVATION: Good 
Response 
SUGAR: 97 mgs%  SUGAR: 72 mgs% 
UREA: 23 mgs% UREA: 22 mgs% 
O.P No: 90354 NAME: Mrs. Kamatchi AGE/SEX: 50 / F FROM: 09.11.2012 TO: 21.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micurination since 5 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8700 cells/cum ALBUMIN: Trace RIGHT KIDNEY: 10.4 mm 
calculus is seen 
TC: 8800 cells/cum ALBUMIN: NIL RIGHT KIDNEY:5 mm calculus 
is seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P:62% DEPOSITS:  LEFT KIDNEY: Normal P: 63% DEPOSITS:  LEFT KIDNEY: Normal 
L: 34% 3-5 epi cells L: 33% NAD 
E: 4% UB: Normal E: 4% UB: Normal 
ESR: ½ hr – 6 mm      
ESR: 1 hr – 10 mm 
ESR: ½ hr – 5 mm      
ESR: 1 hr – 8 mm 
Hb: 79% IMPRESSION: Rt Renel and 
vesicle calculus  
Hb: 80% IMPRESSION:   Rt Renel and 
vesicle calculus 
OBSERVATION: Fair response 
SUGAR: 111 mgs% SUGAR: 81 mgs% 
UREA: 20 mgs% UREA: 19 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 98493 NAME: Mrs. Selvakumaran AGE/SEX: 29 / M FROM: 09.11.2012 TO: 24.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, difficulty in  micturition since 2 1/2 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 7200 cells ALBUMIN: NIL RIGHT KIDNEY:  A calculi size 
of 3.2 mm seen 
TC: 9500 cells/cum ALBUMIN: NIL RIGHT KIDNEY:    Normal 
DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 68% DEPOSITS: LEFT KIDNEY:  Normal P: 65% DEPOSITS: LEFT KIDNEY:   Normal 
L: 38% 5-7 pus cells L: 33% NAD 
E: 4% UB:  Normal E: 2% UB: Normal 
ESR: ½ hr – 8 mm      
ESR: 1 hr – 15 mm 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 6 mm 
Hb: 83% IMPRESSION: Right  renal 
calculus 
Hb: 86% IMPRESSION:   Normal study 
OBSERVATION: Good 
Response 
SUGAR: 188 mgs%  SUGAR: 82 mgs% 
UREA: 21 mgs% UREA: 17 mgs% 
O.P No: 93579 NAME: Mr. Kanagaraj AGE/SEX: 42 / F FROM: 19.11.2012 TO: 24.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micurination since 5 ½ months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 9400 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 4.2 mm 
calculus is seen 
TC: 9300 cells/cum ALBUMIN: NIL RIGHT KIDNEY:Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:67% DEPOSITS:  LEFT KIDNEY: Normal P: 63% DEPOSITS:  LEFT KIDNEY: Normal 
L: 31% NAD L: 33% NAD 
E: 2% UB: Normal E: 4% UB: Normal 
ESR: ½ hr – 2 mm      
ESR: 1 hr – 4 mm 
ESR: ½ hr – 1 mm      
ESR: 1 hr – 2 mm 
Hb: 85% IMPRESSION: Rt Renel and 
vesicle calculus  
Hb: 82% IMPRESSION:   Normal study 
OBSERVATION: Good 
response 
SUGAR: 79 mgs% SUGAR: 81 mgs% 
UREA: 18 mgs% UREA: 19 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 94125 NAME: Mrs. Ethil betty AGE/SEX: 36 / F FROM: 20.11.2012 TO: 26.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin in left side, difficulty in  micturition since 9 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 7000 cells ALBUMIN: NIL RIGHT KIDNEY:  Normal TC: 7100 cells/cum ALBUMIN: NIL RIGHT KIDNEY:    Normal 
DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 55% DEPOSITS: LEFT KIDNEY:  5.7 mm 
calculus is seen 
P: 58% DEPOSITS: LEFT KIDNEY:   Normal 
L: 36% NAD L: 38% NAD 
E: 9% UB:  Normal E: 4% UB: Normal 
ESR: ½ hr – 2 mm      
ESR: 1 hr – 4 mm 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 6 mm 
Hb: 80% IMPRESSION: Lt renal calculus Hb: 82% IMPRESSION:   Normal study 
OBSERVATION: Good 
Response 
SUGAR: 68 mgs%  SUGAR: 78 mgs% 
UREA: 16 mgs% UREA: 15 mgs% 
O.P No: 94129 NAME: Mr. Durai AGE/SEX: 38 / M FROM: 20.11.2012 TO: 25.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micurination since one year 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8000 cells/cum ALBUMIN: NIL RIGHT KIDNEY: Normal TC: 8200 cells/cum ALBUMIN: NIL RIGHT KIDNEY:Normal 
DC: SUGAR: NIL DC:  SUGAR: NIL 
P:62% DEPOSITS:  LEFT KIDNEY: 8 mm calculus I 
seen 
P: 65% DEPOSITS:  LEFT KIDNEY: 2 mm calculus I 
seen L: 30% NAD L: 34% NAD 
E: 8% UB: Normal E: 1% UB: Normal 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 5 mm 
Hb: 85% IMPRESSION: Lt Renel and 
vesicle calculus  
Hb: 87% IMPRESSION:    Lt Renel and 
vesicle calculus 
OBSERVATION: Fair response 
SUGAR: 74 mgs% SUGAR: 92 mgs% 
UREA: 18 mgs% UREA: 16 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 94130 NAME: Mrs. Rukmani AGE/SEX: 36 / F FROM: 20.11.2012 TO: 25.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin since 6 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 8400 cells ALBUMIN: Trace RIGHT KIDNEY:  10.3 mm 
calculus is seen 
TC: 8500 cells/cum ALBUMIN: NIL RIGHT KIDNEY:    3.1 mm 
calculus is seen DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 59% DEPOSITS: LEFT KIDNEY:  10.3 mm 
calculus is seen 
P: 62% DEPOSITS: LEFT KIDNEY:   3.1 mm 
calculus is seen L: 31% 1-3 pus cells L: 33% NAD 
E: 10% UB:  Normal E: 5% UB: Normal 
ESR: ½ hr – 12 mm      
ESR: 1 hr – 24 mm 
ESR: ½ hr – 9 mm      
ESR: 1 hr – 18 mm 
Hb: 76% IMPRESSION: Bilateral  renal 
calculus 
Hb: 78% IMPRESSION:    Bilateral  
renal calculus 
OBSERVATION: Fair Response 
SUGAR: 158 mgs%  SUGAR: 109 mgs% 
UREA: 27 mgs% UREA: 26 mgs% 
O.P No: 94540 NAME: Mrs. Mumtaz AGE/SEX: 37 / F FROM: 21.11.2012 TO: 26.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micurination since 5 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8000 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 7.6 mm 
calculus I seen 
TC: 8200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 2 mm calculus 
I seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P:62% DEPOSITS:  LEFT KIDNEY: Normal P: 65% DEPOSITS:  LEFT KIDNEY: Normal 
L: 30% NAD L: 34% NAD 
E: 8% UB: Normal E: 1% UB: Normal 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 5 mm 
Hb: 85% IMPRESSION: Lt Renel and 
vesicle calculus  
Hb: 87% IMPRESSION:    Rt Renal 
calculus 
OBSERVATION:Goodresponse 
SUGAR: 74 mgs% SUGAR: 92 mgs% 
UREA: 18 mgs% UREA: 16 mgs% 
 DRUG: VEDIUPPU CHENDHURAM       DIAGNOSIS: KALLADAIPPU 
 
 
O.P No: 94547 NAME: Mr. Chellapandian AGE/SEX: 45 / M FROM: 21.11.2012 TO: 26.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin since 8 ½  months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM – ABDOMEN 
TC: 9200 cells ALBUMIN: Trace RIGHT KIDNEY:  Normal TC: 8900 cells/cum ALBUMIN: NIL RIGHT KIDNEY:    Normal 
DC:  SUGAR: NIL DC:  SUGAR: NIL 
P: 58% DEPOSITS: LEFT KIDNEY:  Normal P: 60% DEPOSITS: LEFT KIDNEY:   Normal 
L: 34% 1-3 pus cells L: 36% NAD 
E: 8% UB:  9.4 mm calculus is seen E: 4% UB:  3 mm calculus is seen 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
ESR: ½ hr – 8 mm      
ESR: 1 hr – 17 mm 
Hb: 80% IMPRESSION: Vesicle calculus Hb: 82% IMPRESSION:     Vesicle 
calculus 
OBSERVATION: Fair Response 
SUGAR: 90 mgs%  SUGAR: 95 mgs% 
UREA: 25 mgs% UREA: 23 mgs% 
O.P No: 94550 NAME: Mr. Murugaiah AGE/SEX: 34 / M FROM: 21.11.2012 TO: 26.12.2012 
COMPAINTS AND DURATION: Loin pain radiating to groin, burning micurination since 3 months 
INVESTIGATIONS 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE ULTRASONOGRAM - ABDOMEN BLOOD URINE ULTRASONOGRAM - ABDOMEN 
TC: 8000 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 10 mm 
calculus I seen 
TC: 8200 cells/cum ALBUMIN: NIL RIGHT KIDNEY: 4.2 mm 
calculus I seen DC: SUGAR: NIL DC:  SUGAR: NIL 
P:60% DEPOSITS:  LEFT KIDNEY: Normal P: 65% DEPOSITS:  LEFT KIDNEY: Normal 
L: 38% NAD L: 34% NAD 
E: 2% UB: Normal E: 1% UB: Normal 
ESR: ½ hr – 4 mm      
ESR: 1 hr – 8 mm 
ESR: ½ hr – 3 mm      
ESR: 1 hr – 5 mm 
Hb: 89% IMPRESSION: Rt Renel 
calculus  
Hb: 87% IMPRESSION:    Rt Renal 
calculus 
OBSERVATION:Goodresponse 
SUGAR: 72 mgs% SUGAR: 92 mgs% 
UREA: 16 mgs% UREA: 16 mgs% 
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
Name Mr.RADHAKRISHNAN Age : 56 Sex : M Ward :  PGII I.P.No : 2009 Occupation : Collie 
Date of Admission : 21.06.2012 . Date of Discharge : 21.07.2012    
Drug :  VENNOCHI ILAI CHOORANAM1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration, 
breathlessness tightness of 
chest since 3 months. 
BLOOD  BLOOD  
TC  - 8900cells/cu.mm TC        9600Cells/cu.mm 
DC   P  - 60% L - 35% E- 5% DC   P -  59% L - 39% E - 2% 
ESR ½ hr - 6mm 1 hr - 12mm ESR ½ hr - 4mm 1 hr - 8mm 
Hb  72% Hb  81% 
Diet  
 
Mixed diet  
Bl.Sugar(R) 100mgs% Bl.Sugar(R) 98     mgs% 
Bl. Urea 29 mgs% Bl. Urea 33      mgs% 
Serum Cholesterol 186 mgs% Serum Cholesterol     198 mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
 History of allergy present  
Sugar   Nil Sugar   Nil 
Deposits    Occ pus cells Deposits    NAD 
PEFR 100 Lits/min PEFR 320 Lits/min 
CHEST X – RAY Normal  
RESPONSE Good, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days      1 3 6 9 12 15 18 21 25 30  
Cough P P P P P R R R A A  
Breathlessness         ++ ++ ++ ++ ++ + + + + A  
Sputum 
Colour W W W W W W W W W -  
Quantity 5ml 10ml 10ml 15ml 15ml 10ml 10ml 5ml 2ml A  
Rhonchi  ++ ++ ++ ++ ++ + + + A A  
RR  28/min 28/min 26/min 24/min 23/min 22/min 22/min 20/min 19/min 18/min  
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
 
Name MRS.POILLAMMAL Age : 60 Sex : F Ward :  PGII I.P.No : 2102 Occupation : Coolie 
Date of Admission : 28.06.2012 Date of Discharge : 30.07.2012    
Drug : VENNOCHI ILAI CHOORANAM 1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration, 
difficulty in breathing, tightness 
of chest since 6 months. 
BLOOD  BLOOD  
TC  - 8500cells/cu.mm TC       8900 Cells/cu.mm 
DC   P  - 64% L - 30% E- 6% DC   P -  66% L - 31% E - 3% 
ESR ½ hr - 9mm 1 hr - 20mm ESR ½ hr - 4mm 1 hr - 10mm 
Hb  68% Hb  72 % 
Diet  
 
Mixed diet  
Bl.Sugar(R) 95 mgs% Bl.Sugar(R) 100mgs% 
Bl. Urea 21mgs% Bl. Urea 19 mgs% 
Serum Cholesterol 157 mgs% Serum Cholesterol 167mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
         History of allergy present 
Sugar   Nil Sugar   Nil 
Deposits    NAD Deposits    NAD 
 PEFR 140Lits/min PEFR 340 Lits/min 
CHEST X – RAY Normal  
RESPONSE Good, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days      1 3 6 9 12 15 18 21 25 35 45 
Cough P P P R R R A A A   
Breathlessness          ++ ++ ++ ++ + + + A A   
Sputum 
Colour W W W W W W - - -   
Quantity 5ml 5ml 20ml 20ml 15ml 10ml 5ml 1ml A   
Rhonchi  ++ ++ ++ ++ + + + + A   
RR  27/min 24/min 23/min 23/min 21/min 20/min 20/min 18/min 19/min   
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
Name MRS.VISALAKSHI Age : 48 Sex : F Ward :  PGII I.P.No :  Occupation : Coolie 
Date of Admission : 31.07.2012 Date of Discharge : 17.08.2012    
Drug : VENNOCHI ILAI CHOORANAM 1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration 
breathlessness, tightness of 
chest since 6  months 
BLOOD  BLOOD  
TC  - 8700cells/cu.mm TC        9200Cells/cu.mm 
DC   P  - 68% L - 28% E- 4% DC   P -  60% L - 39 % E - 1% 
ESR ½ hr - 5mm 1 hr - 8mm ESR ½ hr - 4mm 1 hr - 10 mm 
Hb  69% Hb  71 % 
Diet  
 
Mixed diet  
Bl.Sugar(R) 94 mgs% Bl.Sugar(R) 100 mgs% 
Bl. Urea 22mgs% Bl. Urea 20 mgs% 
Serum Cholesterol 158 mgs% Serum Cholesterol 165 mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
         History of allergy present  
Sugar   Nil Sugar   Nil 
Deposits    NAD Deposits    NAD 
PEFR 130 Lits/min PEFR 320 Lits/min 
CHEST X – RAY Normal  
RESPONSE Good, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days      1 3 6 9 12 15 18 21 25 35 45 
Cough P P P P R R R R A   
Breathlessness        +++ ++ ++ ++ + + + + A   
Sputum 
Colour W W W W W W W W -   
Quantity 10ml 15ml 15ml 10ml 10ml 5ml 5ml 4ml           2ml    
Rhonchi  +++ ++ ++ ++ ++ + + + +   
RR  24/min 24/min 24/min 23/min 23/min 12/min 20/min 19/min 18/min   
 
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
Name MR.VASANTAKUMAR  Age : 48 Sex : M Ward :  PGII I.P.No : 2580 Occupation : Farmer 
Date of Admission : 06.08.2012 Date of Discharge : 29.08.2012    
Drug : VENNOCHI ILAI CHOORANAM 1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration 
breathlessness, tightness of 
chest since 8 months 
BLOOD  BLOOD  
TC  - 8200cells/cu.mm TC      9700  Cells/cu.mm 
DC   P  - 64% L - 30% E- 6% DC   P -  60% L - 38% E - 2% 
ESR ½ hr - 12mm 1 hr - 28mm ESR ½ hr - 6mm 1 hr - 12mm 
Hb  68% Hb  69% 
Diet  
 
Mixed diet  
Bl.Sugar(R) 76 mgs% Bl.Sugar(R) 81mgs% 
Bl. Urea 31mgs% Bl. Urea 26 mgs% 
Serum Cholesterol 162 mgs% Serum Cholesterol 171  mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
         History of smoking  
present  
Sugar   Nil Sugar   Nil 
Deposits    2 to 4 epithelial cells  Deposits    NAD 
PEFR 120Lits/min PEFR 210 Lits/min 
CHEST X – RAY Bronchitis  
RESPONSE Fair, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days       1 3 6 9 12 15 18 21 25   
Cough P P P P R R R A A   
Breathlessness         ++ ++ ++ + + + + + +   
Sputum 
Colour W W W W W W W W W   
Quantity 10ml 15ml 15ml 20ml 20ml 20ml   15ml  10ml 10ml   
Rhonchi  ++ ++ ++ ++ ++ + + + +   
RR  25/min 25/min 24/min 24/min 23/min 23/min 22/min 22/min 20/min   
 
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
Name MRS.SARASWATHI Age : 45 Sex : F Ward :  PGII I.P.No : 2588 Occupation : coolie 
Date of Admission : 07.08.2011 Date of Discharge : 24.8.2012    
Drug : VENNOCHI ILAI CHOORANAM 1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration, 
breathlessness tightness of 
chest since 4months  
BLOOD  BLOOD  
TC  - 9100cells/cu.mm TC        9600Cells/cu.mm 
DC   P  - 61% L - 32% E- 7% DC   P -  70% L - 27% E - 3% 
ESR ½ hr - 5mm 1 hr - 10mm ESR ½ hr - 2mm 1 hr - 4mm 
Hb  70% Hb  73% 
Diet  
 
Mixed diet  
Bl.Sugar(R) 80 mgs% Bl.Sugar(R)     94mgs% 
Bl. Urea 21 mgs% Bl. Urea      24 mgs% 
Serum Cholesterol 157mgs% Serum Cholesterol 168 mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
         History of allergy  present  
Sugar   Nil Sugar   Nil 
Deposits    NAD Deposits    NAD 
PEFR 120 Lits/min PEFR 300 Lits/min 
CHEST X – RAY Normal  
RESPONSE Good, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days 1 3 6 9 12 15 18 21 25   
Cough P P P R R R A A A   
Breathlessness        +++ ++ ++ ++ + + + A A   
Sputum 
Colour W W W W W W - - -   
Quantity 5ml 15ml 20ml 20ml 15ml 10ml 5ml 2ml A   
Rhonchi  +++ ++ ++ ++ + + + A A   
RR  26/min 26/min 25/min 23/min 23/min 21/min 20/min 19/min 18/min   
 
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
Name MRS.PETCIAMMAL Age : 55 Sex : F Ward :  PGII I.P.No : 2802 Occupation : Coolie  
Date of Admission : 24.08.2012 Date of Discharge : 24.09.2012    
Drug : VENNOCHI ILAI CHOORANAM 1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration, 
tightness of chest 
breathlessness since 5months 
BLOOD  BLOOD  
TC  -  8200 cells/cu.mm TC -  8500 Cells/cu.mm 
DC   P  - 61% L - 34% E- 5% DC   P -  63% L - 36% E - 1% 
ESR ½ hr - 5mm 1 hr - 10mm ESR ½ hr - 3mm 1 hr - 7mm 
Hb  68% Hb  74% 
Diet  
 
Mixed diet  
Bl.Sugar(R) 94mgs% Bl.Sugar(R)  92mgs% 
Bl. Urea 25mgs% Bl. Urea 30  mgs% 
Serum Cholesterol 177 mgs% Serum Cholesterol 186     mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
         History of allergy present  
Sugar   Nil Sugar   Nil 
Deposits    NAD Deposits    NAD 
PEFR 90 Lits/min PEFR 320 Lits/min 
CHEST X – RAY Normal  
RESPONSE Good, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days       1 3 6 9 12 15 18 21 25 30  
Cough P P P R R R A A A A  
Breathlessness         ++ ++ ++ ++ + + + A A A  
Sputum 
Colour W W W W W W W A A A  
Quantity 15ml 10ml 12ml 15ml 10ml 5ml 2ml A - -  
Rhonchi  ++ ++ ++ + + + A A A A  
RR  28/min 28/min 26/min 26/min 25/min 25/min 20/min 19/min 19/min 19min  
 
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
Name MRS.CHELAKANI  Age : 49 Sex : F Ward :  PGII I.P.No : 3927 Occupation : coolie 
Date of Admission : 19.11.2011 Date of Discharge : 12.12.2012    
Drug : VENNOCHI ILAI CHOORANAM 1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration, 
breathlessness tightness of 
chest since 9 months  
BLOOD  BLOOD  
TC  - 9700cells/cu.mm TC  - 9900 Cells/cu.mm 
DC   P  - 70% L - 24% E- 6% DC   P -  71% L - 25% E - 4% 
ESR ½ hr - 10mm 1 hr - 20mm ESR ½ hr - 6mm 1 hr - 12mm 
Hb  68% Hb  70% 
Diet  
 
Mixed diet  
Bl.Sugar(R) 97mgs% Bl.Sugar(R) 88mgs% 
Bl. Urea 24mgs% Bl. Urea 29 mgs% 
Serum Cholesterol 177mgs% Serum Cholesterol 181  mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
   History of allergy present 
Sugar   Nil Sugar   Nil 
Deposits    NAD  Deposits    NAD 
PEFR 90Lits/min PEFR 220 Lits/min 
CHEST X – RAY Bronchitis  
RESPONSE Fair, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days       1 3 6 9 12 15 18 21 24   
Cough P P P P P R R R R   
Breathlessness          ++ ++ ++ ++ + + + + +   
Sputum 
Colour W W W W W W W W W   
Quantity 10ml 15ml 15ml 10ml 10ml 5ml 4ml 4ml 2ml   
Rhonchi  ++ ++ ++ ++ + + + + +   
RR  26/min 24/min 24/min 23/min 23/min 21/min 21/min 20/min 20/min   
 
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
Name MRS.MERIAMMAL Age : 60 Sex : F Ward :  PGII I.P.No : 3938 Occupation : Coolie 
Date of Admission : 20.11.2012 Date of Discharge : 19.12.2012    
Drug : VENNOCHI ILAI CHOORANAM 1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration, 
breathlessness tightness of 
chest since 5 months  
BLOOD  BLOOD  
TC  - 8700cells/cu.mm TC -   8800  Cells/cu.mm 
DC   P  - 69% L - 26% E- 8% DC   P -  68% L - 30% E - 2% 
ESR ½ hr - 10mm 1 hr - 20mm ESR ½ hr - 4mm 1 hr - 8mm 
Hb  68% Hb  76% 
Diet  
 
Mixed diet  
Bl.Sugar(R) 97 mgs% Bl.Sugar(R) 99 mgs% 
Bl. Urea 23 mgs% Bl. Urea 28mgs% 
Serum Cholesterol 167 mgs% Serum Cholesterol 170  mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
  History of  alllergy present  
Sugar   Nil Sugar   Nil 
Deposits    NAD Deposits    NAD 
PEFR 110 Lits/min PEFR 340 Lits/min 
CHEST X – RAY Bronchitis  
RESPONSE Good, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days        1 3 6 9 12 15 18 21 25 30 45 
Cough P P P R R R A A A A  
Breathlessness          ++ ++ ++ ++ + + + A A A  
Sputum 
Colour W W W W W W A A - -  
Quantity 5ml 10ml 10ml 15ml 15ml 10ml 5ml 1ml A A   
Rhonchi  ++ ++ ++ ++ + + + A A A  
RR  24/min 24/min 25/min 23/min 21/min 20/min 18/min 18/min 18/min 18/min  
 
IN-PATIENT 
 
P – Present  R – Reduced    A – Absent  W – Whitish  Y   Yellowish 
 
Good Response  :   Significant amelioration of signs & symptoms  Mild +  Moderate ++  Severe +++ 
Fair Response    :   Partial amelioration of signs and symptoms 
Poor response    :  In significant amelioration of signs and symptoms 
 
 
Name MRS MAHAMAIAMAL  Age : 50 Sex : F Ward :  PGII I.P.No : 4019 Occupation : Coolie  
Date of Admission : 03.11.2011 Date of Discharge : 01.12.2011 No.of Days Treated : 29  
Drug : Perunkanchori ver Chooranam 1gm bd a Day With Luke Warm Water Diagnosis Eraippu Erumal 
Complaints & Duration Investigations Before Treatment Investigations After Treatement 
Cough without expectoration, 
difficulty in breathing tightness of 
chest since 6months  
BLOOD  BLOOD  
TC  - 8300cells/cu.mm TC -    8700 Cells/cu.mm 
DC   P  - 54% L - 42% E- 4% DC   P -  50% L - 49% E - 1% 
ESR ½ hr - 4mm 1 hr - 8mm ESR ½ hr - 2mm 1 hr - 3mm 
Hb  69% Hb  70% 
Diet  
 
Mixed diet  
Bl.Sugar(R) 90mgs% Bl.Sugar(R) 95 mgs% 
Bl. Urea 20mgs% Bl. Urea 22 mgs% 
Serum Cholesterol 192mgs% Serum Cholesterol 197 mgs% 
URINE   URINE   
Albumin  Nil Albumin  Nil 
History 
 
         History of allergy present  
Sugar   Nil Sugar   Nil 
Deposits    NAD Deposits    NAD 
PEFR 150 Lits/min PEFR 370 Lits/min 
CHEST X – RAY Bronchitis  
RESPONSE Good, No adverse effect. SPUTUM FOR AFB Negative  
MANTOUX Negative  
Days       1 3 6 9 12 15 18 21 25   
Cough P P P R R R R A A   
Breathlessness          ++ ++ ++ + + + + + A   
Sputum 
Colour W W W W W W W W -   
Quantity 5ml 10ml 10ml 20ml 20ml 10ml 5ml 2ml A   
Rhonchi  ++ ++ ++ ++ + + + + A   
RR  25/min 25/min 24/min 23/min 23/min 23/min 22/min 19/min 18/min   
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BT P W P P 24 8000 64 38 8 8 12 70 96 22 143 NIL NIL NAD 280
AT A A A A 18 8400 66 32 2 4 8 72 98 24 150 NIL NIL NAD 350
BT P W P P 22 8700 60 35 5 10 15 65 82 23 153 NIL NIL FPC 290
AT A A A A 16 8900 65 34 1 5 7 69 90 18 164 NIL NIL NAD 340
BT P W P P 26 8200 53 39 8 5 10 70 86 17 185 NIL NIL NAD 190
AT A A A A 18 8500 56 40 4 3 6 72 88 19 163 NIL NIL NAD 320
BT P W P P 22 8800 58 38 4 2 5 68 75 23 170 NIL NIL FPC 280
AT A A A A 16 9200 62 34 2 3 6 72 84 18 188 NIL NIL NAD 340
BT P W P P 22 8200 59 35 6 10 12 69 92 18 160 NIL NIL NAD 180
AT A A A A 14 8100 58 39 3 4 8 74 85 20 182 NIL NIL NAD 182
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BT P W P P 24 7800 58 36 6 3 6 72 92 20 153 NIL NIL FPC 200
AT A A A A 18 8200 60 35 5 2 4 74 87 21 155 NIL NIL NAD 320
BT P W P P 20 9000 62 35 3 8 12 68 95 19 168 NIL NIL NAD 280
AT A A A A 14 9200 60 38 2 5 9 73 78 22 152 NIL NIL NAD 350
BT P W P P 22 8300 59 37 4 12 19 79 74 31 137 NIL NIL NAD 220
AT A A A A 16 8800 61 36 3 8 11 80 77 27 150 NIL NIL NAD 350
BT P W P P 26 7900 50 40 10 18 22 67 79 26 170 NIL NIL NAD 180
AT A A A A 22 8000 52 39 9 12 16 73 75 22 157 NIL NIL NAD 200
BT P W P P 22 8700 56 37 7 9 12 72 70 20 177 NIL NIL NAD 250
AT A A A A 17 8400 60 36 4 4 5 75 80 18 168 NIL NIL NAD 380
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sneezing
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without 
expectoration
02.08.2012 
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06.09.2012
6 55797
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Gandhimat
hi / F / 41
Cough without 
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BT P W P P 22 9000 64 31 5 5 9 68 98 30 153 NIL NIL NAD 200
AT A A A A 18 9200 68 29 3 4 6 70 90 29 140 NIL NIL NAD 320
BT P W P P 26 8600 58 31 11 11 21 69 89 32 160 NIL NIL FPC 180
AT A A A A 18 8700 63 30 7 8 10 71 90 31 162 NIL NIL NAD 340
BT P W P P 26 8900 59 37 4 7 14 78 75 28 129 NIL NIL NAD 150
AT A A A A 16 8800 61 36 3 3 9 76 80 32 148 NIL NIL NAD 320
BT P W P P 20 9200 65 30 5 8 16 71 81 27 179 NIL NIL NAD 220
AT A A A A 14 10000 64 33 3 5 8 74 83 25 164 NIL NIL NAD 350
BT P W P P 26 8200 57 35 8 13 20 65 88 23 128 NIL NIL NAD 280
AT A A A A 16 9000 60 35 5 9 15 73 90 18 113 NIL NIL NAD 360
23.08.2012 
to 
27.09.2012
Good
15 64154
Mr. 
Mahalinga
m / M / 48
Cough without 
expectoration, 
sneezing, 
breathlessness, 
chest tightness
21.08.2012 
to 
25.09.2012
Good
14 64810
Mr. 
Chandrabo
se / M / 53
Wheezing, chest 
tightness, Cough 
without 
expectoration
Good
Good
16.08.2012 
to 
20.09.2012
12 62819
Mr. 
Muthaiah 
/ M / 50
Cough without 
expectoration, 
breathlessness
11 60871
Mr. 
Ayyakutti / 
M / 65
Cough, 
breathlessness, 
chest tightness 
09.08.2012 
to 
13.09.2012
16.08.2012 
to 
27.09.2012
Good13 62919
Mrs. 
Kanniyam
mal / F / 
36
Cough, 
breathlessness, 
chest tightness, 
headache, 
sneezing
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BT P W P P 24 8800 64 32 4 9 13 68 90 22 160 NIL NIL NAD 190
AT A A A A 18 8900 69 30 1 5 9 75 89 25 170 NIL NIL NAD 320
BT P W P P 20 8000 63 32 5 4 8 69 78 18 165 NIL NIL NAD 200
AT A A A A 14 8500 68 30 2 3 5 71 74 22 151 NIL NIL NAD 350
BT P W P P 28 7300 56 38 6 15 33 78 75 21 174 NIL NIL FPC 180
AT A A A A 18 7700 59 39 2 10 18 76 83 23 156 NIL NIL NAD 250
BT P W P P 21 8100 55 39 6 7 12 74 79 19 171 NIL NIL NAD 280
AT A A A A 16 8500 59 37 4 5 10 75 71 21 162 NIL NIL NAD 350
BT P W P P 20 8200 60 35 5 10 15 72 80 22 150 NIL NIL NAD 180
AT A A A A 14 8800 59 38 3 5 9 71 83 20 155 NIL NIL NAD 340
13.10.2012 
to 
17.11.2012
Good20 81642
Mr. 
Muthuram
alingam / 
M / 37
Cough without 
expectoration, 
sneezing, 
breathlessness, 
chest tightness
03.10.2012 
to 
07.10.2012
Good
18 75566
19 78335
Mr. 
Pechiappa
n / M / 45
Wheezing, chest 
tightness, Cough 
without 
expectoration
Miss. 
Rama / 28 
/ F
Cough without 
expectoration, 
breathlessness
07.09.2012 
to 
02.10.2012
Good
12.09.2012 
to 
17.10.2012
Good
25.09.2012 
to 
30.10.2012
Fair
17 71217
Mrs. 
Kanmani / 
F / 40
Cough, 
breathlessness, 
chest tightness, 
headache, 
sneezing
16 69649
Mr. 
Janakiram
an / M / 40
Cough, 
breathlessness, 
chest tightness 
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BT P W P P 22 8200 60 32 8 7 12 68 70 19 170 NIL NIL NAD 180
AT A A A A 18 8300 62 35 3 4 8 69 81 21 160 NIL NIL NAD 320
BT P W P P 24 8600 60 32 8 6 10 76 84 23 168 NIL NIL NAD 190
AT A A A A 16 9000 62 35 3 3 5 75 87 26 175 NIL NIL NAD 350
BT P W P P 20 9000 65 30 3 4 6 68 71 28 159 NIL NIL FPC 240
AT A A A A 14 9300 62 37 1 2 3 72 74 24 162 NIL NIL NAD 350
BT P W P P 19 8700 55 40 5 4 10 63 70 22 189 NIL NIL NAD 180
AT A A A A 14 8900 59 38 3 2 6 67 73 25 170 NIL NIL NAD 340
BT P W P P 26 9500 62 35 3 5 11 68 77 19 167 NIL NIL NAD 180
AT A A A A 20 9800 62 36 2 3 7 70 79 22 170 NIL NIL NAD 220
03.11.2012 
to 
01.12.2012
Good
03.11.2012 
to 
01.12.2012
Fair25 87776
Mrs. 
Rosalin / F 
/ 36
Cough without 
expectoration, 
sneezing, 
breathlessness, 
chest tightness
24 87775
Mr. 
Mahalinga
m / M / 46
Wheezing, chest 
tightness, Cough 
without 
expectoration
25.10.2012 
to 
29.11.2012
Good
22 84952
23 84980
Mrs. 
Muthulaks
hmi / F / 
45
Cough without 
expectoration, 
breathlessness
Mr. 
Muthaiah 
/ M / 50
Cough, 
breathlessness, 
chest tightness, 
headache, 
sneezing
25.10.2012 
to 
29.11.2012
Good
25.10.2012 
to 
29.11.2012
Good
21 84937
Mrs. 
Subbuthai 
/ F / 32
Cough, 
breathlessness, 
chest tightness 
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BT P W P P 31 8800 65 29 6 18 35 70 81 24 165 NIL NIL NAD 90
AT A A A A 18 8200 66 32 2 9 10 71 85 19 180 NIL NIL NAD 200
BT P W P P 24 9100 58 36 4 7 10 69 79 20 170 NIL NIL NAD 180
AT A A A A 16 9000 60 37 3 3 5 75 83 22 180 NIL NIL NAD 340
BT P W P P 22 8500 55 38 7 5 8 70 81 22 160 NIL NIL FPC 90
AT A A A A 20 8700 59 37 4 3 4 72 84 18 175 NIL NIL NAD 180
BT P W P P 20 8200 63 33 4 6 8 69 77 23 170 NIL NIL NAD 160
AT A A A A 14 8000 59 37 2 4 6 71 84 21 180 NIL NIL NAD 350
BT P W P P 22 7900 60 34 7 20 35 68 81 25 175 NIL NIL NAD 180
AT A A A A 18 8200 59 39 2 8 15 70 82 20 180 NIL NIL NAD 300
BT P W P P 20 8100 50 35 6 10 12 70 81 25 171 NIL NIL NAD 110
AT A A A A 14 8400 61 37 4 4 8 72 84 20 180 NIL NIL NAD 340
12.12.2012 
to 
02.01.2013
Good
30 90359
31 99462
Mrs. 
Ranjitham 
/ F / 42
Cough, 
breathlessness, 
chest tightness, 
headache, 
sneezing
Mr. 
Sumsudee
n / M / 40
Cough without 
expectoration, 
sneezing, 
breathlessness, 
chest tightness
08.11.2012 
to 
13.12.2012
Fair
08.11.2012 
to 
13.12.2012
Good
09.11.2012 
to 
14.12.2012
Good
29 90077
Mrs. 
Seethalaks
hmi / F / 
48
Wheezing, chest 
tightness, Cough 
without 
expectoration
28 89847
Mrs. 
Rafiya 
Begham / 
F / 44
Cough without 
expectoration, 
breathlessness
06.11.2012 
to 
12.12.2012
Good
26 89014
27 89038
Mr. 
Govindan / 
M / 50
Cough, 
breathlessness, 
chest tightness, 
headache, 
sneezing
Mrs. 
Velammal 
/ F / 45
Cough, 
breathlessness, 
chest tightness 
06.11.2012 
to 
12.12.2012
Good
  
 
 
PIPER BETEL, Linn 
 
VERNACULAR NAMES: 
 
English : betel leaf 
Gujarati : paan 
Hindi : pan 
Kannada : panu 
Malay : se keh 
Tamil : vettrilai 
 
TAXONOMICAL CLASSIFICATION: 
  
 Kingdom : Plantae 
 Subkingdom : Tracheobionta 
 Superdivision : Spermatophyta 
 Division : Magnoliophyta 
 Class : Magnoliopsida 
 Subclass : Magnoliidae 
 Order : Piperales 
 Family : Piperaceae 
 Genus : Piper 
 Species : betel   
                                            A handbook to the flora of Natal / by J. Medley Wood 
 
HABIT – The betel plant is an evergreen and perennial creeper, with glossy heart-shaped                                      
leaves and white catkin. 
HABITAT – Mostly found in moist and hot climatic condition. In India, it is in found in 
Bihar, Bengal and South India.  
  
Parts used: leaves 
 
 
Leaves - cordate, alternate , Aromatic, dark green with entire margin, 
acuminate apex and unequal base with stout petiole.                               
The leaves are stimulant, antiseptic and sialogogue. Essential oil 
from leaves— antispasmodic, antiseptic. 
 
The Ayurvedics claim that the leaves are anthelminthic, aphrodisiac, 
carminative and laxative. They are also known to be stomachic and tonic. 
 
The Yunani regard the leaves as a styptic and a vulnerary. They prescribe it 
to improve the appetite and taste, to strengthen teeth and as tonic for the 
brain, heart and liver. 
 
CHEMICAL CONSTITUENTS: 
 
Leaves contain protein 3.1 %, carbohydrate 6.9 %, minerals 2.3 %, and tannins 2 
%. It contains calcium, phosphorus, iron, iodine and potassium is also present. 
Vitamin B, vitamin c and vitamin A. leaves contains bitter compounds that are 
about 0.7 to 2.6 %. It also contains an aromatic compound and stable oils like 
phenol and terpene. Besides this it contains eugenol, chavibetol and 
hydroxychavicol.,Allyl pyrocatecol,piper betol 
 
 
Effects of the active substance: 
 
 
 The juice of betel leaves is credited with diuretic properties. Its juice mixed 
with diluted milk and sweetend, slightly help in easing urination.  
 
The juice of a few betel leaves, with a teaspoon of honey will serve as a 
good tonic.The betel leaf has analgesic and cooling properties 
 
A mixture of onion and betel leaves juice can cure fungal infection.  
Eugenol in leaves prevent deadly fungus Candida albicans, anti-
convulsive, analgesic, anesthetic, relieving spasms in smooth muscles. 
 
Tannin  Present  in leaf is a astringent it is liver protective . 
 
  
International Journal of Pharmaceutical Research & 
Development, Vol 4,Chandra Vikash 
                       
LATERAL RESEARCH WORKS: 
 
 
Radio protective activity Mammalian systems if exposed to radiation can cause damaging 
effects leading to cell death and an increased risk of degenerative diseases. Recently the 
radioprotective property of ethanolic extract of P.betle leaves was studied as alternative 
low cost preventive medicine to synthetic radioprotectants which are reported to be toxic. 
The capacity of the extract in preventing g-ray induced lipid peroxidation and 
DNA damage in rat liver mitochondria were assessed and evaluated to establish the 
mechanism of its radioprotective action. The study revealed significant immunomodulatory 
and superior radical scavenging activities which may be due to the presence of phenolic 
bioactives such as chavibetol and allyl pyrocatechol 
Available online on www.ijprd.com 
 
 
Protective and healing activity Most recently, a study was undertaken to evaluate the 
protective and healing effects of allylpyrocatechol against the indomethacin- induced 
stomach ulceration in rat model. Results showed that allylpyrocatechol can protect 
indomethacin-induced gastric ulceration due to its antioxidative and mucin protecting 
properties [53] 
 
                                                     www.ijprd.com, International Journal of Pharmaceutical 
Research & Development 
Antibacterial activity: 
 
 The bioactive molecule thought to be responsible for 
antibacterial activity is sterol which has been obtained in 
large quantities  in piper betel extract .The mode of action  
is surface interaction of sterol  with the  primary structure of 
cell  wall membrane, ultimately leading to pore formation 
and degradation of bacterial component 
 
                 International Journal of Pharmacy and Pharmaceutical Sciences 
                            Vol 3, Suppl 3, 2011 
  
 
Anti inflammatory activity: 
 
  
Eugenol, one of the principal constituent of betel  shows to possess  anti 
inflammatory effects in various animal models of studies with various 
inflamogens (Dohi et al., 1989; Lee et al., 2007). 























